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The biomedical burden of large bone defects caused by trauma, infection, tumours or 
inherent genetic disorders remains a clinical challenge. Autologous bone or autograft 
continue to be the clinical “gold standard” for most effective bone regeneration, which is 
limited by bone supply and donor site morbidity. Thus, current synthetic substitutes need 
to be improved to match the performance of autografts. 
 
Bone tissue engineering is an attractive approach for regeneration of bone especially in 
relation to critical sized defects and a scaffold with osteoinductive properties and 
adequate mechanical properties is expected to enhance bone formation. The aim of the 
study is to enhance bone regeneration and the concept is based on adequate design of 
three dimensional scaffolds that mimic the structure of bone, which by virtue of its 
inherent properties have the ability to localise fluids rich in osteoinductive factors. 
The hydrogels and composites were all synthesized with a base polymer polyvinyl 
alcohol (PVA), which is both robust, biocompatible and FDA approved material. Facile 
methods of crosslinking such as air-drying and freeze-drying which introduces a level of 
porosity in the materials due to the lyophilisation process, were used to render the 
hydrogels insoluble, and conditions optimised to yield materials with properties suitable 
for soft bone tissue applications. 
 
PVA hydrogels were synthesized and characterised, results indicated that water uptake, 
glass transition and tensile strength were influenced by varying concentration of the 
polymer solution.  
A new type of dual network (DN) hydrogel composed of PVA and alginate was 
developed and optimised. Characterisations by spectral and thermal analysis, confirmed 
incorporation of alginate within the PVA network structure. Hydration dynamics and 
tensile properties, indicated that DN formed from a PVA base crosslinked by two freeze 
thaw cycles yielded tough hydrogels with controlled swelling, making them suitable for 
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soft tissue applications as well as the diversity of being further incorporated with ceramic 
fillers for the development of bone composite substitutes.  
Incorporation of bioglass® 45S5 within the polymeric network structure of the DN led to 
enhancement of the mechanical properties such as tensile strength and fracture 
toughness as well as imparting bioactivity within the hydrogel composites, which was 
demonstrated by the  development of hydroxy carbonated apatite on the surface and 
internal structure of the composites, this result was further corroborated by the increase 
in tensile strength and stiffness of the composites when placed in simulated body fluid 
over a period of 28 days. 
 
The second group of hydrogel composites was composed of a PVA fluid phase and 
calcium metaphosphate (CMP) ceramic phase, crosslinked by freeze drying. This 
hydrogel composite was developed to have a high mineral content with properties that 
closely resemble the properties of bone based on its inorganic/organic nanocomposite 
structure. Compression and water uptake behaviour of the composite could be 
modulated by varying concentration of PVA and the composite system properties were 
found to be suitable and lie within the range values for trabecular bone. 
 
In vitro cell culture tests were used to assess biocompatibility and the selected scaffolds 
were seeded with human osteoblast cells (HOB) and were evaluated by MTT, and live 
dead staining. All the systems were found to be biocompatible and cells were able to 
attach and proliferate within the scaffolds. Biofunctionality was assessed on the scaffolds 
which all showed a peak increase in alkaline phosphatase activity (ALP) at day 14, an 
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Chapter 1  
Introduction to thesis 
The musculoskeletal system of the human body acts as a scaffold providing mechanical 
support, protecting vital internal organs and, assisting in movement. The skeleton is 
composed of bones supported by ligaments, tendons, muscles and cartilage. Bone 
function includes storage of crucial nutrients, lipids and minerals, production of blood 
cells that nourish the body and play a vital role in protecting the body against infection, 
and storage of chemical energy.  Bone is highly dynamic and is constantly remodelling 
and changing shape to adapt to the daily forces which it incurs. It has remarkable 
regenerative properties with the capability of scar-less self-renewal. Bone cells and 
osteoid make up the organic component of bone, and hydroxyapatite (HA) the inorganic 
component [2]. Natural bone has elastic modulus and tensile strength in the ranges  0.05 
– 30 GPa and 10 – 150 MPa respectively, with properties dependent on its 
inorganic/organic nano-composite structure containing approximately 70% mineral (HA), 
22% proteins (type I collagen) ad 8% water by weight [3].  
 
Musculoskeletal disorders are the most common cause of severe long term pain and 
physical disability affecting hundreds of millions of people around the world.  There are 
more than 150 different musculoskeletal disorders which encompass a range of acute 
onset conditions to life-long disorders, some of which are accompanied by symptoms of 
pain and or inflammation and can involve limitation of motion, disability and even death 
[4, 5]. In some cases day to day functioning can be severely restricted due to 
significantly high levels of pain and limitation in movement which can result in serious 
complications such as pressure sores or increased infections. All these factors combined 
can lead to negative psychological developments due to potential deformity and 
consequential fears of failing or social interactions.   
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According to the World Health Organisation (W.H.O), skeletal trauma, violence and road 
traffic accidents are listed by  as the leading causes of disability and injury accounting for 
16% of the global burden of disease [6]. Trauma can result in large or critical bone size 
defects impairing revascularisation, leading to insufficient provision of nutrients and 
oxygen to the bone cells. This results in compromised bone healing, delayed union, mal-
union and non-union, thus leading to significant clinical problems. Non-union can also be 
associated with poor nutrition, pre-existing diseases such as diabetes, HIV and AIDS, 
cancer, poor and compromised blood supply, medication, and old-age due to decline in 
regenerative abilities such as in cases of osteoporosis,  inflammation and infection of the 
bone and surrounding tissue [3]. These are major health concerns with huge 
socioeconomic implications. 
 
Reconstruction of extensive bone defects still remains a technical challenge, bone 
grafting is often used to provide an osteoconductive, osteoinductive and osteogenic 
environment to promote bone healing and repair. Osteoconductive material is one that 
acts as a scaffold, supporting the attachment of osteoprogenitor cells and ingrowth of 
capillaries. Osteoinduction refers to the process where host mesenchymal stem cells are 
recruited from the surrounding tissues and differentiate into bone forming 
osteoprogenitor cells characterised by the presence of bone morphogenetic proteins 
(BMPs) and their growth factors.  Osteogenesis is the ability of the graft to produce new 
bone, and this process is dependent on the presence of live bone cells (i.e. 
osteoprogenitor cells) in the graft. Autografts remain the gold standard as they are 
histocompatible and non-immunogenic, and they offer essential components to achieve 
osteoinduction, osteogenesis and osteoconduction, all of the imperative properties 
required of a bone graft material. Allografts represent the second most common bone-
grafting technique, they are available in various forms including demineralised bone 
matrix (DBM), morselised and cancellous chips, cortico-cancellous and cortical grafts. 
Several studies have however highlighted considerable shortcomings, limitations and 
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complications of autologous and allogenic transplantations [7]. Reconstructive surgeries 
are still limited by the paucity of autologous materials available and donor site morbidity.  
The limitations in the application of autografts and allografts have necessitated research 
for alternatives and the development of synthetic bone graft substitutes.  Given the 
continuing research in this area, the understanding on the biological aspects of bone 
regeneration, tissue engineering and regenerative medicine has significantly improved 
the new knowledge created and presents an exciting platform and new prospects in 
addressing development of synthetic bone grafts, these developments give surgeons 
new options for restoring bone form and function.  
Bone tissue engineering focuses on alternative treatment options that will enhance bone 
repair and regeneration.  Ideally bone scaffolds should be biocompatible and closely 
mimic the natural bone extracellular matrix niche and should allow for sufficient 
vascularisation to meet the needs of the growing tissue. The philosophy of tissue 
engineering is to aim to develop synthetic materials that establish key interactions with 
cells in ways that unlock the body’s innate powers of organisation and self repair, as 
opposed to attempting to recreate complex living tissues ex vivo [8]. 
The purpose of the scaffold is to provide mechanical support and function as the 
extracellular matrix to facilitate cell infiltration, adhesion, and proliferation whilst enabling 
delivery of growth factors.  Synthetic, natural and decellularized tissues have been 
widely explored as scaffolds substitutes that have led to the development of several 
bone substitutes such as hydroxyapatite, β-tricalcium phosphate and bioactive glasses 
and composites thereof. Ceramic components enables mimicking the inorganic 
component of bone, it lacks the organic counterpart, which creates the adequate 
microenvironment for osteogenesis to take place. Thus, polymers including both natural 
and synthetic polymers such as Polyvinyl alcohol (PVA), polycaprolactone (PCL), 
poly(lactic-co-glycolic acid) (PLGA), poly(l-lactic acid) (PLLA), alginate (Alg), collagen 
(Col), gelatine (Gn), Chitosan, silk fibroin (SF) and glycosaminoglycans (GAGs) have 
been employed and studied [9-11]. A number of in vitro studies proved that using 
polymer gels of stiffness between 10s to 100s KPa, increased the potential of materials 
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to foster cell proliferation, migration and differentiation [12]. This has been attributed to 
the fact that hydrogels have some similarity to natural soft tissues due to their highly 
hydrated 3D structures that can resist dissolution in aqueous environment, and they 
have the advantage of relative ease of fabrication, with modifiable physicochemical 
properties and tailorable architecture [9]. Biocomposites have been developed from 
calcium phosphates, ceramics and polymers to balance out limitations of the individual 
ceramics and polymer phases. Examples of composites currently being investigated for 
bone and soft tissue engineering include but are not limited to chitosan in combination 
with nano hydroxyapatite (nHA) or bioactive glass [13, 14], Gelatine with bioactive glass 
[15], Alginate with β-TCP [16], silk fibroin with nHA [17], and PVA and biphasic calcium 
phosphate [18]. In most of the previous studies undertaken, different methods have been 
applied to assess cell attachment, proliferation and differentiation as well as the 
biomechanical function of the composites. However, recent studies have used 
orthobiologics and mechanobiology, and it is imperative that future research directions 
consider both approaches in order to provide an overlap in bone development as well as 
to respond to variations in the stiffness of bone as these are influenced by the type and 
anatomical location of different bone. 
Another important aspect in tissue engineering is the capability to translate research and 
technology innovations into the clinical field. Lessons learnt from the short history of 
industrial tissue engineering are that the provision of effective products is not in itself 
sufficient to ensure commercial success. Success in the market often depends on a 
combination of clinical performance marketing and cost effectiveness. It is important to 
identify the simplest functional performance required to resolve a defined clinical 
problem, as financial considerations dictate that the complexity of biomaterial designs be 
kept at a minimum because over engineering devices or materials may lead to unlikely 
and unsuccessful translations to clinical use [8]. 
 
The goal of this study was to design and fabricate hydrogel composite scaffolds with 
features to promote bone tissue regeneration with optimal trade-off between the 
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biological and mechanical criteria towards clinical translation. Translation requires that 
the process meets the FDA system requirements and hence reproducibility and ease of 
manufacture were important considerations.  The selection of biomaterials, process and 
design methods were aimed to decrease micro-motion in situ, enhance toughness, be 
conducive to entrapping growth factors, specifically platelet rich plasma and be 
applicable both as cell free and cell loaded scaffolds. In this study simple and facile 
methods were employed to crosslink and fabricate PVA hydrogels, and the key 
processing parameters were systematically varied and their influence on the architecture 
and mechanical features of the hydrogels was assessed. The most effective method of 
crosslinking of PVA was then employed in the next stage to create a composite with a 
high ratio of calcium metaphosphate (CMP) as the filler in order to decrease the rigidity 
of the CMP scaffold and further allow controlled expansion to closely fit the bone defect 
and enhance the clinical applicability towards a bone plug. However, PVA is brittle in 
nature, hence a toughening of this matrix was then studied using the analogy of double 
networks hydrogels and dual networks where tough interpenetrating dual networks of 
PVA and SA were developed. Therefore the dual network phase of development was 
carried out with the hypothesis that, by combining the two polymers, mechanical 
properties would be enhanced whilst lowering the swelling ratio, which would in turn 
improve cell attachment and proliferation on the surface and internal structure of the 
hydrogels. The dual network system was then further developed to form bone 
composites by incorporating fillers such as bioglass, which would enhance the 
mechanical properties, impart bioactivity to the hydrogels via apatite formation, 
enhancing biomaterial/host integration and the attachment of osteoblast cells. All 
developed composites were fully characterised and their biocompatibility determined. 
 
This thesis is divided into 7 chapters. Chapter 1 provides an introduction to the thesis 
whilst Chapter 2 highlights the literature review relevant to this study. Chapters 3, 4, 5 
and 6 are the experimental chapters. Each experimental chapter is comprised of an 
introduction with a mini review of the specific materials used for fabrication of scaffolds in 
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the respective chapter, followed by results, discussion and conclusion. Chapter 7 
presents an overall summary and future work.  
Chapter 3 describes the fabrication of PVA single network hydrogels which were fully 
characterised. The hydrogels were fabricated via simple methods of crosslinking i.e. 
freeze thawing, freeze thawing+air-drying and air-drying for three varying concentrations 
of PVA polymer at different concentration to identify an optimal processing route. 
Chapter 4 focusses on the fabrication of PVA and CMP composites via freeze drying. 
Varying concentrations of PVA were used in the development of the composites and 
these, were fully characterised. Selected composites on the basis of optimal properties 
were further assessed for biocompatibility and functionality, and the outcomes have been 
reported. 
Chapter 5 describes a study on the fabrication of dual networks. The dual networks were 
fabricated using PVA and sodium alginate and the processing parameters are described 
followed by their characterisation. Since the properties of the dual networks were 
deemed suitable for both wound dressings and drug delivery vehicles, a preliminary 
study on the ability of the dual networks to release vancomycin is reported and finally 
evaluation of biocompatibility of the hydrogels was assessed.  
Chapter 6 focusses on the development of dual network composites with Bioglass®, 
where non-porous and porous composites were developed and fully characterised. 
Bioactivity of the composites was also assessed with characterisation of the apatite 
formed on the surface of the composites. Biocompatibility of the hydrogel composites 
were assessed. 
Chapter 7 provides an overall discussion and conclusion of the study, which provides a 
platform for the potential benefits and applications of this biomedical engineering 





Chapter 2     
Literature review 
2.1 OVERVIEW   
There is a global demand for bone substitutes due to the prevalence of bone diseases 
encountered in the clinical environment, as well as trauma cases. Bone graft substitutes 
which are often incorporated during reconstructive procedures, improve the healing rates 
and provide a clinical response to pathologies such as degenerative diseases, congenital 
deformity, tumour and avascular necrosis [19].  In oral and maxillofacial treatment, dental 
implantation in the posterior maxilla often requires bone augmentation procedures, 
maxillary sinus grafting procedures have been performed with autografts or non-
autogenous grafting materials [20], bone augmentation is also required to reconstruct the 
alveolar ridge so as to provide a base sufficient for functional and aesthetic implants [21]. 
Osteoporosis as well as bone loss due to failed hip and knee replacements is 
increasingly becoming a major problem and this has been exacerbated by the increase 
in the number of joint replacements. The morbidity of fractures and the consequent 
delays in unions and non-unions remains a technical challenge to date [22]. Bone is 
reported to be the second most transplanted tissue in the world and a major financial 
burden to the world economies  [23]. The main contributory factors have been reported 
as accidents, bad health (obesity, diabetes), ageing population, infections and 
degenerative diseases.   
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Figure 2-1: [A,B,C,D] Clinical case showing the craniofacial scaffold applications for 
orbital floor fractures, using a mouldable medical grade polycaprolactone (mPCL) 
scaffold sheet. CT images show defect site (above) before surgery and clinical follow up 
2.5years (below) post-surgery. Adapted from Henkel et al [24].  
 
The reports on the incidence and prevalence of non-union vary significantly based on 
anatomic region and the criteria used to define non-union [25]. “In the UK, there are 
approximately 850 000 new fractures seen each year of which the majority heal without 
difficulty. Rates of non-union of 5–10% of fractures have been indicated, there is 
however insufficient data available to validate the estimates. The cost to the National 
Health Service (NHS) of treating non-union has been reported to range between £7000 
and £79 000 per person. However, this does not take into account the morbidity and loss 
of earnings of the individual nor any long-term health burden [26].” A 2012 comparative 
report  by Frost & Sullivan on the global investment in Tissue Engineering Research 
reported that the United States contributes 48.6%, while Europe contributes 40.2% of 
global market revenue to tissue engineering solutions and that the USA is the leading 
country dedicating 60% of the global tissue engineering expenditure to research and 
development (R&D), while the UK dedicates 8% [22]. 
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Figure 2-2: Frost & Sullivan analysis on countries leading in the area of tissue 
engineering, as represented by their revenue and R&D expenditure. Adapted from Liu et 
al [22]. 
 
2.2 BIOLOGY OF BONE 
Bone composition 
Bone tissue is comprised of two distinct structures being cortical and cancellous bone. 
Cortical bone (80%), is a dense and heavily calcified structure found at the surface and 
is responsible for the stability of the skeleton. Cancellous bone (20%) is found in deeper 
areas of the bone and is less heavily calcified with a greater surface area. The proportion 
of trabecular and cortical bone varies by skeletal site. The bone matrix is composed of 
70% inorganic components which include mineral hydroxy apatite, bicarbonate, 
potassium and magnesium ions and 30% of organic components such as collagen, 
proteins (22%) and water (8%). 
 
Figure 2-3: Hierarchical structure of human cortical bone. The structure of bone spans 
numerous length-scales from the macroscopic whole-bone structure to the nanoscale 
collagen and mineral components. Adapted from Zimmermann et al [27]. 
 
34 
This specialised connective tissue has 3 dominant types of cells being osteoblasts 
(mononuclear cells 15-30µm in size), osteocytes (15µm in length) and osteoclasts (large 
multi-nucleated). Osteoblasts synthesize and release organic material of bone i.e. 
collagen rich osteoid containing type I collagen and proteins such as osteopontin, 
osteocalcin, osteonectin, osteoprotegrin (OPG), bone morphogenetic proteins (BMPs), 
and glycoproteins, in which mineralisation occurs. Osteocytes are derivatives of 
terminally differentiated osteoblasts, they are the most abundant and are present in the 
lacunae within the mineralised matrix (calcified bone) as they develop from osteoblasts 
that are trapped in newly formed extracellular matrix. They are sensory cells in the bone 
for mechanotransduction, enabled by their interconnected 3 dimensional cellular 
network. Osteoclasts play a key role in bone resorption to maintain bone homeostasis 
[28, 29]. All these cells form an interconnected network allowing for communication and 
transport between the osteocytes deep within the tissue and the osteoblasts and 
osteoclasts located within the vicinity of vascular spaces and bone surfaces to which the 
loads are conveyed. The neighbouring osteoblasts and osteocytes are connected with 
numerous gap junctions that allow coordinated cellular activity, whereas the intracellular 
communication in the form of a calcium signal exists between osteoblasts and 
osteoclasts and among osteoclast via receptors  [28]. 
 
Biomechanics 
Tissues of the body have a wide range of mechanical properties, as bone, connective 
tissue, cartilage and epithelial tissue all have varying properties. Cartilage is reported to 
behave like a viscoelastic material, epithelial tissue behaves like a synthetic elastomer 
[30], and bone is said to exhibit a tough behaviour at low strain rates, attributed mostly to 
its hierarchical, as well as porous structure, which is able to stop crack propagation after 
small amounts of cracking. However bone fractures more like a brittle material at high 
strain rates [31]. The properties of compact, cancellous bone, and some soft tissues 
usually affected during bone injury are listed on Table 2-1. 
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Property Cortical bone Cancellous bone Cartilage Skin 
Compressive 
strength (MPa) 
100 - 230 2 - 12   
Tensile strength 
(MPa) 
50 - 150 10 - 20 9 - 40 1 – 20 
Strain to failure (%) 1 - 3 5 - 7 60 – 120 30 – 70 
Young’s modulus 
(GPa) 
7 - 30 0.5 - 0.05   
Table 2-1: Comparative table of mechanical properties of different tissue types. Adapted 
from Henkel et al [24]. 
 
Process of bone healing 
When bone is injured, the trauma  results in the interruption of skeletal integrity as well 
as disruption of vascular structures and nutrient flow in the bone leading to reduced 
oxygen tension and disruption of marrow architecture. The healing process to restore the 
tissue to its original physical and mechanical properties is influenced by a highly 
regulated multi stage process involving a variety of systemic and local factors. Bleeding, 
extracellular matrix, growth factors and stem cells are necessary factors that play a key 
role in the healing of fractured bone, their cellular and molecular components are present 
at elevated levels around the fracture site.  At the cellular level, there are inflammatory 
cells, vascular cells, osteochondral progenitors and osteoclasts. At molecular level pro-
inflammatory cytokines and growth factors, pro-osteogenic factors and angiogenic 
factors drive fracture repair [32]. There are two processes of healing; primary and 
secondary healing.  
Primary bone healing: This is mainly known to occur in cortical bone repair, it is 
initiated when bone fragment ends are aligned and fixed avoiding any relative 
movements at the fracture site. This allows osteoblasts to lay across the fracture lines 
and rebuild new bone oriented along the dominant mechanical loading direction [33]. 
Secondary bone healing: Secondary healing occurs when there is a remaining gap 
between the bone fragment ends and a complete anatomic reconstruction of the 
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displaced fragments is not possible. In this case healing occurs in three distinct but 
overlapping stages: 1) the early inflammatory stage 2) the repair stage and 3) the late 
remodelling stage. 
The inflammation stage begins the moment the bone is broken or injured, bleeding 
around the injured area leads to the formation of a haematoma during the first few hours 
and days. Inflammatory cells like granulocytes, macrophages, lymphocytes, monocytes, 
degranulating platelets and fibroblasts infiltrate the haematoma in-between the fracture. 
This helps combat infections as secreted cytokines such as tumour necrosis factor-alpha 
(TNF-α), and interleukin-1, -6, -11 and -18 (IL-1, -6, -11 and -18) lead to the recruitment 
of inflammatory cells which in turn recruit mesenchymal stem cells to the site of injury 
[29]. The clot eventually advances into a fibrous thrombus, leading to ingrowth of 
vascular tissue, and migration of mesenchymal cells. At this stage the exposed 
cancellous bone and muscle aid in providing nutrients and oxygen supply to the injured 
site. 
During the repair stage, intramembraneous ossification starts to consolidate the injured 
area in the periosteal regions distant of the fracture ends (due to sufficient provision of 
oxygen in that area), fibroblast cells that are present in the granulation tissue begin to 
form cartilage and fibrocartilage (endochondral ossification, occurring in hypoxic 
environment) [34]. The cartilage formed in this process is usually the primary tissue to 
bridge the fractured zone, which helps support vascular ingrowth, as the process is 
accompanied by trafficking of stem cells and progenitor cells with regenerative potential, 
and provides substantial stability to the bone fragments and reduces inter-fragmentary 
movement during healing. 
As vascular ingrowth progresses, a collagen matrix is laid down while osteoid is secreted 
and subsequently mineralized, which leads to the formation of a soft callus around the 
repair site. The callus remains quite weak to external stresses for around six weeks and 
eventually ossifies allowing for osteoblasts at the periosteum to begin laying down woven 
bone. The woven bone results in a callus that has a larger diameter than the original 
bone which in turn provides sufficient mechanical stability with an increased polar 
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moment of inertia against torsion and also withstanding bending loads. Due to the 
formation of the external callus, the internal callus becomes mineralised with calcium 
hydroxyapatite forming a hard callus of woven bone. 
 
Figure 2-4:  Schematic diagram illustrating consecutive phases of bone healing. Adapted 
from Pearson education [35]. 
 
In the final stage of remodelling the large fracture callus is replaced by secondary 
lamellar bone, restoring the size of the new bone to that of the original bone’s shape, 
structure and mechanical strength, accompanied by reversion of vascular supply to the 
normal state. This phase of remodelling occurs slowly over a period of months to years 
influenced by mechanical loads and stresses incurred on the bone, however it has been 





Disorders of bone union 
Severe trauma can result in open fractures with tissue devascularisation and bone loss 
and if a fracture or wound site is not healed after 4 months, it can be considered a 
delayed union. If no bony healing is obtained in 6 months after the fracture, it can be 
clinically considered as non-union [38]. Delayed union occurs when the fracture gap is 
more than 1mm, resulting in reduced blood supply or infection at the wound site. Non-
unions occur when there is a wide separation of bone ends resulting in soft tissue 
interposition, lack of blood supply, infection or an adverse biomechanical environment. 
The pathophysiology of non-unions has not been clearly established and consequently  a 
variety of patient attributes and lifestyle factors such as, age, sex, diabetes, use of 
medications such as corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs), 
smoking, excessive alcohol intake and poor nutrition, have been hypothesised to 
contribute to the development of complications encountered in bone healing [38]. Non-
union fractures can be categorised as being hypertrophic or atrophic non-unions 
presented in Figure 2-5.  
 
Figure 2-5: Types of non-unions, including avascular and vascular non-unions. Adapted 
from Liu et al [22]. 
 
Hypertrophic: It presents with a large broad vital callus that is inefficient to regenerate 
and form a bone union. The bone ends appear sclerotic and flared owing to excess 
callus formation, the non-union is also termed elephants foot due to its radiographic 
appearance. The gap between the bone ends is filled by cartilage and inefficient and 
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unstable fixation of the wound is attributed to multidirectional motion of the fracture 
fragments [39, 40].   
Atrophic: It presents with a wound site that has no attempt in healing, due to impaired 
biological support, damaged vascular supply, and the destruction of the periosteum and 
endosteum. The bone ends are usually resorbed and rounded, and in most cases 
associated with soft tissue damage accompanied by detraction of the surrounding 
tissues. The gap between the bone ends is often very wide, filled with fibrous tissue and 
can be classified as a critical sized bone defect [39, 40]. The treatment of atrophic bone 
non-unions requires a surgical intervention that will reduce fracture gap and allow for 
distribution of mechanical loads while allowing for introduction of new cells, vascular 
supply and healthy bone tissue formation in the fracture gap.  
 
2.3 BONE GRAFTS AND SUBSTITUTES 
Various forms of bone grafts are available and classified into 3 categories: autogenous 
bone, allografts and synthetic graft substitutes. 
Autografts (autogenous bone grafts): They are currently the gold standard for bone 
replacement and involves the harvesting of cortical or cancellous bone from the patient’s 
own donor site. The most common sites of sourcing the autograft is the anterior and 
posterior iliac crest of the pelvis. This form of grafting provides minimum immunological 
rejection and histocompatibility as the graft acts as an osteoconductive scaffold, 
providing osteoinduction from bone morphogenetic proteins (BMPs) and other growth 
factors, and also allowing osteogenesis of osteoprogenitor cells [41, 42]. This method 
has some disadvantages as the length of time for surgery is increased and complication 
due to second site morbidity. It is reported that the complication rates are within the 
range of 8.5-20% and this includes complications such as haematoma formation, blood 
loss, nerve injury, ureteral injury, fracture, pelvic instability as well as cosmetic defects. In 
addition, the amount of healthy bone that can be harvested from the patient at any one 
time also poses a major limitation [43]. 
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Although autografts are considered the ‘gold standard’, complications have been 
reported. A study published in 2013 where a cortico-cancellous block bone was grafted 
into the maxillary sinus, underwent a negative remodelling of its volume during the first 
period of healing. The authors argued that this was most likely due to graft resorption of 
the cortex, coupled with, primarily, an increase in the density of the spongious area [20]. 
A reduction of graft height after alveolar ridge reconstruction using iliac bone has also 
been reported [44], whereas calvarial bone grafts have been reported to have minimal 
bone resorption [45]. Graft resorption in extensive bone transplantation has been 
identified as a major concern and it presents a risk which can lead to insufficient bone 
regeneration and further complications [21]. 
Allografts (allogenic banked bone grafts):  Bone harvested from a different donor to 
that of the patient mainly referred to as cadaver from other humans. Cadaveric allograft 
bone is available in either cancellous, cortical forms or demineralised bone matrix 
(DBM). In the United Kingdom allografts are mainly used in arthroplasty and are sourced 
from osteo-arthritic femoral heads removed during total hip replacement [46]. Allogenic 
bone has been found to have both osteoinductive and osteoconductive properties, but 
due to sterilisation and purification procedures this is limited [47] due to absence of 
viable cells, which leads to lack of osteogenic properties. However, the advantages are 
that it is readily available in various shapes, form and sizes, and there is no donor site 
morbidity. Allografts are available in frozen and freeze dried forms, and can be sterilised 
using ethylene oxide, gamma-irradiation or autoclaving, however these processes 
reduce mechanical integrity and osteoinductive capabilities of the graft. These methods 
of sterilisation have also been reported to be ineffective towards prion proteins, including 
variant Creutzfeldt-Jakob disease, raising the possibility of iatrogenic transmission [46]. 
Other limitations include harvesting and conservation of the grafts, higher risk of rejection 
and it does not vascularise as well as autografts [42, 47]. A study on logistic regression 
analysis of existing foot and ankle fusion literature, suggested that patients treated with 
cancellous autograft, structural autograft, and cancellous allograft have odds of fusion 
equal with or better than those treated either without graft or with structural allograft [19]. 
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DBM is available in different forms such as powder, putty, crushed granules and gel filled 
syringes, and can be used alone or in combination with other materials such as 
allogeneic bone chips and calcium sulphate granules. DBM has been used in spinal 
infusions, healing of unicameral bone cysts, and treatment of long bone lesions and 
management of stiff non-unions. The osteoinductive ability of a particular DBM product is 
highly dependent on the type and specific preparation of bone used [48, 49]. 
Xenogenic: Harvested from non-human species usually of bovine origin, they are 
considered to carry the risk of transmitting zoonotic diseases as well as triggering certain 
immune responses [3, 50] despite the xenograft material being processed at very high 
temperatures (up to 1000°C) to remove all proteins. Systematic reviews have shown that  
bovine derived graft materials may carry risk of prion transmission to patients [51].  
Synthetic grafts: Grafts are synthesized and fabricated from natural or synthetically 
derived materials which do not originate from humans or animals. Research in this area 
was primarily aimed at counteracting disadvantages and limitations of the 
aforementioned bone graft substitutes by providing an osteoconductive framework for 
bone growth while eliminating risk of infection and disease transmissions. Synthetic 
grafts can be fabricated from various types of materials either individually or in 
combination to form composites. They can be designed to be bioactive, interact and 
integrate with biological tissue assisting in regeneration. A major advantage is that 
synthetic grafts can be designed and tailored to have specific degradation rates, 
mechanical properties as well as be incorporated with biological molecules and drugs, to 
improve osteoinduction, enhance regeneration and recovery time whilst drugs may be 
incorporated to counteract infections during healing. Synthetic bone grafts commonly 
comprise of; ceramics and glasses such as, calcium phosphates, hydroxyapatite, 
bioactive glass, and polymer or polymer composites. Biological polymers usually 
employed include collagen, gelatine, chitosan and hyaluronic acid, whilst synthetic 
polymers include polyfumarates, polylactic acid (PLA), polyglycolic acid (PGA), 
polycaprolactone, poly vinyl alcohol (PVA) and copolymers of PLA and PGA (PLGA). 
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Commercial bone grafts 
A review on bone graft substitutes currently available in orthopaedic practice identified a 
total of 59 bone graft substitutes marketed by 17 different companies in the United 
Kingdom [46]. However, internationally there are currently over 200 different bone grafts 
available, and many of the commercially available bone grafts have not been peer 
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and distal femur, 












✓ ✓ ✓ Approved for fusion 
with spinal cage, open 





60% to 80% 
porosity 
HA ✓  ✓ Tibial plateau, distal 
tibial, calcaneal, 
distal radial fractures 
and in bone 
tumour surgery 
Table 2-2: Summary of commercially available, currently used bone graft substitutes in 
orthopaedic practice. Adapted from Kurien et al [46]. 
 
A report on currently available bone grafts for implantation in the UK suggests that only 
Alpha-BSM, Cortoss, Norian SRS and Vitoss can be clinically considered as equal or 
superior to autografts [46]. Clinical trials on bone non-union augmentation with graft 
substitutes highlight  some of the limitations of current commercial grafts, for example; 
Ziran et al [52] reviewed 41 patients with various non-union treated with Allomatrix  
where they found a total of 20 patients (51%) developed post-operative drainage 
problems and 13 required debridement (removal of dead and damaged tissue), and the 
non-union persisted, with 11 developing deep infection. Similar problems have arisen 
when Osteoset was used in non-union surgery [53]; Chu and Shih recently described the 
treatment of 15 patients with non-union of the scaphoid using percutaneous fixation 
supplemented with GeneX, where union was confirmed in 14 patients (93%) at a mean 
of 15.3 weeks [46, 54]. More recently, a novel system for harvesting autologous 
intramedullary reamings as a bone graft from the canal of the femur or tibia called 
reamer-irrigator-aspirator (RIA), has been reported with emerging evidence that RIA 
possesses equivalent osteoconductive and vascular properties. Clinical evidence also 
suggests that larger volumes of graft can be obtained with RIA and that it causes less 
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harvest site morbidity and pain [55]. Thus, the current bone graft biomaterials tend to 
suffer from lack of integration with the host tissue, and in some cases bone formation is 
limited only to the ends of the grafts which again lead to non-union [56, 57]. In other 
cases late allograft graft fractures at ~10 years have been reported to be as high as 
60%, with 50% loss in bone strength [58]. 
 
2.4 BONE TISSUE ENGINEERING 
Strategies in design 
Bone tissue engineering (BTE) focusses on the development of alternative solutions for 
fracture repairs in order to improve and enhance the quality of clinical responses to bone 
grafting procedure. In addressing the challenges of BTE therapies, it is not only 
important to understand the underlying causes resulting in non-union repair but, it is also 
critical to understand the material properties of native tissue, as each tissue serves a 
specific function and purpose. Parameters such as hydration dynamics and material 
stiffness are known to provide substantial feedback in cell-scaffold interactions and 
dictate cell phenotype, it is therefore imperative that  these properties be understood and 
emulated for enhanced integration and  performance of the scaffold in its biological role. 
Scaffolds should be tailored for different types of bone and fracture sites and it is 
essential that their design should take into consideration the ease of manufacturing and 
clinical handling of the graft in the operating room. Requirements for an ideal scaffold 
should include the following; 
Biocompatibility: Can be defined as “the ability of a material to locally trigger and guide 
non-fibrotic wound healing, reconstruction and tissue integration” [59].  An ideal scaffold 
must be osteoconductive and osteoinductive. The osteoconductive properties provide a 
guide for newly forming bone by allowing bone cells to adhere, proliferate and form 
extracellular matrix on the surface and internal structure of the scaffold. This process 
supports normal cellular activity without being toxic on native tissue. The osteoinductivity 
induces bone formation through the recruitment and stimulation of progenitor cells and 
biomolecular signalling. 
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Mechanical properties: Mechanical properties and architecture of ideal bone substitute 
scaffolds should closely mimic those of the native tissue they are intended to augment, 
as proper load transfer is important. Inappropriate stiffness and material strength may 
result in consequential resorption of native bone tissue, which may severely impede the 
progression of bone repair, of which functional union repair may take up to several years 
[60, 61]. 
Porosity: There is a greater degree vascular infiltration, and faster rate of bone tissue 
ingrowth or apposition with percentage of porosity, as higher porosity is expected to 
enhance osteogenesis. Macropores (>100µm) are believed to favour cell migration and 
enhance bone ingrowth and osseointegration, whereas micropores (<5µm) results in 
larger surface area that is believed to contribute to higher bone inducing protein 
adsorption. An integral and essential property for scaffolds is interconnected porosity, 
which impacts ingrowth of new bone especially in long term tissue interface 
maintenance. Pore size should be at least 100μm in diameter for successful diffusion of 
essential nutrients and oxygen for cell survivability and at least > 300µm for improved 
osteogenesis, these values have been reported to be sufficient to support vascularisation 
and blood vessel invasion [62]. The pattern of bone ingrowth is reported to vary 
according to the scaffold architecture, this was demonstrated in a study where 
continuous bone-forming pattern was observed inwards of scaffolds with a random pore 
size, while scaffolds with pores of the same size but with solid walls led to the formation 
of discontinuous bone islets throughout the scaffold [63]. Even though porosity reduces 
the mechanical properties of scaffolds and increases the complexity for reproducible 
fabrication, studies have established that multi-scale porous scaffolds involving both 
micro and macro porosities can perform better than only macro porous scaffolds [64]. 
Biodegradability/Bioresorbability: An ideal scaffold should be able to degrade in vivo 
at a rate that is proportional to new tissue formation whilst maintaining some mechanical 
integrity during tissue regeneration process. The degradation behaviour of the scaffolds 
should vary based on applications such as 9 months or more for scaffolds in spinal 
fusion or 3 to 6 months for scaffolds in cranio-maxillofacial applications [65]. 
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These requirements lay the groundwork and foundation of the 4Fs (form, function, 
fixation, formation) for the design of an effective scaffold. A scaffold must  conform to the 
3D shape of the defect (form), while maintaining mechanical properties to the bone in 
repair (function),and allowing for the ability of integration and attachment to the existing 
bone and neighbouring soft tissue (fixation), as well as providing an osteoconductive 
environment (formation) [23]. 
 
Types of scaffolds 
Different materials have been used to fabricate an increasing number of novel scaffolds 
for bone tissue engineering over the past years and different methods of fabrication have 
been applied [29]. Composites of polymers and ceramics are the most popular class of 
composites investigated, due to the ability to mimic the bone architecture, with an ever 
increasing number of publications in this area. The criteria for selecting materials for 
application as biomaterials for tissue engineering is based on the materials chemistry, 
molecular weight, solubility, hydrophilicity/hydrophobicity, surface energy, degradation, 
structure, and erosion mechanism.  
 
Polymers 
Natural and synthetic polymers have been widely researched as scaffolds for tissue 
engineering due to their versatile properties. Natural polymers are biodegradable and are 
characterised by biocompatibility, enabling the adhesion and migration of cells within 
their structures [22]. The most commonly used natural polymers in bone tissue 
engineering include collagen, alginate, fibrin, hyaluronic acid, silk, gellan gum and 
chitosan. The main advantage of natural polymers is their ability to support tissue growth 
and remodelling, however they are mechanically weak.  
There are biologically inspired synthetic polymers that have also been investigated for 
tissue repair and regeneration, which are derived from amino acids, such as tyrosine-
derived polycarbonates, polyethers and, to a lesser extent polyarylates, [66, 67]. 
Synthetic polymers have an advantage of the ability to tailor their micro- (composition, 
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architecture and binding groups) and macro-scale (porosity, stiffness and elasticity) 
features for specific applications. Synthetic polymers such as poly (lactic acid) (PLA), 
poly (glycolic acid) (PGA), and polycaprolactone (PCL), Poly (vinyl alcohol) (PVA), 
polyethylene glycol (PEG) and poly (methyl methacrylate) (PMMA), among others are 
commonly used in bone tissue engineering. Some of the polymers can be degraded via 
the natural physiological pathway, however for some, the degradation mechanism results 
in a local acidic environment (e.g. PLA or PGA)  that can have adverse tissue responses 
[65]. 
Currently polymers have been employed in the development of; smart hydrogels which 
allow for tailoring properties such as mechanical stability and release kinetics for the 
desired application, therefore rendering them as multicomponent hydrogels capable of 
responding to multiple triggers or forming mechanically strong hydrogels. They include in 
situ chemically crosslinkable hydrogels, double network hydrogels, combinations of 
natural and synthetic polymers as well as composite hydrogels [9, 68, 69]; hydrogels 
used as delivery vehicles for drugs and osteogenic factors [70-72]. Polymers have also 
been explored as coating materials for permanent bone implants to improve the interface 
integration with native tissue, examples include coating of ceramics (polymer coated HA 
graft [73]), titanium (titanium coated with a microwave plasma polymer made from 
allylamine (PPAAm) [74]), hard polymer scaffolds and even allografts. One successful 
study aimed at developing a novel scaffold for bone tissue engineering, worked on bone 
xenografts coated with degradable synthetic poly(L-lactide-co-Ɛ-caprolactone) (PLCL) 
and with natural polysaccharide polymers  in order to increase their mechanical 
properties on one side and to improve cell adhesion on the other [75]. 
Limitations of polymers include difficulties in processing and purification as well as 
concerns regarding immunogenicity for natural polymers. The potential also exists for 
batch-to-batch variability in materials, diminishing the predictability of results in the clinic, 
and lastly natural polymers are not capable of matching the mechanical properties of 
bone tissue. Limitations of synthetic polymers include lack of bioactivity which restricts 
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positive biomaterial–host interactions, particularly in comparison to naturally derived 
polymers that have ECM-binding domains [76]. 
 
Ceramics 
Inorganic materials, such as calcium phosphate (CaPs) and bioactive glasses, are 
known to have good biocompatibility. They form bonds with hard and in some cases soft 
tissue. CaPs have been studied extensively as scaffolds for bone tissue engineering as 
they are a major constituent of bone. Majority of research has been focused on 
hydroxyapatite (HA), beta-tricalcium phosphate (β-TCP) or mixture of HA and β-TCP, 
known as biphasic calcium phosphate (BCP), which have been found to successfully 
support new bone formation [65]. Inorganic materials vary in terms of mechanical 
properties and the rate at which they are resorbed. Calcium sulphate is reported to have 
the fastest resorption of between 4 to 12 weeks whilst hydroxyapatite has slow 
resorption and has been observed radiographically 10 years after implantation. Calcium 
phosphates depending on the characteristic phase exhibit slow to rapid resorption that 
can range from  around 6 months to 10 years, while TCP resorption occurs between 6 to 
18 months [77]. 
Recently the addition of dopants such as zinc and strontium into β-TCP structure have 
shown an increase in type I collagen gene expression and extracellular signal regulated 
kinases (ERK) secretion that positively regulates angiogenesis, osteoblast proliferation, 
differentiation and morphogenesis [78]. The addition of dopants into the β-TCP structure 
was also found to allow for control of dissolution rates, densification behaviour, 
mechanical strength, and biocompatibility [79, 80]. Many different compositions of 
bioactive glasses have been explored, with their main attribute being able to form a layer 
of hydroxy carbonate apatite (HCA) on the surface of the scaffold when placed in 
physiological conditions. This HCA layer significantly enhances osteoblast activity and 
adsorbs proteins and growth factors that facilitate new bone formation in vivo. These 
characteristics make them highly desirable material in bone tissue engineering [81, 82]. 
However, ceramics are limited by their brittleness and have low fracture toughness 
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usually with a comparatively high compressive modulus and in some cases their 
biocompatibility and biodegradability is often insufficient. 
 
Composites 
The current strategies to enhance clinical success of scaffolds have been focussed on 
the development of composites and hybrid scaffolds, which combine the desirable 
properties of individual material components to achieve a synergistic effect in their 
resultant properties.  Composites properties  can be modulated according to need and 
application  by controlling the volume fraction of components as well as composition, this 
process results in scaffolds with strength that is able to match that of the properties of 
bone [65]. Composites can be broadly categorised into particle-reinforced, fibre-
reinforced and structural composites, arising in numerous composites available for 
review in bone tissue engineering. However the review of composites in this section is 
limited to providing a background on hydrogel composites, which relate to biocomposites 
that can be used in conjunction with orthobiologics for bone healing, fabricated in this 
study. 
 
Ceramic fillers such as calcium phosphates and hydroxyapatite can be incorporated with 
polymers to create hydrogel composites with enhanced mechanical properties with the 
ability to promote bioactivity in vitro and vivo. They can be tailored to have controlled 
porosity as well as be incorporated with drugs for drug delivery [83, 84]. Nano particles 
can be engineered from a variety of sources (e.g. polymers, minerals, metals and 
semiconductors) into various shapes, and have been incorporated in hydrogels to form 
composites [85]. Organic clay nanoparticles have been used to reinforce hydrogels for 
example, polymer/clay nano-composites composed of N-isopropyl acrylamide and 
hectorite clay Laponite XLG were formed by free radical polymerisation of the polymer in 
an aqueous suspension of clay. The resulting hydrogel had tensile modulus in the range 
of 270-300kPa and elongation of up to 1300%. The nano-composite gels could also 
withstand high levels of deformation in twisting bending and knotting [86]. A PVA 
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hydrogel reinforced with organic substituted clay nanoparticles was reported to have 
enhanced tensile strength and diminished microbial penetration, while maintaining high 
water absorbency [87]. Polymeric NP such as dendrimers and micelles have been 
incorporated into hydrogels for drug delivery systems [88]. 
Gold nanoparticles (AuNPs) possess useful electronic and optical properties and are 
being actively explored as biosensors (e.g. quantized capacitance and surface plasmon 
resonance) [89]. Gold nano particles/Poly(acrylamide) (AuNP/PAAm) composite 
hydrogels have been reported to demonstrate significant increase in electrical 
conductivity. Silver nano particles (AgNPs) have unique antibacterial properties and have 
been investigated for their use as antibacterial wound dressings [90] with a specific one 
being marketed by Smith and Nephew for wound dressings. 
Strategies of coating magnetic nanoparticles (MNPs) with hydrogels have been explored 
to increase their hydrophilicity and biocompatibility, as well as reduce non-specific 
protein absorption e.g. a sol-gel reaction was utilised to coat iron oxide MNPs with silica 
hydrogel [91]. Because MNPs have the ability to produce heat under applied magnetic 
field (“magnetocaloric effect”), they have been explored in hyperthermia-based cancer 
therapies for use as thermal ablation and temperature sensitive drug delivery, where one 
study showed that magnetisation of PEG-MNP composite hydrogels generated enough 
heat to kill glioblastoma cells [92, 93].  
Carbon based nanoparticles (CBNs) such as carbon nanotubes (CNTs) and graphene 
have excellent multi-functions such as mechanical strength, electrical, thermal and 
optical conductivity. They have been researched for a variety of applications such as 
high strength materials, nano scale electronic circuitry, sensors and actuators, as well as 
to reinforce hydrogel for biomedical applications [94, 95]. 
 
Fabrication of scaffolds 
Various methods have been employed in the fabrication of scaffolds, the primary 
requirement has been that techniques selected should ensure consistency in the 
fabrication processes and reproducible results, and that simultaneously the material 
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properties and the desired scaffold design requirements should not be adversely 
affected.  Fabrication of scaffolds can be grouped by their various processing techniques 
presented on Table 2-3. 
Fabrication Method Description 
Solvent casting Consists in dispersing calibrated mineral (e.g., sodium 
chloride, sodium tartrate and sodium citrate) or organic 
(e.g., sucrose) particles in a polymer solution. This 
dispersion is then processed either by casting or by 
freeze-drying in order to produce porous scaffolds. 
Particulate leaching Polymer is mixed with a porogen (e.g. sodium chloride, 
sucrose) and loaded into a mould, followed by subjection 
to heat treatment, freeze drying or air-drying, after which 
the polymer-porogen composite is immersed in a solvent 
for the selective dissolution of the porogen. Various 
shapes can be produced to form 3D porous scaffolds by 
simply changing the mould geometry. 
Fibre bonding Consists of individual fibres woven or knitted into 3-D 
patterns of variable pore size. Its main advantage is the 
large surface area, for cell attachment and rapid diffusion 
of nutrients. 
High pressure based 
methods 
Based on the CO2 saturation of polymer disks, through 
their exposure to high-pressure CO2. A thermodynamic 
instability is then created by reducing the CO2 gas 
pressure to an ambient level, which results in nucleation 
and expansion of the dissolved CO2, generating 
macropores. 
Freeze drying Relies on a thermally induced phase separation, which 
occurs when the temperature of a homogeneous polymer 
solution, previously poured into a mould, is decreased. 
Once the phase-separated system is stabilized, the 
solvent-rich phase is removed by vacuum sublimation 
leaving behind the polymeric foam. This methodology has 
been used to develop scaffolds from natural and synthetic 
origin. 
Rapid prototyping It is a computerized fabrication technique that can produce 
highly complex three dimensional physical objects using 
data generated by computer assisted design (CAD) 
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systems, computer based medical imaging, digitizers and 
other data makers. It is also known as solid freeform 
fabrication (SFF). 
Table 2-3: Summary of some commonly used conventional fabrication techniques of 3-D 
scaffolds. Adapted from Salgado et al [96]. 
 
Biomolecules/orthobiologics to promote bone healing 
It has been stated that “the enormous anticipated promise of gene therapy in the 1990s 
has not been realized, mainly due to safety concerns related to adverse immune 
responses that have led to some well-publicized patient deaths in clinical trials. For 
clinical applications, gene therapy requires extensive information regarding the safety 
and efficacy of the expressed target gene as well as its delivery vehicles.” [23]. This has 
led to the much safer use of orthobiologics in the clinical field. Orthobiologics can be 
defined as materials made from high concentration of substances that are naturally 
found within the body and can be used to help improve healing time of the injured tissue. 
With bone being highly vascularized, the performance of a bone scaffold is dictated by its 
ability to induce new blood vessel formation, as improper and insufficient vascularization 
leads to oxygen and nutrient deficiency, which may result in non-uniform cell 
differentiation and cell death. It is known that growth factors control osteogenesis, bone 
tissue regeneration and ECM formation via recruiting and differentiating osteoprogenitor 
cells to specific lineages [97]. Therefore, incorporating different growth factors and other 
biomolecules are of special interest for bone tissue engineering [65]. The most 
commonly applied growth factors are bone morphogenetic proteins (BMPs) as they have 
been reported to have the capability to modulate stem cell activity towards bone 
regeneration [98]. Current strategies have also adopted the inclusion and use of platelet 
rich plasma (PRP) to enhance regeneration and recovery time [99]. 
 
Bone Morphogenetic Proteins (BMPs) 
Bone morphogenetic proteins (BMPs) are considered to be the gold standard for 
promoting bone fusion. They have been commercially available for a decade, and this 
has enabled surgeons to work with the osteoinductive product, however there are 
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collateral effects in its clinical interaction and use, most specifically its prohibitive high 
cost, which has limited its accessibility and use. BMPs are multifunctional growth factors 
which induce formation of both bone and cartilage, and are known to also play a role in a 
number of non-osteogenic developmental processes. BMP-2, -4, -5, -6, and -7 have the 
greatest osteogenic properties and  extensive studies have demonstrated that they are 
important factors in regulating chondrogenesis and skeletogenesis during normal 
embryonic development [100, 101]. 
BMP Function 
BMP-2 Induces bone cartilage formation, as it is expressed in areas surrounding initial 
cartilage condensation periosteal and osteogenic zones. Plays a key role in 
osteoblast differentiation as it induces expression of RUNX2 and osterix. 
BMP-4 Expressed in perichondrium. It also regulates the formation of teeth, limbs and 
bone from mesoderm, and plays a key role in fracture repair. 
BMP-5 Performs functions in cartilage development. Mutations of which have been 
found to be a direct cause of skeletal defects. 
BMP-6 Plays a key role in joint integrity of adults. 
BMP-7 High levels expressed in perichondrium, and plays a key role in osteoblast 
differentiation as it induces of critical transcript factors RUNX2 and Osterix. 
Received approval for long bone non-union and has been demonstrates to be 
equivalent to autogenous bone grafting in the setting of tibial non-unions [77]. 
Table 2-4: BMPs with high osteogenic capacity and a description of their function [100, 
101]. 
 
The use of BMP’s in bone healing has been on the rise in the last decade [101], however 
there are controversial outcomes being reported past animal and human studies. Of the 
known bone morphogenetic proteins, only BMP-2 and BMP-7 have been approved by 
the United Sates Food and Drug Administration (FDA), which have also shown to 
encourage neovascularisation [77]. BMPs have generally been substantial to restore 
bone defects in animal models as well as humans. Segmental defects in the mandible of 
young monkeys implanted with rhBMP-2 in a poly-D, L-lacticco-glycolic acid coated 
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gelatine sponge showed successful regeneration [102], whilst a clinical study on 14 
patients with mandibular continuity defects showed successful osseointegration with 
rhBMP-2 in a collagen carrier without a concomitant bone grafting material [103]. Several 
clinical studies have been summarised in a review by Asahina,  et al, (2014) where the 
use of BMP led to comparable results obtained on the use of autogenous bone grafts 
[104]. Despite the benefits reported on BMPs, clinical translation to induce new bone 
formation requires a larger amount of BMPs 10~100 times more in humans as compared 
to smaller animal species (rodents). However, high doses of BMPs have been reported 
to induce significant edema or swelling, a case study example whereby a high dose of 
rhBMP-2 was used in anterior cervical spinal fusion procedures, caused an inflammatory 
response resulting in upper airway obstruction between post-operative days. As a result 
these patients were noted to have significantly longer stays in the hospital [105], similar 
observations were reported elsewhere [106] as well as in a study where a high dose of 
INFUSE graft was used for a similar application [107]. Other clinical studies reported that 
using off-label rhBMP-2 failed to restore mandibular bone defects in 2 out of 5 of their 
patients [108], with [109] adding to their findings  potential contribution of the off-label 
BMP2 to abnormal neurologic findings in their patients. With these varying reports on 
BMPs it can be suggested that, the growth factors are able to regenerate small bony 
defects such as extraction sockets or the sinus floor, but are not conclusive in restoration 
of large bony defects such as segmental bone defects in the mandible [22, 104].  
 
Platelet Rich Plasma (PRP) 
PRP is a volume of plasma fraction from autologous blood with a platelet concentration 
49 times that of the baseline level, it can be activated by thrombin or calcium chloride 
which induces the platelets to secrete growth factors. Enhancement or clinical efficacy in 
healing can be expected with platelet concentration of 1000000 platelets/µl in 5ml of 
plasma [110, 111], due to the high concentration of growth factors and secretory proteins 
present. The clinical use of platelet-rich plasma for a wide variety of applications has 
been reported, most prevalently in the problematic wound, maxillofacial, and orthopaedic 
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literature[112], and currently being explored the use of platelet concentrates to improve 
healing and replace fibrin glues [99, 113]. Examples of biologically active factors 




PD-EGF Promotes wound healing by encouraging cell growth recruitment and 
differentiation. Basically stimulating the proliferation of keratinocytes and 
dermal fibroblasts. Also responsible for cytokine secretion [99, 114]. 
PDGF A + B Stimulates production of other growth factors, chemo-attraction, cell 
recruitment & proliferation as well as blood vessel growth and 
granulation. Leads to matrix formation with BMPs (collagen & bone) via 
growth factor secretions. Promotes messenchymal stem cell, and 
endothelial cell replication, & osteoid production [99, 110, 114].  
PDAF Has the capacity to induce vascularisation by stimulating the vascular 
endothelial cells [99]. 
PF-4 This is a chemo-attractant for fibroblasts and a potent anti-heparin agent 
and is known to stimulate the initial influx of neutrophils into wounds [99]. 
FGF Potent inductor in cell proliferation. Responsible for cell migration and 
growth. As well as angiogenesis (blood vessel growth) and fibroblast 
proliferation [110, 115]. 
EGF Responsible for cell proliferation and differentiation of epithelial cells 
[110]. 
VEGF Main inducer for formation of blood vessels (angiogenesis), vessel 
lumen, migration and mitosis of endothelial cells and also responsible for 
vasodilation by indirectly releasing nitrous oxide. Creates fenestrations 
and chemotactic for macrophages and granulocytes [99, 115]. 
ECGF Responsible for angiogenesis and endothelial cell proliferation [114]. 
TGF-β1 Promotes bone matrix synthesis and enhances proliferative activity of 
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fibroblasts. Stimulates cell replication, biosynthesis of type I collagen and 
fibronectin as well as blood vessels. Responsible for growth inhibition 
and apoptosis (cell death) by inhibiting osteoclast formation, bone 
resorption, differentiation and activation [99, 114]. 
IGF-I, II Enhances bone formation by proliferation and differentiation of 
osteoblasts and responsible cell growth, differentiation, recruitment and 
collagen synthesis with PDGF, as well as being chemotactic for fibroblast 
and stimulating protein synthesis [99, 114, 115]. 
Table 2-5: Biomolecules found in platelet granules; PD-EGF( platelet-derived endothelial 
growth factor); PDGF (platelet derived growth factor); PDAF (platelet derived 
angiogenesis factor) FGF (fibroblast growth factor); EGF (epidermal growth factor); 
VEGF (vascular endothelial growth factor); ECGF (endothelial cell growth factor); TGF 
(transforming growth factor); IGF (insulin like growth factor). 
 
PRP also contains white blood cells such as monocytes and polymorphonuclear 
neutrophils, which trigger a localised inflammatory effect beneficial to tissue healing, but 
neutrophils have been hypothesized to impede healing. PRP is used in orthopaedic 
applications to enhance bone healing, especially in fracture repair as a method of 
improving fusion or non-union rates [116]. However, the use of PRP continues to be 
controversial in terms of its effect on enhanced or accelerated bone healing which may 
be attributed to the lack of localisation of PRP at the wound site, or due to rapid 
distribution within the body. Tricalcium phosphate/chitosan in combination with 
autologous PRP, have been reported to enhance osteogenic differentiation of MSC’s in 
vivo (in goats),  indicating induction of significant osteogenesis with PRP [117], however 
another study comparing the bone regenerative effect of PRPs of different species (rat, 
goat, human) using human bone graft and HA/TCP reported that in rats and goats, PRP 
did not enhance bone regeneration, but human PRP combined with HA/TCP resulted in 
significant bone regeneration [16]. The combination of CPC’s with PRP in conjunction 
with polymers also indicate contradicting reports on the effect of the inclusion of PRP on 
the properties. CPC’s in combination with 10% PRP were reported to cause a reduction 
in the modulus of the cements by 20-50%, it however resulted in greater new bone tissue 
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formation at 9 weeks in rabbits in comparison to cements with no PRP [118], whereas a 
PRP/TCP collagen cement reported no loss in the properties of the CPC. A clinical trial 
on twenty three patients with periradicular bony defect, evaluating the osteogenic 
potential of alloplastic (G-bone synthetic composed of TCP and HA) bone substitute with 
and without PRP, reported early bone regeneration in grafts with PRP [119]. An 
observational study that examined the clinical results and complications after the use of 
autologous platelet concentrate (APC) in 62 patients undergoing a variety of foot and 
ankle surgery with risk of non-union and 56 patients with APC and bone graft, concluded 
that the platelet concentration may be beneficial [120]. A similar study using APC with 
local autograft plus tricalcium phosphate and hydroxyapatite (TCP/HA) reported that 
addition of autologous platelet concentration to a mixture of autologous bone graft plus 
TCP/HA decreased the rates of posterolateral lumbar fusion [121]. One study examining 
a two year follow up on determining the efficacy of platelet glue in instrumented 
posterolateral lumbar fusion  with local bone graft in 67 patients 34 of whom were treated 
with platelet glue concluded that there was not enough evidence to support the 
advantages of using platelet glue [122]. A retrospective study evaluating two groups 
undergoing lumbar fusion (one with and one without autologous growth factors) in 
lumbar intertransverse fusions, concluded that the use of autologous growth factors 
resulted in inferior rates of arthrodesis as compared to autogenous bone grafts alone 
[123]. A review by Hsu et al, on PRP in orthopaedic applications concluded that there is 
limited clinical evidence demonstrating any beneficial effects from the use of PRP in 
bone healing applications, citing that “clinical evidence indicates that PRP is not 
efficacious either alone or as an adjunct to local bone in these applications” [124], 
however a correspondence to this publication by Padilla et al, stated that “we should no 
longer compare the biologic and therapeutic efficacy of very distinct products in  
musculoskeletal orthopaedic surgery by lumping all autologous platelet- and plasma-
derived products together. In the field of PRP products, we must not take oranges for 
apples simply because they are both fruit [125].” 
 
59 
2.5  CLINICAL TRANSLATION – Challenges for the future of bone 
tissue engineering  
In order to translate scaffolds from bench to bedside, it is imperative to precisely assess 
the clinical demands for specific scaffold characteristics. To achieve a broad and 
optimised range of clinical applications, the scaffold is required to perform as a 
developmentally conducive extracellular niche with a dynamically long-lasting yet 
degradable three-dimensional architecture, which  over time, can be replaced by cell-
derived tissue function. An important gate keeper to the translation of scaffolds for 
clinical use is the design and manufacturing processes [24]. Therefore new scaffolds 
should meet the following clinical translation requirements:  
 FDA approval. 
 Cost effective manufacturing process. 
 Ability to be sterilised by industrial techniques. 
 Must be user friendly and easy to handle with minimal preparatory procedures 
and turnaround time in the operation theatre. 
 Scaffolds should be radiographically distinguishable from newly formed tissue. 
[24] 
 
Advancement in bone tissue engineering remains a challenge, the progress achieved to 
date is very low with limited clinical solutions attained, despite the significant investment 
in research and development. Intensive investigations with large numbers of publications 
yearly have been undertaken as well as various clinical translation studies. The most 
pressing challenge remains to be the issue of long term mechanical integrity as well as 
insufficient vascularisation in the grafts which limits the cell survival rate thus resulting in 






Vascularisation Poor vascularisation within large grafts, attributed to the porosity 
within the graft/scaffold. 
Osseointegration Poor osseointegration of implant with host bone. 
Infection Wound site susceptible to infection depending on sterility 
techniques adopted during scaffold fabrication, and implantation. 
Lack of/slow resorption of grafts, typically HA increases the 
possibility of infection over long term. 
 
Degradability Ability to degrade and resorb, ideally in tandem with rate of new 
bone formation. Hydroxyapatite (HA) scaffolds used are non-
resorbable and in some cases take years to resorb. Calcium 
sulphates undergo fast resorption which is not in proportion to the 
rate of new bone ingrowth. 
Strength Low stiffness and strength. 
Table 2-6: Main factors that limit success in clinical orthopaedic applications. adapted 
from Liu et al [22]. 
 
It has been hypothesised that the inconclusive reports obtained from the use of 
orthobiologics such as PRP have been due to the limited ability to retain the product 
within the graft and localisation of the product at the wound site. Some studies have also 
reported that  incorporating the product in the stages of scaffold fabrication results in 
growth factors that are not fresh nor the patient’s own(autologous) at the time of 
transplantation. These factors have limited the use of orthobiologics in clinical practice. 
Additionally the cost of current commercial bone grafts to date, are high and even more 
expensive when incorporated with orthobiologics such as BMPs, and therefore  
representing an enormous cost to the health system [46]. However the current ability of 
doctors to spin autologous blood to obtain PRP therefore increases the feasibility for it to 





CONCLUSION AND AIMS 
The drawbacks and limitations associated with the use of autografts, allografts and 
xenografts are a significant factor indicating the need for focussed research and 
development in synthetic bone grafts. The review of literature confirmed that composite 
biomaterials have the potential to significantly improve bone regeneration. The 
complexity in the challenges of tissue engineered bone formulations need to extend 
beyond simple void fillers to more challenging biomimetic, biofunctional constructs, which 
will then be subjected to the standard lengthy approval process for clinical translation. 
Despite the challenges encountered in bone tissue engineering, there is tremendous 
optimism on the potential to replace damaged and degenerate structures and tissues. 
Undoubtedly, there is a large and essentially unmet clinical need for highly effective 
smart bone substitutes that can be used in conjunction with orthobiologics. Ideal 
characteristics of a bone substitute should be; 
 Non immunogenic and non-toxic. 
  Design controllable, inexpensive and readily available. 
 Contain minimal number of components so as to reduce its complexity. 
 
The overall objectives of this study were therefore to; 
 Develop a clinically viable technology to repair, regenerate and enhance bone 
healing across bone defects.  
  Develop an osteoconductive bone substitute with good structural properties.  
 Develop a graft that can readily absorb autologous PRP becoming rich in growth 
factors, as well as retaining them, allowing for their local delivery at the wound 
site, so as to imbibe osteoinductive properties, which assist in the process of 
bone healing.  
 
The following steps were followed with the aim of accomplishing this goal. 
1) Development of matrix: Matrices were fabricated via facile methods of 
crosslinking  
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I. PVA hydrogels and composites,  
II. PVA-alginate dual network hydrogels and their composite networks,  
For applications as scaffolds for soft tissue and bone augmentation and 
regeneration, specifically focusing on the ability of the fabricated materials to be 
able to absorb and retain biological fluids rich in growth factors (orthobiologics) 
which aid in enhancing tissue regeneration. In addition the composite hydrogels 
were synthesised in micro and macroporous form, which is expected to confer 
the ability of these materials to support functional extracellular matrix.  
2) Composite systems for load bearing: The functional stiffness of bone varies 
depending on its type of collagen content and its recognised effect on fracture 
healing. This concept was applied to develop optimum formulations of composite 
hydrogel systems. Physico chemical and mechanical properties to understand 
the potential limits of applications the hydrogels and composites can address. 
Biocompatibility and functionality assessment:  Preliminary studies were 
carried out and various in vitro assays were used to assess the cell material 
interaction. However further in-depth evaluation of in vitro studies will be required 
prior to in vivo implantation and finally to clinical translation. The study however 













Chapter 3  
Poly(vinyl alcohol) hydrogels 
fabricated using facile methods of 
crosslinking 
3.1 INTRODUCTION TO HYDROGELS 
Hydrogels are three dimensional polymeric networks that are able to absorb and retain 
large amounts of water or biological fluids. A strong gel consists of an almost frequency 
independent G’ and G’’ moduli, where G’ values are typically 1-2 orders of magnitude 
greater than G’’ (G’>>G’’, G’’/G’<0.1). A weak gel has a profile G’ and G’’ moduli with a 
slight frequency dependence (G’’/G’>0.1) [126]. The fluid retaining polymers result in soft 
tissue like consistency with a relatively porous structure that resembles living tissues 
thereby minimizing inflammatory response to the surrounding cells [127]. Hydrogels can 
be ‘reversible’, which are primarily formed via the molecular entanglements or through 
involvement of secondary forces such as ionic, H bonding and hydrophobic forces and 
these physical gels can be reversed by altering the environment,  whilst ‘permanent’ gels 
are obtained via covalent bonding through cross linking of the macromolecular chains. 
Chemical crosslinking has permanent junctions formed by covalent bonds, while physical 
crosslinking has transient junctions arising from either polymer chain entanglements, 
crystallite formation, or weaker physical interactions such as ionic interactions, hydrogen 
bonding, or hydrophobic interactions [127]. Both physical and chemically crosslinked 
hydrogels are not homogenous, due to inhomogeneities arising from clusters of 
molecular entanglements, or hydrophobically or ionically associated domains.  Transient 
network defects also contribute arising from, free chain ends or chain loops in physical 
hydrogels and or due to cluster formation. Cluster formation occurs due to regions of low 
water swelling and high crosslink density, that are dispersed within regions of high 
swelling, and as well as low crosslink density in chemical hydrogels [128]. 
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A gel consists of continuous solid with fluid phases of colloidal dimensions, gelation of 
the gel can be induced by rapid evaporation of the solvent. Drying under normal 
conditions gives rise to capillary pressure that causes shrinkage of the gel network 
resulting in a dried gel called a xerogel. If the gel is dried under supercritical conditions, 
where there is no interface between liquid and vapour, so there is no capillary pressure 
and relatively little shrinkage, this results in an aerogel. Hydrogels can absorb from 10-
20% up to thousands of times their dry weight in water, many of these properties are 
governed not only by degree of swelling, but also directly by the chemical nature of the 
polymer network and network morphology [9]. The interactions responsible for water 
sorption include capillary, osmotic and hydration forces exerted by the crosslinked 
polymer chains resulting in expansion of the polymer chains. The magnitude of these 
opposing effects determines the equilibrium swollen state, which to a large extent 
determine some important properties of the hydrogel, including internal transport and 
diffusion characteristics and mechanical strength.  
 
The suitability of hydrogels as biomedical materials and their performance in a particular 
application depend to a large extent on their bulk structure. The most important 
parameters used to characterise the network structure of hydrogels are:  
 The polymer volume fraction in a swollen state (a measure of the amount of fluid 
imbibed and retained by the hydrogel). 
 The molecular weight of the polymer chain between two neighbouring 
crosslinking points which can either be chemical or physical in nature (a measure 
of the degree of crosslinking of the polymer). 
 The corresponding mesh size (a measure of space available between the 
macromolecular chains, very useful for diffusion of drugs). 
These parameters are inter-related and can be determined by applying the equilibrium –
swelling theory and rubber elasticity theory. With neutral gels, Flory–Rehner theory is 
also useful for analysis [129], this theory describes swelling by stating that “crosslinked 
polymers will reach equilibrium in a fluidic environment by the thermodynamic force to 
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reduce entropy via mixing as opposed to by the elastic or retractile force of the polymer 
chains themselves to contract.” 
 
Hydrogels have numerous applications in the pharmaceutical and medical industry, due 
to their ability to be fabricated in many different physical forms, such as solid moulded 
forms in the case of soft contact lenses, membranes or sheets for use as a reservoir in a 
transdermal drug delivery patch, or for 2D electrophoresis gels, pressed powder matrices 
applied as pills or capsules, micro particles applied as bio adhesive carriers or wound 
dressings, and coatings on implants or catheters [128]. 
 
3.2 CLASSIFICATION OF HYDROGELS 
Hydrogels can be characterised based on their derivation and composition which can be 
divided into natural polymer hydrogels, synthetic polymer hydrogels and combinations of 
the two classes (bio hybrid hydrogels). 
Natural polymers are derived from natural sources such as marine and algae that yield 
polysaccharides such as alginate and agarose, or can be obtained from mammalian 
extracellular matrix, examples include, collagen, hyaluronic acid, fibrin, gelatine, 
chondroitin sulphate, elastin and heparin. They are appealing for biological applications 
since they are biocompatible and have low toxicity, which has rendered them as effective 
matrices for cellular growth especially as they contain many cell signalling domains 
present in the in vivo extracellular matrix. However, hydrogels from natural polymers are 
mechanically weak and can seldom be used in native form. 
Synthetic polymers offer great versatility in controlling polymer architecture, which is 
essential to prepare hydrogels with structured network, mechanical properties, 
degradation rates, chemical and biological response to stimuli. Some examples of 
synthetic hydrogels in biomedical use are poly ethylene glycol (PEG), poly(hydroxyethyl 
methacrylate) (PHEMA), polyvinyl alcohol (PVA) and polyacrylamide (PAM).  
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Hybrid hydrogels are derived from the integration of  natural and synthetic polymers to 
create novel systems with high affinity specificity of binding with tailorable properties 
[129].  
 
Ullah et al. 2015 stated that “The classification of hydrogels depends on their physical 
properties, nature of swelling, method of preparation, origin, ionic charges, sources, rate 
of biodegradation and observed nature of crosslinking.” [130]. However other modes of 
classification of hydrogels have been proposed [Peppas [127]], which include the method 
of preparation, ionic charge and physical structural features. 
 
Hydrogels based on method of preparation: Hydrogels have been classified further 
into four groups of, homopolymer, copolymer, multipolymer and interpenetrating 
hydrogels. Homopolymer hydrogels are cross-linked networks of one type of hydrophilic 
monomer unit, whereas copolymer hydrogels are produced by cross-linking of two 
comonomer units, at least one of which must be hydrophilic to enable swelling of the 
hydrogel. Multipolymer hydrogels are produced from three or more comonomers reacting 
together. Finally, interpenetrating polymeric hydrogels are produced by preparing a first 
network that is then swollen in a monomer, the latter reacts to form a second 
intermeshing network structure which can be further crosslinked or not [127]. 
 
 
Figure 3-1: Schematic diagram for molecular structure of (a) Homopolymeric hydrogel, 
(b) Block copolymeric hydrogel, (c) Graft copolymeric hydrogel, (d) Alternating 
copolymeric hydrogel, (e) Random type copolymeric hydrogel, (f) multi-polymeric 




Ionic charge: The hydrogels have been classified as neutral, cationic, anionic, or 
ampholytic hydrogels. This refers to the overall charge of the hydrogel, where neutral 
hydrogels have no charged groups; anionic hydrogels have negatively charged groups 
(they dissociate more in higher pH media, and hence, display superior swelling in neutral 
basic solutions); cationic hydrogels have positively charged groups (their swelling is 
dependent on pH of the aqueous medium, which determines the degree of dissociation 
of the ionic chains. Cationic hydrogels display superior swelling in acidic media since 
their chain dissociation is favoured at low pH); whilst ampholytic hydrogels have both 
negative and positive charged groups rendering them with a dual behaviour (a change in 
pH can change the overall ionic properties). The anionic, cationic and ampholytic groups 
are described as ionic hydrogels or polyelectrolytes [127]. 
 
 
Figure 3-2: Schematic representation of different hydrogels based on presence of 
electric charge (a) non-ionic, (b) cationic, (c) anionic, (d) ampholytic and (e) hydrophobic 
modified hydrogels. Adapted from Singhal et al [131]. 
 
Physical structural features: Hydrogels can be classified as amorphous, semi 
crystalline, hydrogen bonded or complexation structures. In amorphous (non-crystalline) 
hydrogels, the macromolecular chains are arranged randomly; semi crystalline hydrogels 
include a mixture of amorphous and crystalline phases possessing dense regions of 
ordered macromolecular chains (crystallites); hydrogen bonds (if the hydrogel network is 
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based on electrostatic interactions) and complexation structures may be responsible for 
the three-dimensional structure formed [132, 133].  
 
Figure 3-3: Schematic illustration of physical features of polymers  (a) amorphous (b) 
semi-crystalline and physical crosslinking of polymers via (c) hydrogen bonding, (d) ion-
polymer complexation and (e) polymer-polymer complexation. Adapted from Singhal et 
al [131]. 
 
3.3 SYNTHESIS OF HYDROGELS 
Many different routes have been employed in the design and synthesis of hydrogels, 
either via chemical or physical crosslinking. 
 
Chemical crosslinking of hydrogels 
Chemically crosslinked hydrogels can be synthesized by chain growth polymerisation, 
addition or condensation polymerisation. Copolymerization or cross-linking free-radical 
polymerizations are commonly used to produce hydrogels by reacting hydrophilic 
monomers with multifunctional cross-linkers. The reaction can be initiated by photo-
initiators, radiation, ultraviolet or chemical catalysts and the choice of the initiator 
depends on the type of monomer used. The reaction can be carried through bulk, 
suspension or solution polymerisation methods. However, all the methods used for 
biomedical applications need to consider the biological effects of the initiators and 
reaction conditions. This becomes further challenging if in vivo gelation is desirable, 




Physical cross linking of hydrogels 
On the other hand physical hydrogels are crosslinked via physical means, and these 
include ionic interaction, stereocomplex formation, hydrophobic association, protein 
interaction, crystallization and hydrogen bonding [130].  
Hydrogen bonding can also function as a crosslinking tool in polymers containing a 
multitude of hydroxyl groups such as poly-vinyl alcohol. Aqueous solutions of polymers 
(gelatine, PVA etc.) are able to gradually gel and experience a small increase in elasticity 
upon standing at room temperature, with increase in time at this temperature partial and 
complete drying of the polymer solution can be achieved resulting in hydrogels with 
varying strengths depending on the polymer concentration, but in most cases weak 
physical gels with reversible links are formed from temporary associations between 
chains (e.g. hydrogen bonds). This form of drying is termed air-drying. 
Crystallization involves a freezing and thawing process and creates a strong and highly 
elastic gel. PVA is an example of hydrogels that can be formed by physically crosslinking 
through repeated freezing/thawing cycles. Freeze thawing entails repeated cycles of 
freezing polymer solutions at temperatures below ~ -10°C and thawing with repeated 
cycles for constant known periods of time. This process produces dense thermo-
reversible gel that are physically crosslinked polymers, which may contain uncrosslinked 
polymer and water. Properties of the resultant hydrogel are highly dependent on the 
molecular weight of the uncrosslinked polymer, concentration of the aqueous solution, 
temperature with length of time of freezing, and number of freeze-thaw cycles [134]. 
 
Principles of freeze-drying  
Freeze drying or lyophilisation is an effective drying process, mostly done with water as a 
solvent. The first step entails freezing the product (polymer solution) to a minimum of -
40°C, so as to allow for the water and solids to be fully crystallized whereby ice and 
solids are enclosed in zones in which amorphous concentrated solids and water remain 
in a mechanically solid state. 
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Once the suspension is crystallized, moisture (ice or water in an amorphous phase) can 
be extracted through sublimation from solid state (ice) directly to vapour phase (gas), 
whilst maintaining the materials crystalline structure. This method of drying results in 
scaffolds with random pore structure and network (porosity is achieved from the areas 
that had been previously occupied by the sublimated solvent.) The initial concentration of 
the polymer solution, the end temperature of cooling, and the length of time at this 
temperature are some of the factors that determine crystallisation [135]. 
The principle of sublimation can be explained with reference to a vapour pressure phase 
diagram (Figure 3-4), which demonstrates that at normal atmospheric pressure, water 
freezes below 0°C and boils at 100°C. The boiling point is reduced at lower pressures 
(principle on which vacuum distillation is based) and conversely raised at higher 
pressure (principle on which the pressure cooker operates). The triple point exists at 
exactly 6.11mbar and this is where the melting-point curve, vapour-pressure curve and 
sublimation-pressure curve meet. Below 6.11mbar H2O passes directly from a solid to a 
gaseous state. 
 
Figure 3-4: The phase diagram of water and the area in which this transfer from solid to 
vapour is possible. NB: atmospheric pressure = 101325 Pa (1.01325 bar). 
 
Freeze-drying technique are widely used in pharmaceutical, biotechnology and food 
industry, where it has been used for: preserving characteristics of a substances such as 
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conserving archaeological finds, pharmaceutical products and milk; or for conditioning 
materials in cases of dried fruits in yoghurts; and also in chemical analysis of soils and 
organic substances in foodstuffs.  
In recent years this drying technique has found use in the biomaterial industry as a 
process of physically crosslinking hydrogels with the use of bench top freeze driers to 
fabricate materials for tissue engineering applications. These freeze-dryers consist of, a 
vacuum system and condenser chamber (-55°C to -105°C) depending on the type of 
system. The vacuum, creates a pressure free environment which facilitates easy flow 
and migration of moisture as well as extraction of non-condensable vapours from the 
frozen gel and the shelf unit of which the sample is placed, to the condenser chamber as 
vapour naturally travels towards cooler surfaces. 
 
The freeze drying technique of crosslinking to obtain hydrogels has advantages in that 
chemicals are not required for crosslinking, which may affect the biocompatibility of the 
resultant hydrogel, or require multiples washes to remove remnants of toxic substances, 
however this method does have limitations in that : 
 There is limited control in the tailoring of porosity.  
 The process of crosslinking is lengthy and time consuming. 
 Benchtop freeze dryers are expensive.  
 
Hydrogels fabricated in this manner have been found to be highly applicable in 
regenerative medicine, due to the nontoxic manner of fabrication and resultant micro and 
macroporous structure. Regenerative medicine relies on imbibing appropriate cellular 
activity through a combination of cells and a matrix. The matrix is usually a 3 dimensional 
biodegradable matrix with structural features emulating the extra cellular matrix (ECM) 
that supports tissue regeneration. Research pertaining to the criteria of selection and 
application of biodegradable matrices are still mainly empirical, however it is now 
recognised that the structural support, stiffness of the substrate, chemical composition 
and the signalling molecules provided, play an important role in controlling cell 
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behaviour. These parameters gives rise to a complex set of requirements and need 
consideration in conjunction with the already established correlation of biomaterials and 
cell behaviour [7]. 
 
3.4 POLY (VINYL ALCOHOL) HYDROGELS 
Poly(vinyl alcohol), PVA is a water soluble semi crystalline synthetic polymer, produced 
via partial or full hydrolysis of polyvinyl acetate (PVAc) by replacement of the acetate 
group in vinyl acetate with the hydroxyl group in the polymer chain, in the presence of 
either a base or acid catalyst. Vinyl acetate is polymerised followed by alkaline hydrolysis 
with e.g. sodium hydroxide, which is an important catalyst for alcoholysis in the presence 
of an alcohol such as methanol and ethanol [136] (Figure 3-5). The level of hydrolysis 
governs the physical, chemical and mechanical properties of the resultant PVA [137]. 
PVA is commercially available in different grades based on their degree of hydrolysis 
and are classified as: partially hydrolysed 84.2 to 89.0% (can be considered as a 
polymer mixture of vinyl alcohol and vinyl acetate), moderately hydrolysed grade ranges 
from 92.5 to 96.5%, and completely hydrolysed ranges from 98.0 to 99.0% [138]. The 
degree of hydrolysis has a significant effect on solubility, which decreases with increase 
in the level of hydrolysis, as more hydroxyl groups cause strong intra and inter hydrogen 
bonding, whilst viscosity increases with degree of hydrolysis. 
 
 Figure 3-5:  The reaction sequence for synthesis of PVA. 
 
Crosslinking PVA 
PVA contains a secondary hydroxyl group, which can be crosslinked either via chemical 
or physical crosslinking. Chemical crosslinking can be carried out by reacting with 
73 
aldehydes such as formaldehyde, glyoxal, glutaraldehyde [139, 140]; dicarboxylic acids 
[141] or  inorganic compounds i.e. borate [142]. Physical crosslinking of PVA can be 
achieved via radiation photo-crosslinking [143, 144], air drying and repeated freeze-
thawing cycles. Chemical crosslinking usually has residual amounts of the crosslinking 
agents (initiators, chain transfer agents and stabilisers) in the PVA hydrogel, which then 
require time consuming extraction procedure in order to remove the residue, so as to 
render the hydrogel applicable for biomedical and pharmaceutical applications. To 
counteract this, crosslinking of aqueous PVA solutions via freeze-thawing technique was 
pioneered by Peppas (1975). Crosslinking via freeze thawing process not only obviates 
the use of chemical cross linking agents but is reported to yield PVA hydrogels with 
higher mechanical strength than those crosslinked by chemicals or irradiation 
techniques.  Repeated freezing and thawing of PVA induces crystal formation in the 
materials that allows for the formation of a network structure crosslinked with the quasi-
permanent crystallites. The resultant hydrogel obtained, thus possess a macro porous 
structure, imprinted by the formation of ice crystals within the homogenous aqueous PVA 
system during the freezing step. Ice crystals expel amorphous polymer segments that 
finally separate the initial PVA aqueous solution into polymer-rich parts and polymer poor 
parts of a porous network. Polymer chain folded micro crystallites are formed in polymer 
rich phases as network junctions in physical PVA cryogels [145]. The properties of the 
resultant PVA hydrogel are dependent on the molecular weight of the polymer, 
temperature, duration and the number of freeze-thawing cycles. This method is the 
preferred method for preparation of PVA hydrogels as it allows for the formation of an 
ultrapure network without the use of crosslinking reagents, resulting in hydrogels with 
high degree of swelling in water, a rubbery and elastic nature and high mechanical 
strength. There have been many investigations of the molecular structure of PVA gels 
formed via freeze-thaw cycling [146-149]. A schematic representation of the freeze 
thawing processes is presented on Figure 3-6.  
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PVA homogenous aqueous solution 
                                 
 
PVA aqueous solution frozen at -80°C prior to freeze drying 
                
 
PVA subjected to freeze drying 
 
               
 
 
Figure 3-6: Schematic representation of PVA hydrogels prepared freeze drying method 
highlighting the microstructure of PVA through the processes of crosslinking with PVA-





Applications of PVA 
PVA has a well-documented history of successful applications in areas such as food 
chemistry, biotechnology, pharmaceuticals, medicine and tissue engineering.   PVA 
exhibits excellent mechanical properties, good biocompatibility and biodegradability in 
human tissues and fluids, which has led to several biomedical applications [150]. PVA 
has been employed in the design and manufacture of tri-leaflet heart valve prosthesis 
whose design incorporated precisely defined geometries [151]. The authors found PVA 
to have a significant advantage which allowed replacement of heart valves via closed 
chest surgery, as well as pose as a superior alternative to total artificial heart implants 
and ventricular assist devices. PVA hydrogels have also been investigated for 
replacement of damaged cartilage, due to their high water content, as well as their 
rubbery elastic and compressive mechanical properties, with tensile strengths in the 
cartilage range of 1–17 MPa. Applications of these PVA hydrogels on cartilage were 
found to have lower wear factor with increasing thickness and water content of the 
hydrogel [152, 153]. The overall morphology, microstructure and stability of freeze-
thawed PVA hydrogels show that the stability of the hydrogels can be significantly 
enhanced by increasing the number of freeze thaw cycles and increase in chain length 
as well as free volume within the network together to allow for secondary crystallization 
to proceed as the material swells [154]. It is reported that PVA gels prepared by freeze 
thawing technique show increased mechanical strength over most hydrogels due to the 
presence of crystalline regions that serve as physical crosslinks [155]. PVA based 
scaffolds have been developed and studied for potential applications as artificial grafts, 
examples include but are not limited to, electrospun gellan-PVA based nanofibers as a 
hydrophilic scaffolding material for skin tissue regeneration [156], sterculia (an acid 
polysaccharide) crosslinked PVA and PVA-AAm hydrogel [157], savlon loaded PVA 
hydrogels[158] and PVA-alginate blends for wound dressing [159], as well as PVA 
composite matrix for artificial cornea [160]. PVA has very low acute oral toxicity and does 
not accumulate in the body when administered orally and it was approved by the Food 
and Drug Administration (FDA) and other regulatory organizations for embolization [161] 
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and a summary of current applications of PVA hydrogels in the biomedical field is 
presented in Table 3-1.  
Application Qualifying properties of PVA for application 
Soft contact lenses High water content, high oxygen permeability, high optical 
clarity and low protein adsorption [162, 163] 
Artificial cartilage and 
meniscus tissues 
Elastic and compressive mechanical properties, and high water 
content. Usually prepared from high concentration of high 
molecular weight polymers (30% PVA or higher) [164-166]. 
Artificial pancreas Membrane permeability of the hydrogels, and adaptability of 
PVA hydrogel to be fabricated in various desired shapes [167, 
168]. 
Haemodialysis Membrane permeability in combination with drug loading and 
release within PVA hydrogels [169]. 
Hydrophilic coatings Polymeric coating of catheters, leads 
Vascular embolism 
treatment 
PVA fabricated into particles used to induce contralateral lobar 
hypertrophy in patients with liver-only metastases and normal 
underlying liver function [170, 171]. Ability of PVA particles to 
adhere to the vessel wall, which were then covered by the 
thrombus and organized into a collagenous mass. However 
there have been contradicting reports on the efficacy of PVA 
applications in this manner [172]. 
Drug delivery Excellent maintenance of drug within the hydrogel during the 
dry state, as well as minimal level absorption of PVA from the 
gastro intestinal tract into the blood stream. As well as 
elimination of the polymer reported to proceed via renal 
excretion and complete within 40 days [173, 174]. 
Table 3-1: Applications of PVA polymer hydrogels in the biomedical field,  and related  




PVA based medical products in the market 
Product and detailed explanation of medical use Image of product 
COLDEX®Extra is an open cell PVA hydro foam with 
interlinked pores that are super absorbent with fluid 
retaining qualities, suitable for wound exudates 
removal hence optimized for the treatment of wounds 
by means of negative pressure. It can be used for a 
variety of wound applications such as traumatic, 
infected and surgical wounds as well as leg and 
diabetic ulcers and pressure sores [175]. 
[175] 
Ear, nasal, sinus, epistaxis and post operational 
tampons. Products include those by MONDOCEL® 
products, ideally used in otologic and rhinologic 
procedures. The products have small pore sizes 
minimizing tissue ingrowth thus facilitating atraumatic 
removal [176].  
[176] 
PVA RETRACTORPAD® and RETRACTORCOVER, 
were designed for abdominal and pelvic operations to 
cushion the intestines enhancing exposure of the 
surgical area. These pads possess antislip properties 
and possess excellent absorptive qualities. The 
retractocover was developed to cover the retractor 
and protect tissues and organs from the points and 





RESOMED® is a femoral canal tampon used in total 
hip surgery. The femoral shaft can be plugged with the 
tampon until the prosthesis is ready for insertion as it 




PVA  sponge products are used during cataract and 
other refractive surgeries, such as PVA spears. These 
products are available in the market from companies 




PVA foam emobilization particles are used for 
embolization of the blood supply to hypervascular 
tumours, symptomatic uterine fibroids, and 





Table 3-2: PVA based products currently used and applied in the medical field. All 
images were adapted from the denoted reference next to the image. 
 
Although freeze thawing has been shown to impact mechanical properties a systematic 
study that correlates concentration, molecular weight and comparable freeze-thaw 
process to make PVA gels is not available, and also despite the large number of studies 
on PVA for biomedical applications, there is a lack of dedicated and systematic study on 
the properties of physically crosslinked PVA hydrogels. PVA is an FDA approved 
synthetic biocompatible polymer, that can be modified  through blending with other 
natural or synthetic polymers [182], as well as the ability to be incorporated with calcium 
phosphates to form bone composites with good structural and mechanical properties 
applicable for bone augmentation and regeneration. Based on the evidence from 
literature and the versatility of the properties of PVA, it was chosen as a base polymer 
towards the development of scaffolds for this study, thus a systematic evaluation of the 
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properties of PVA hydrogels with a known molecular weight crosslinked via facile 
physical crosslinking methods is reported in this chapter. The aim is to obtain a baseline 
understanding of the properties of PVA, in relation to different physical crosslinking 
methods, and was carried forward to analyse the effect freeze thaw cycles on PVA of a 
known concentration and molecular weight, which formed the basis for fabrication of 
interpenetrating dual networks of PVA and alginate subsequently. The specific focus 
related to the optimisation and development of these polymers to yield tough hydrogels 
with controllable water uptake properties that would allow for cell attachment infiltration 
and proliferation within the hydrogel. The physical characteristics of the hydrogels such 
as toughness, porosity and water uptake can be controlled by varying methods of 
fabrication.  
 
Therefore the objective of this study was to:  
 Fabricate 3D PVA hydrogels with varying concentrations of PVA, crosslinking via 
physical means such as air-drying and freeze thawing. 
 Characterise the physical properties of the hydrogels.  
 Study the effect of the different concentrations of PVA on the properties of the 
gels. 
  Considering the importance of the method of physical crosslinking on the final 
properties of PVA, the effects of air-drying, freeze drying and both together on the 









Polymer Chemical Structure 
Poly(vinyl alcohol) (PVA), 145,000 mol. wt. 
hydrolysis≥98% (Merck) 
 [CH2CH(OH)]n 
Table 3-3: Polyvinyl alcohol used for fabrication of hydrogels. 
 
PVA polymer stock solutions  
PVA granules were weighed in appropriate amounts and dissolved in distilled water, and 
magnetically stirred at 350rpm at a temperature of 121°C until dissolved to form 
homogenous solutions of concentration 10, 20 and 30%. The aqueous polymer solutions 
were stored in Duran bottles. The viscosity of the PVA solutions was found to increase 
with increasing concentrations as expected. However it was found that a concentration 
higher than 30% led to a lumpy mass and the maximum workable concentration was 
found to be at 30% w/v, whilst 10% and 20%w/v polymer solutions were easier to handle 
as mentioned. Due to the high viscosity of the PVA 30% solution and difficulty in 
handling, a method was developed for preparing the of 30%w/v solution where: 
 Polymer solution was prepared by dissolving 2/3rd of the weight of required PVA 
with 70% distilled water at 121°C until a homogenous solution was obtained. The 
remaining 1/3rd of PVA was mixed with cold water and later added to the 
homogenous polymer solution. 
 Magnetic stirring was maintained between 150-250rmp depending on the varying 
viscosity as PVA granules were added. Once formed, the homogenous solutions 
were cast into desired moulds whilst it was warm at 40-50°C. 
 
PVA hydrogels 
In order to form the hydrogels, the PVA polymer solutions were cast into moulds, then 







The sample moulds were  frozen to -80°C in a freezer for 1 hour 
before vacuum freeze drying (Vitris SP Scientific) at -59°C with 
vacuum of 17mT for 24hours. Samples in this study were placed in 
the condenser chamber for freeze drying. The xerogel were then 
allowed to thaw at room temperature for 12 hours before testing. 
This was considered as 1 freeze thaw cycle (1FT). 
Air Drying (AD) Air-dried hydrogel sheets of relatively uniform thickness were 
formed by leaving polymer solutions in moulds to air dry at room 
temperature for 7days. Care was taken to limit introduction of air 
bubbles. 
Air Drying + 
Freeze Thawing 
(AD+FT) 
The air-dried hydrogels were then hydrated in distilled water for 5 
minutes before being frozen in a -80˚C freezer for an hour followed 
by vacuum freeze drying (Virtis SP Scientific) at -59.4°C with a 
vacuum of 17mT for a period of 24 hours before being thawed at 
room temperature for 24 hours before testing. 




The hydrogels fabricated were characterised using FTIR, differential scanning 
calorimetry, equilibrium water content and ultimate tensile strength.  Based on the 
results, a select group was taken for further characterisation by Raman micro-
spectroscopy and scanning electron microscopy. 
 
Viscosity 
Viscosity measurements were carried out using a Brookfield viscometer. ~3.8ml of 
aqueous PVA solution was placed in a small chamber, after which a rotating spindle was 
placed inside the chamber allowing for determination of viscosity. The rotation speed of 
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the spindle  were set to 100rpm and viscosity values were obtained from the viscometer 
were at 13%, 12.4 and 85% full range for PVA10, 20 and 30 respectively. 
  
Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR – 
FTIR) 
ATR/FTIR spectra of hydrogels were recorded on a Perkin Elmer Spectrum One 
spectrometer.  The hydrogels prepared were placed in a desiccator for 24h prior to 
testing, and all spectra were obtained in the wavelength range of 4000-650 cm-1 with 4 
cm-1 resolution. Spectrum software (Perkin Elmer) was used for analysis and processing 
with all spectra normalised. 
 
Differential Scanning Calorimetry (DSC) 
Perkin Elmer Jade DSC system was used to determine thermal properties of the 
hydrogels and Perkin Elmer Jade series software was used to process and analyse the 
raw data. The system was calibrated with zinc/indium, and all hydrogel samples were 
placed in a desiccator for a minimum of 24 hours prior to testing. 10-20mg samples were 
tested in crimpled aluminium pans, scans were carried out with reference pan calibrated 
using Indium49 under a Nitrogen7 atmosphere. Two cycles of heating and cooling were 
carried out, starting from 0 to 250°C followed by a cooling cycle to 10°C at a rate of 10°C 
per minute. The glass transition temperature (Tg°C) and melting temperature (Tm°C) 
were determined. Tg is manifested by a change in the base line, indicating a change in 
the heat capacity of the polymer. The baselines before and after the transition are 
extrapolated from the linear portion of the phase transition and the intersections used to 
determine Tg. 
 
Equilibrium Water Content (EWC) 
Hydrogels were immersed in deionised water at 37°C and mass monitored using 
conventional gravimetric method until equilibrium was reached. The EWC and degree of 
swelling of the xerogels were determined using the following equation: 
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where Ws is hydrated weight and Wd the dry weight of xerogel prior to swelling.  
 
Tensile Strength 
Hydrogels were cut into dog bone shaped specimens (l=24mm t=4mm) and hydrated to 
equilibrium before tensile testing. Tensile test were carried out on a universal testing 
machine (Instron 5569A) at a rate of 5mm/min using a 50KN load cell. Bluehill (Instron) 
software was used to collect the mechanical data and measure: the tensile load (N), 
tensile stress (MPa), extension at tensile strength (mm) and Young’s modulus (MPa). 
 
Raman micro-spectroscopy 
The Raman spectra were recorded using Renishaw In-Via Raman Microscope with a 
785 nm diode laser, 1200 grating. Extended scans were carried out between 100-3500 
cm-1 frequency of the Raman spectra. 
 
Scanning electron microscopy (SEM) 
Scanning electron microscopy was carried out on selected samples placed on aluminium  
stubs using conductive blue then coated in a thin layer of gold before being placed in a 
vacuum container of quanta field emission scanning electron microscope (Quanta 200F 
microscope (FEI), using 10-20kV and 10,000x Magnification. 
 
3.7 RESULTS 
Viscosity of PVA polymer solutions 
A 98% hydrolysed PVA with an average molecular weight of 145,000 was used to 
prepare the aqueous solution of PVA. To obtain a homogenous solution even at high 
concentrations, the polymer was dissolved in water at 121°C with mechanical agitation to 
yield clear polymer solutions that did not require prolonged incubation in water. 
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Table 3-5: Viscosity of PVA solutions at 10, 20 and 30% concentration (w/v). 
 
The viscosity of the PVA polymer solutions are shown in Table 3-5 and as expected it 
was found to increase with increasing concentration. This indicated that an aqueous 
solution of PVA10 could be manipulated more easily   in comparison to PVA30. An 
increase of 10% concentration led to an approximate 11-12 fold rise in viscosity of the 
solutions. 
 
FTIR- infrared spectroscopy 
 
Figure 3-7: A comparison of the infrared absorbance peaks of air-dried only PVA10, 20 














































































































































3270 2919  1636 1424 1323 1088  836 
PVA air-
dried 
3276 2913 2960 1662 1417 1327 1087 916 840 
PVA 1FT 3319 2941 2969 1707 1419 1329 1089 919 842 
Table 3-6: The major FTIR absorption bands of the PVA granules and 10%(w/v) PVA 
hydrogels crosslinked by 1 freeze-thaw cycle and air-drying.  
 
 
Figure 3-8: A comparison of the infrared absorbance peaks of 10%PVA (w/v) air-dried 
only (AD), air-dried +one cycle of freeze-thaw (AD+1FT), and one cycle of freeze-thaw 
only (1FT) hydrogel films. 
 
A comparison of the FTIR spectra of all the PVA hydrogels with varying concentration 
and different methods of crosslinking is shown in Figure 3-7 and Figure 3-8. All showed 
characteristic absorption bands of PVA which can be assigned to the vibrations arising 
due to C=O, C-H, C-OH, C-O bonds, which are described in Table 3-6. A strong 
86 
characteristic feature of PVA is the O-H stretching band, indicating the presence of both 
the strong hydrogen bonding internally to OH or terminal vinyl OH groups,  with broad 
peaks centred at 3265, 3285 and 3269 cm-1 [183, 184] which were observed for all 
hydrogels. Hydroxyl groups from residual water also contribute to the peak intensity 
[185]. Two strong peaks arising from the C-H stretching of the alkyl groups at 2916 cm-1 
to 2969 cm-1, are characteristic bands of the C-H symmetric (νs) and CH2 asymmetric(νas) 
stretching vibration, with their position suggesting that the hydrocarbon chains of the 
polymer takes a trans zigzag conformation. The weak peak at 1595 cm-1 – 1636 cm-1 can 
be assigned to the C=O group from the residual acetate in PVA that result from 
manufacturing of PVA from hydrolysis of polyvinyl acetate. 
The peaks at 1416-1424 cm-1 can be assigned to the -CH2 bending with deformation 
bands of C-CH3 appearing at 1377 cm-1. The peaks at 1263 cm-1 and 1326 cm-1 are 
associated with CH2 wagging and the C-C, C-O-C stretching vibrations respectively. The 
sharp absorption bands indicate that the film formed by this process resulted in a semi 
crystalline PVA. The peaks at 1038-1088 cm-1 are attributed to –C-O-H bending and C-O 
stretching vibration coupled with -OH bending vibration. The atactic form of PVA is 
shown by the peaks at 915 – 918 cm-1 (-CH2 rocking) and 836 – 845 cm-1 (C-C 
stretching) [185-187]. 
 
Thermal analysis by differential scanning calorimetry (DSC) 
PVA 10, 20, 30%(w/v) were subjected to different crosslinking methods and the glass 
transition (Tg) and melting temperature (Tm) of the hydrogels post different treatments 
are presented in Table 3-7.  The 1st heating cycle of 1FT PVA displayed two endotherm 
melts that can be attributed to the loss of moisture or melting of crystallites due to the 
strong hydrogen bonding between PVA-water and PVA chains themselves [188]. Melting 
temperatures Tm for all remained relatively in a close range of 220.6 – 227°C. The 
literature value for the melting endotherm of PVA has been reported to be 230°C, which 
is slightly higher than the observed values [188]. The glass transition Tg, however 
showed that air dried (AD) gels had lower Tg (58.0 – 74.25 °C) than those of AD+1FT 
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and 1FT (61.1 -75.2°C, 69.4 – 73.4°C) respectively. Literature values for Tg of PVA have 
been reported to be ~80°C [189], but do range between 59°C to 74°C as noted in in 
previous studies [190]. 
 
Sample Name                      Conc. Of PVA in water (%) (Tg °C) (Tm °C) 
     Commercial PVA granules 69.6 226.2 
Air-dried (AD) 
10  74.2 228.1 
20  61.1 220.6 
30  58.0 226.4 
Air-dried and one cycle freeze 
thawed (AD + 1FT) 
10 75.2 226.5 
20  67.3 225.0 
30  61.1 222.2 
One cycle freeze thawed (1FT) 
10  73.4 227.0 
20  72.4 226.8 
30  70.5 227.0 
Table 3-7: Glass transition (Tg) and melting temperatures(Tm) of PVA 10,20,30%(w/v) 
crosslinked by air-drying, air-drying prior to freeze-thawing and one cycle of freeze-











Figure 3-10: The Raman spectra of  (a) PVA10 air dried (b) PVA10 air-dried and freeze 
thawing (c) and PVA10 freeze dried only. 
 
 Raman Spectra (cm-1) 
  
Assignment PVA10 Freeze dried 
only 
PVA10 Air-dried 





2920 2913   
C-H as stretching 2718 2709 2717 
amide, C=O, C-N 
stretching 
1651     
CH2 bending/ 
scissors 
1445 1443 1443 
CH bend 1358 1369 1372 
CH2 twist 1123 1148 1147 
C-C ring breathing 918 919 919 
C-C ring 857 857 858 
Table 3-8: The Raman peaks of each of the PVA hydrogel films cross-linked via three 
different methods along with its peak assignments. 
 
Figure 3-9 and Figure 3-10 illustrates and compares the Raman spectra of 
representative PVA10, 20 and 30 hydrogels cross-linked via air-drying, and PVA10 
hydrogels crosslinked via three different methods. The main differences between AD, 
AD+1FT, 1FT films, lie in the peaks between 1595-1661 cm-1 that corresponds to C=O 





groups. With the C=O peaks at 1600 cm-1, AD gels produced broader and multiple peaks 
at this frequency of the spectra compared to the sharper intense peaks of the AD+1FT 
and 1FT films. Individual absorption bands are described in Table 3-8 [191]. 
 
Equilibrium water uptake 
 
Figure 3-11: Equilibrium water uptake of the different hydrogel films of varying 
concentration prepared by one cycle freeze-thawing (1FT), air dried with  one cycle 
freeze–thawing (AD+1FT) and air dried (AD). (n=3) (* P<0.0001, ** P=0.28 and *** P≤0. 
013); asterisk linked with lines indicate significant difference in values between the 
groups 
 
Figure 3-11 shows the EWC attained from the different crosslinking methods with varying 
concentrations of PVA. The hydrogel films prepared by air drying (AD) exhibited the 
lowest EWC followed by air drying plus one cycle of freeze thawing (AD+1FT) and one 
cycle of freeze thawing (1FT) only. The EWC showed that with increasing concentration 
of PVA there was a decrease, irrespective of the method used to form the hydrogels, and 
that freeze thawing resulted in hydrogels with high water uptake as compared to all other 








Figure 3-12: A comparison of the tensile strengths (uniaxial tensile tests) of PVA 
hydrogel films with varying concentrations crosslinked by one cycle freeze-thaw (1FT), 
air-dried and one cycle freeze–thaw (AD+1FT) and air-dried (AD) films, tests were 
carried out on fully hydrated hydrogel films. (n=6) (* P=0.004, **P=0.016, *** & **** 
P=0.003, ***** P<0.001 and ****** P=0.019); asterisk linked with lines indicate significant 
difference in values between the groups 
 
 
Figure 3-13: A comparison of the Young’s modulus of PVA hydrogel films with varying 
concentration, carried out at equilibrium hydration after one cycle freeze-thaw (1FT), air-
dried and one cycle freeze–thaw (AD+1FT) and air-dried (AD) films. (n=6) (* P=0.030 
and ** P=0.049); asterisk linked with lines indicate significant difference in values 
between the groups 
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Results shown in Figure 3-12 indicated that, the tensile strength of all the hydrogels with 
different crosslinking methods increased with increasing concentration of PVA. The  
hydrogels subjected to freeze-thawing (FT) only, also exhibited the highest tensile 
strength, followed by AD+1FT and AD only hydrogels, in decreasing order. Stiffness of 
the hydrogels was variable (Figure 3-13 ), where with 1FT and AD+1FT there was no 
significant difference between the varying concentrations of PVA. 
 
Scanning Electron Microscopy (SEM) 
 
Figure 3-14:  Scanning electron micrographs of the surface of, [A] freeze thawed PVA 
showing undulated striations of PVA, [B] air-dried plus freeze thawed, [C] and air-dried 






The scanning electron micrographs of the AD, AD+1FT and FT only hydrogels of PVA10 
hydrogels are shown in Figure 3-14. The micrograph elucidated the varying 
morphologies of the hydrogels, and a smooth and homogenous surface was observed 
for the AD only hydrogel with faint, randomly arranged lines whilst the AD+1FT hydrogel 
had visible and aligned fibres, and the FT only hydrogel had a rough surface, with more 
visible directionally orientated fribrillar structure. The presence of crevice like gaps on the 




PVA hydrogels derived from physical process of gelation occur due to the numerous 
interchain hydrogen bonds between the hydroxyl groups and Van der Waals interaction 
between the hydrocarbon polymer back-bone. The controlling parameters are the 
molecular weight, degree of hydrolysis and concentration of the polymer, however there 
is a lack of information on the correlation of these parameters.  
The presence of the hydroxyl groups in each repeating unit, renders PVA with high 
hydrophilicity and ability to form hydrogen bonds enabling it to form crosslinked 
hydrogels. PVA hydrogels of concentrations 10, 20 and 30 (w/v %) were fabricated via 
physical crosslinking, the three techniques used were to just air dry (AD), air drying 
followed by freeze-thawing (AD-FT) and freeze thawing only (FT). The PVA hydrogels 
formed  were characterised and dedicated to developing a systematic understanding of 
how the microstructure, water uptake, thermal and mechanical properties of the 
fabricated hydrogels were affected by varying  the concentration of PVA polymer with a 
known molecular weight as well as the effects of different crosslinking methods on the 
aforementioned properties of the resultant hydrogels, as published literature does not 
provide understanding of these properties in a systematic manner.   
 
The dissolution of PVA is essential to form physical hydrogels. The dissolution of PVA in 
water is dependent on the molecular weight and the degree of hydrolysis of the polymer. 
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It has been reported that high dissolution temperatures are required to dissolve PVA in 
water, especially if it has a high degree of hydrolysis [55, 56] due to the strong intra and 
intermolecular hydrogen bonds. However, PVA with a low degree of hydrolysis contains 
too many acetate groups, which renders the polymer too hydrophobic to dissolve in 
water. In this study, a 98% hydrolysed PVA of molecular weight of 145,000 was used 
and the dissolution was conducted in water at 121°C with mechanical agitation to yield 
clear polymer solutions with ease that did not require prolonged incubation in water. The 
viscosity of PVA aqueous polymer solutions was found to increase with increasing 
concentration of PVA (Table 3-5), and an eleven fold increase in viscosity  was observed 
by doubling the concentration of PVA from 10 to 20 w/v% and a 12 fold increase from 20 
to 30 % w/v. The higher viscosity solutions posed some   difficulties in preparation of the 
polymer solution and fabrication of the hydrogels. The short range of action of both 
hydrogen bonding and Van der Waals interactions influences the interaction between the 
interacting chains and hydroxyl groups that dramatically affects the resultant gels.  
 
The effect of concentration of PVA solution on the properties of the PVA hydrogel 
films  
There are three basic models that explain the mechanism of gel formation via these 
physical means of crosslinking namely, i) hydrogen bonding, ii) polymer crystallite 
formation and iii) liquid-liquid phase separation [192], hence viscosity of the precursor 
solutions affect the three routes to gel formation. 
 
FTIR spectra of the PVA hydrogels formed with different concentrations of PVA 
solutions 
Infrared spectroscopy probes the molecular vibrations, and detects frequencies of 
infrared light that are absorbed by a molecule. Molecules absorb these frequencies of 
light because they correspond to the frequencies of vibrations of bonds in the molecule. 
Functional groups can be associated with characteristic infrared absorption bands, which 
correspond to the fundamental vibrations of the functional groups. For a molecule to 
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show infrared absorption it must possess a specific feature, which is an electric dipole 
moment which changes during vibration as the bond expands and contracts, strong IR 
absorptions are observed for groups with a permanent dipole such as the carbonyl 
groups. IR spectrometer records light absorbed from around 4000 cm-1 to 400 cm-1, 
whereby frequencies with higher wavenumbers have more energy, while those with 
lower wavenumbers have less energy. Two types of vibration giving rise to absorption 
can involve either change in bond length (stretching) or bond angle (bending). With 
stretching bonds can stretch in-phase (symmetrical stretching) or out of phase 
(asymmetric stretching). Bending which is due to change in bond angle can either be in 
plane (rocking, scissoring) or out of plane (wagging, twisting) [193]. 
 
A comparison of the infrared absorbance peaks for air-dried PVA hydrogels of 
concentration 10, 20 and 30 are presented on Figure 3-7. No major distinct differences 
were observed in the spectra, however in general broad, high intensity peaks in PVA 30 
were noted, arising due to the higher concentration of the polymer. Characteristics peaks 
at the 2850-2920, 1494-1427, 1280-1315 and 1160-1230 cm-1 frequencies associated 
with C-H vibrations of the PVA backbone (Table 3-6) were observed in the native PVA 
and the hydrogels. This was expected since the chemical composition of all the 
hydrogels remained unchanged. Compared to PVA granules, the OH peaks of 3000-
3600 cm-1 frequency in the PVA hydrogels were shallower and broader indicating less 
hydroxyl groups in hydrogels especially at  high PVA concentrations [194], this due to the 
loss of unbound H2O in the hydrogels during the process of air-drying.  
 
Thermal analysis of the films with different concentration of PVA solutions 
Differential Scanning Calorimetry (DSC), is a thermal analysis technique that measures 
the energy changes that occur as a sample is heated, cooled or held isothermally, 
together with the temperature at which these changes occur. The energy changes 
enable measurement of the transitions that occur in the sample quantitatively, while 
noting the temperature where any changes occur, so as to allow for characterisation of 
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glass transition temperature, melting processes and phase changes [195]. The glass 
transition (Tg) is when a material transitions from a solid to a soft rubbery state due to 
independent movement of molecules in the structure. In non-crystalline and semi-
crystalline polymer of any type, the Tg is the best indicator of material properties. As the 
Tg changes due to either different degrees of polymerization or modification by additives, 
the physical properties of the material change [196]. 
 
The melting temperature Tm of the hydrogels fabricated and formed as films using 10, 20 
& 30% concentration of PVA in water was found to have values between 220-228°C, 
which was in close range with those reported in literature for PVA.  PVA has been 
reported to exhibit a melting point of 230°C and 180-190°C for the fully hydrolysed and 
partially hydrolysed grades respectively.  
The Tg values of the experimental hydrogels were between 58-700C, whilst literature 
values report them between ~60 to 80°C, after which PVA gels tend to lose their 
mechanical integrity [197]. The close agreement in the values with literature clearly 
showed that the heating regime used to dissolve the PVA initially to form the aqueous 
solutions did not have any effect on the polymers. However, it was expected that Tg 
would increase with increased polymer concentration because, the segmental mobility of 
polymer chains becomes restricted as the solution concentration is increased, possibly 
due to enhanced intermolecular hydrogen bonding but in fact Tg values were found to 
decrease with increasing concentration of PVA within each of the 1FT, AD+1FT and AD 
only groups. This indicated lower thermal stability in hydrogels with increasing 
concentration of PVA which, may be attributed to the presence of bound water within the 
gels. It has also been reported that glass transition can decrease significantly in the 
presence of water, thus this indicates that there may have been some residual water left 





Raman spectra analysis  
Raman scattering is a spectroscopic technique, where photons induce a change in 
polarizability of a molecule with respect to its vibrational motion. The interaction of 
polarizability with the incoming radiation creates an induced dipole moment in the 
molecule, and the radiation emitted by this induced dipole moment contains the 
observed Raman scattering. The light scattered by the induced dipole moment contains 
both Rayleigh scattering and Raman scattering. Rayleigh scattering corresponds to the 
light scattered at the frequency of incident radiation, whereas Raman radiation is shifted 
in frequency, and hence energy, from the frequency of the incident radiation by the 
vibrational energy that is gained or lost in the molecule.  
This form of spectroscopy allows for the distinction of primary and secondary alcohols 
based on the location of the peaks assigned to the deformation of the hydroxyl group 
[198]. The medium intensity bands between 1140 and 1085 cm-1 are assigned to the C-O 
stretch of secondary alcohols on the PVA backbone, and the weak band at 1050 – 1000 
cm-1 attributed to the C-O stretch of primary alcohols on the ends of the polymer chain, 
whilst the ~1085-1000 cm-1 region is also attributed to O-H bending. The bands at 1145 
cm-1 and 1445-1475 cm-1 are associated with C-C stretching and CH2 deformation 
respectively. The presence of high intensity broad peaks in the 1444, 1157 and 1094 cm-
1 frequency in all three Raman spectra indicate PVA’s crystallinity [191]. Differences in 
the spectra were observed in the intensity of the absorbance peaks, where low intensity 
was observed with PVA30 hydrogels whilst the highest was observed with PVA20 
hydrogel. 
 
Water uptake of hydrogels  
When a biopolymer network is in contact with an aqueous solution or a biological fluid, 
the network starts to swell due to the thermodynamic compatibility of the polymer chains 
and water. The first water molecules entering the matrix will hydrate the most polar, 
hydrophilic groups, leading to ‘primary bound water’. As the polar groups are hydrated, 
the network swells and exposes hydrophobic groups, which also interact with water 
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molecules, leading to hydrophobically-bound water, or ‘secondary bound water’. Primary 
and secondary bound water are often combined and simply called the ‘total bound 
water’. After the polar and hydrophobic sites have interacted with and bound water 
molecules, the network will imbibe additional water, due to the osmotic driving force of 
the network chains towards infinite dilution. The additional swelling water that is imbibed 
after the ionic, polar and hydrophobic groups become saturated with bound water is 
called ‘free water’ or ‘bulk water’, and is assumed to fill the space between the network 
chains, and/or the centre of larger pores, macropores or voids. The swelling force is 
counterbalanced by the retractive force induced by the cross-links of the network and the 
swelling equilibrium is reached when these two forces are equal. As the network swells, 
if the network chains or crosslinks are degradable, the gel begins to disintegrate and 
dissolve, at a rate depending on its composition. The character of the water in a hydrogel 
can determine the overall permeation of nutrients into and cellular products out of the gel 
[128, 199]. 
Hydration results are presented on Figure 3-11, and a comparison of the effect of 
increasing PVA concentration on EWC within the 3 different crosslinking groups was 
analysed. Results indicated that EWC decreased with increasing polymer concentration 
for all groups of crosslinking.  For the freeze thawed groups, PVA10-1FT had a 
significantly higher EWC of 83.1% 
than PVA20 (69.1%) and 30-1FT 
(66.7%), at P values <0.001 
respectively. PVA10-AD+1FT had 
a EWC of 69.6% which was 
significantly higher (P=0.028) than 
that of PVA20-AD+1FT (60.7%), 
however there was no difference in 
EWC comparison between PVA30 
and 20 AD+1FT. Hydrogels crosslinked by air-drying only, showed that PVA10-AD had 
an EWC of 61.8% which was significantly higher than PVA20 (52.8%) and 30 (55.2%) 
Figure 3-15: Effect of varying concentration of PVA 
on the EWC (%) of the hydrogel films. 
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AD (P= 0.04 and 0.013 respectively) with no significant difference between PVA 20 and 
30 AD. This demonstrated that concentration of PVA does have a direct effect on the 
EWC of the hydrogels, implications were that lower concentration of PVA has a higher 
capacity for bulk and bonded water that make up the increase in weight. The decrease in 
EWC with increasing concentration demonstrated in this study was in agreement with 
results reported in literature where it was found that swelling ratio of their freeze thawed 
PVA hydrogels decreased with increase in PVA concentration using concentrations 6, 12 
and 25%PVA [158, 200]. This was as a result of the increasing volume fraction of the 
polymer in the freeze dried gel, which effectively enhance the interaction between the 
PVA-PVA chains, thus an increased extent of crosslinking in the hydrogel results in a 
decrease in the swelling ratio.  
 
Tensile strength of films formed with different concentrations of PVA solutions  
Concentration of 10%PVA hydrogels exhibited the lowest tensile strength in comparison 
to PVA 20 and 30 
hydrogels Figure 3-12. A 
comparison of the effect 
of varying PVA 
concentration within the 
individual groups of 
crosslinking showed that, 
in the case of hydrogels 
prepared by FT and 
AD+1FT, the tensile 
strength of PVA 20 and 30 hydrogels (5.9 and 5.2MPa)FT, (5.1 and 5.0MPa)AD+1FT 
respectively were found to be significantly higher than that of PVA10 hydrogels prepared 
by both methods (P<0.016). However there was no significant difference in tensile 
strength between the PVA20 and 30 hydrogels within each of the two FT and AD+1FT 
Figure 3-16: Effect of varying concentration of PVA on the 
ultimate tensile strength of the hydrogel films. 
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groups. With AD hydrogels there was a significant increase in the tensile strength of the 
hydrogels with increasing concentrations (P< 0.019). These results are in agreement 
with those obtained from the EWC, where the highest water uptake was obtained with 
PVA10 hydrogels. The explanation for this being that with a lower concentration of PVA 
there is less hydrogen bonding as compared to hydrogels with higher polymer 
concentration, therefore resulting in higher water up take for hydrogels of 10%PVA 
concentration. Also when water is removed from the aqueous polymer solutions of lower 
concentration i.e PVA10, by AD or FT this results in less crystallised and more 
amorphous regions within the hydrogel as compared to those formed in the presence of 
high polymer concentration. Results exhibited the highest tensile strength increase with 
PVA 20 hydrogels, which then decreased with increase in polymer concentration to PVA 
30, with the exception of AD hydrogels, whose tensile strength was found to increase 
with increasing concentration of PVA. These results are in agreement with those from 
literature where, in a study on preparation of self-healable PVA hydrogels fabricated by 
freeze thawing the authors found tensile strength of PVA hydrogels to increase with 
increase in PVA content [200]. Another study on effect of freeze thaw cycles (15FT) and 
polymer concentration on tensile strength of PVA, reported that tensile strength of their 
hydrogels increased with increasing concentration of PVA [201].   
Young’s modulus of the hydrogels with varying concentration of PVA was found to 
provide results with no significant difference within the FT and AD+1FT crosslinked 
groups. However with AD hydrogels it was found that PVA10 and PVA30 hydrogels had 
a stiffness (2.4 and 2.2 MPa respectively), which was significantly higher than that of 
PVA20 hydrogels P=0.030 and 0.049 respectively. The trend of these results is 
contradictory to those in literature where PVA stiffness was found to increase with 






The effect of different crosslinking methods on the properties of the PVA hydrogel 
films 
One of the main advantages of crosslinking of PVA solutions by repeated cycles of 
freezing and thawing is that no additional crosslinking agents are used. The air-drying 
prior to freeze thawing also has the same advantage, however forming homogenous 
films and imbibing porosity at a later stage on the formed film by eliminating water allows 
better control on maintaining shape and form. Crosslinking methods employed were 
reproducible cost effective with ease of fabrication. 
 
FTIR- infrared spectroscopy films crosslinked by different methods 
The FTIR spectra of AD, AD+1FT and 1FT are shown in Figure 3-8. The OH- stretching 
mode observed in the infra-red spectrum is a suitable band for monitoring the presence 
of hydrogen bonds that are involved in the crosslinking and gelation process of PVA 
hydrogels. The intensity of the peak at 1141 cm-1 in the IR spectrum depends on the 
degree of crystallinity, the band arises from a C-C stretching mode and increases with 
increase in the degree of crystallinity, which is determined by the method of fabrication. 
The spectra indicated that there is a higher degree of crosslinking in the FT and AD+FT 
groups as the peaks associated with the –OH are sharp with lower intensity in 
comparison to just air dried PVA hydrogel film. Stretching of the C-O bonds from primary 
alcohol groups in PVA can be observed through the peaks 1050-1095 cm-1 in crosslinked 
PVA, and this peak is associated more with the aliphatic ethers present in crosslinked 
polymers. 
 
Thermal analysis of films crosslinked by different methods 
Thermal analysis results of the hydrogels crosslinked by different methods showed that 
thermal stability is improved with freeze-thawing.  A clear trend was observed (in the 
case of PVA20 and 30) across the different groups where Tg increased in value from AD 
to AD+1FT and 1FT presenting with the highest Tg, however with the exception of 
PVA10 even though there was no significant difference between the values. PVA20 
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Figure 3-17: The effect of the crosslinking methods on the 
EWC (%) of the hydrogel films. 
(61.1-67.3-72.4)°C, PVA30 (58.0-61.1-70.5)°C for AD, AD+1FT and 1FT respectively. 
This result implied that there is greater thermal stability and formation of crystalline 
networks as a result of freeze thawing compared to air-drying alone. 
 
Water uptake of hydrogels (EWC) crosslinked by different methods 
A trend was observed on the EWC results obtained by the different methods of 
crosslinking, where EWC decreased in order with FT hydrogels exhibiting the highest 
EWC followed by AD+1FT and AD only hydrogels.  PVA10-1FT exhibited the highest 
EWC (83.1%, P≤0.001) 
as compared to PVA10 
AD and AD+1FT. EWC of 
PVA10-AD+1FT was 
significantly higher (P= 
0.010) than that of 
PVA10-AD. For PVA20 
hydrogels EWC of 
PVA20-1FT (69.1%, 
P≤0.002) hydrogels was 
significantly higher that of the PVA20 AD+1FT and AD only hydrogels, while comparison 
of PVA20-AD+1FT hydrogels showed a significantly (P=0.001) higher difference than the 
PVA20-AD hydrogel. Comparison of different crosslinking methods on PVA30 showed 
that FT resulted in significantly higher water uptake (66.7%) than AD and AD+1FT, 
P=0.003 and 0.009 respectively. Overall for all concentrations of PVA this indicated that 
water content of the hydrogels was higher for freeze-dried as compared to just air-dried 
hydrogels. This could be attributed to the micropores that result from the crystallising of 
bulk water molecules and its subsequent removal by vacuum suction from the hydrogel 
matrix as a result of freeze thawing. The presence of micropores could have facilitated 
the ingression of water and created more space within the matrix for storage of bulk 
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Figure 3-18: the effect of method of crosslinking on 
the final tensile strength of the hydrogel films. 
water thus the higher EWC. The subsequent exposure to distilled water during the 
hydration cycle allows for these spaces to be refilled through the pores created. 
 
Tensile strength of hydrogels crosslinked by different methods 
The effect of different methods 
of crosslinking on the resultant 
PVA hydrogels was analysed. 
Within the individual groups of 
PVA concentration, the tensile 
strength was found to 
decrease in order from FT 
hydrogels with the highest 
tensile strength, followed by 
AD+1FT and AD only 
hydrogels. Comparative analysis on the effect of crosslinking method for each individual 
concentration groups of the hydrogel films indicated that, for PVA 10 and 20 hydrogels 
tensile strength results of FT (3.0 and 5.9MPa) and AD+1FT (2.5 and 5.1MPa) hydrogels 
respectively was significantly higher than that of AD hydrogels at P (0.004 and 0.018) 
and P (<0.001 and 0.002) for PVA10 and 20 respectively. PVA30 hydrogels showed that 
the method of cross linking had no direct influence on the tensile strengths with only a 
slight lowering observed with the air drying method. The trend observed in this study 
where FT hydrogels exhibited higher tensile strengths than AD hydrogels is in agreement 
with reports on a study investigating the tensile strength of PVA films of freeze thawed 
cycled gels, where the tensile strength values from their cast PVA gels were lower than 
those from the freeze thawed gel [202]. This observation is simply explained by the fact 
that freeze thawed hydrogels undergo crystallite formation which can be reinforced by 
increasing cycles of FT, the presence of crystalline regions serve as the physical 
crosslink junctions along which mechanical load is distributed, hence resulting in higher 
tensile strength. The different methods of crosslinking between the PVA10 and 30 
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hydrogels displayed no significant difference in stiffness, whilst with PVA20 hydrogels FT 
and AD+1FT hydrogels significantly higher stiffness as compared to the AD hydrogels 
P= 0.039 and 0.002 respectively. Stiffness values displayed by the PVA201FT and 
AD+1FT  against the AD hydrogels, are in close agreement with those obtained in 
published literature where the authors observed  FT hydrogels to have higher Young’s 
modulus than cast PVA hydrogels [202].  
 
SEM analysis 
SEM micrographs of FT, AD+1FT and AD hydrogels are displayed in Figure 3-14  which 
show that the different methods of fabricating the hydrogels results in vividly contrasting 
microstructures of the resultant hydrogel. It was observed that with FT and AD+1FT 
hydrogels a fribrilar microstructure was present, which was more pronounced on the FT 
only hydrogels, this can be explained by the formation of crystallites on the hydrogels 
during the freeze thawing process. Also this fribrilar structure exhibited gross oriental 
order over macroscopic length resulting from abrupt dendritic growth of crystals  during 
the first freezing of aqueous polymer solution at -80°C before subjecting the gels to 
freeze drying, similar observations have been reported [197] where the author went 
forward to state that “the basic scaffolding for this crystallisation is mechanically 
imprinted in the polymer network presumably occurring during the first quench, because 
the water structure is lost during the thaw portion of each cycle.” Interpretation of this 
statement to observations from this study was that the imprinting of the crystal 
orientation on the hydrogels first occurs when they are subjected to freezing at -80°C as 
water is lost through sublimation during the freeze drying process. It was also observed 
that FT hydrogels were opaque, AD+FT hydrogels presented with a less opaque overall 
structure and AD only hydrogels looked translucent, a similar observation was observed 
in one study self-healable PVA hydrogels, however their observations were discussed 
with  reference to PVA hydrogel morphologies fabricated from various concentrations on 
PVA. Briefly they stated that PVA crystallites formed at low concentrations of PVA form 
easily and are larger. The larger crystallites scatter more visible light which make the 
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hydrogels look opaque [200]. It can be inferred that for AD hydrogels the crystallite size 
is small hence resulting in hydrogels that look nearly transparent, the notion of small 
crystallites forming on AD hydrogels is deduced from a published discussion [197], which 
presented opinions from various published papers which argued that the driving force for 
spontaneous gelation of aqueous PVA solutions at room temperature is partly due to the 
role of crystallinity in polymer rich phases or liquid-liquid phase separation, which has 
been argued by other authors that crystallinity may be occurring from frustrated 
crystallisation kinetics instead of arising from polymer rich phases in the solution, 




3D hydrogels were obtained by facile methods of crosslinking and it was evident that 
both the concentration and method of crosslinking affected the physical and mechanical 
properties. Since the polydispersity, molecular weight and degree of hydrolysis of the 
PVA used in the study was identical for formulating the solutions to yield the hydrogels, it 
can be concluded that indeed an optimum concentration leads to optimised mechanical 
and physical properties. The high EWC results indicated that there is a high microporisity 
in the FT hydrogels in comparison to the AD+1FT and AD only hydrogels. The lack of a 
more pronounced crystalline structure is observed with AD hydrogels characterised by 
their low tensile strength, apart from the PVA30 hydrogels due to a high polymer-polymer 
chain interaction by virtue of the high concentration of PVA.  These results have enabled 
the identification of base line properties of PVA with known molecular weight as follows. 
 PVA of 10%(w/v) concentration had the lowest viscosity and was found to be 
easier to prepare and handle during fabrication of hydrogels. This implied that 
when moving forward to optimise studies for formation of dual networks, this 
concentration would be selected. 
 Freeze thawing technique was found to yield hydrogels with higher tensile 
strength, indicating that for fabrication of mechanically tough hydrogels (dual 
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networks) this method would be selected as the 1st option for crosslinking. 
However due to the limited significant difference between FT and AD+1FT, dual 
networks developed by both methods would be studied to develop a clear distinct 

























Chapter 4  
Combinatorial design of 
mechanically tough bone-like 
biocomposites 
4.1 INTRODUCTION 
Calcium phosphate based biomaterials have been recognised for the pivotal role they 
play in bone regeneration. Traditionally, biomaterials such as hydroxyapatite have been 
used as biomimetic supports to allow cell adhesion and maintain cell viability, however in 
the last two decades the importance of a porous interconnected network in a bone 
substitute has been established, and has been shown to play an important role in their 
performance. An interconnected porous network facilitates mass transfer and nutrient 
flow; a large surface area favours cell adhesion and proliferation whereas high pore 
volume allows the delivery of cell population for the regeneration process. Although a 
porous architecture is beneficial, it has an adverse bearing on the mechanical properties.  
Thus, the brittleness of the ceramic calcium phosphates combined with porosity leads to 
a fragile structure. It has also been highlighted that adequate wettability of the 
biomaterial has a direct correlation on protein adsorption and eventually the cell fate. 
Furthermore, the ability of a bone substitute to release biomolecules to enable rapid 
tissue formation is a consideration that is becoming apparent, whilst designing new 
biomaterials to function as efficacious bone substitutes. 
Calcium phosphates (CaPs) are the major constituents of bone mineral and have 
received much attention as bone substitutes. The most extensively used CaP ceramic for 
bone replacement is hydroxyapatite (HA), because of its chemical similarities to the 
inorganic components of bone. It has been subsequently shown that these materials 
were able to enhance bone formation, guide bone ingrowth on their surface and undergo 
direct bonding with bone, without the formation of a ﬁbrous capsule [203]. Hydroxyapatite 
is deemed to be the most stable phase and slight imbalances in the Ca/P ratio of HA 
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(1.67) can lead to the appearance of different phases. For example if Ca/P is lower than 
1.67, β-tricalcium phosphate (β-TCP) and other phases such as tetracalcium phosphate 
(TTCP), is often seen with the HA phase. Tri calcium phosphate (TCP) is a 
biodegradable bioceramic that has four polymorphs, the most common being α and β; α-
TCP is produced at temperatures in excess of 1125°C and β-TCP at lower temperatures 
800-1000°C [204]. Both these phases are less stable than HA and hence more soluble in 
aqueous environments. The use of a tailor made mixture of HA and β-TCP known as 
biphasic calcium phosphate (BCP) has been used as bone substitute, which combines 
the low solubility and osteoconductivity of apatite with a more soluble phase such as 
TCP. Its resorption rate can be monitored and controlled by varying ceramic particle 
ratios, for example a higher ratio of TCP in BCP leads to a higher dissolution rate [205]. 
By mixing various calcium phosphates, setting cements be formed, called a calcium 
phosphate cement CPC, [206]. CPCs are hydraulic cements that undergo setting when 
one or more calcium orthophosphate powders and a liquid phase usually water or an 
aqueous solution is mixed under ambient conditions. The end results of this reaction only 
has two different end products i.e. precipitated HA at a pH >4.2 or brushite (DCPD) at a 
pH<4.2. The hydroxyapatite formed on the setting of CPC is similar to the biological 
apatites than the ceramic hydroxyapatite, which takes place at body temperature in a 
physiological environment [207]. The setting and solidification process of CPCs are 
based on two types of reactions which are hydrolysis and acid-base reactions [208, 209]. 
This mouldable or injectable paste can be adapted to bone defect sites due to their 
ability to set under ambient conditions hardening inside the damaged bone tissue and 
generating low heat transfer that avoids the premature death of surrounding cells [210]. 







Type of calcium phosphate Abbreviation Formula Ca/P 
ratio 
Hydroxyapatite HA Ca10(PO4)6(OH)2 1.67 
Tetracalcium phosphate TTCP Ca4O(PO4)2 2.0 
Tricalcium phosphate (α,β,γ) TCP Ca3(PO4)2 1.5 
Octacalcium phosphate OCP Ca8H2(PO4)6.H2O 1.33 
Dicalcium phosphate dihydrate 
(brushite) 
DCPD CaHPO4.2H2O 1.0 
Dicalcium phosphate (monetite) DCP CaHPO4 1.0 
Monocalcium phosphate 
monohydrate 
MCPM, CPM Ca(H2PO4)2.H2O 0.5 
Calcium metaphosphate CMP Ca(PO3)2 0.5 
Table 4-1: Various calcium phosphates with the respective Ca/P ratios [205]. 
 
Traditionally, calcium phosphate ceramics have been processed by sintering at high 
temperatures, this type of process is restricted basically to obtaining stoichiometric HA 
and TCP. It can also be employed in the production of both dense, porous and 
mechanically stable grafts, as the fusion of crystals during sintering process reduces the 
porosity (obtained from compaction before sintering) while increasing the strength and 
density of the ceramic scaffold. Variation of pressure, temperature and the chemical 
composition of initial powders influences the final structure of the sintered CaP ceramic 
[211].  
 
HA grafts are osteoconductive [212] and can  induce a high rate of cellular activity, 
proliferation, differentiation and mineralisation in vivo [213, 214]. However HA is 
considered non resorbable as cellular resorption by macrophages is hardly seen, with 
the exception of small sized HA particle sizes (85nm to 3.2μm), which can be resorbed 
by phagocytes [215-217]. HA has also been used as surface coating material on 
implants such as titanium dental implants and hip and knee prostheses [218].  
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β-TCP bone graft substitutes in clinical use and animal studies [219, 220] show that both  
particle size as well as architectural design (pore size and interconnectivity) determine 
the resorption rate of β-TCP in vivo. TCP resorbs in the early phases making way for 
tissue invasion and bone formation whilst the graft resorbs. The osteoinductivity of CPCs 
in particular varies significantly depending on material properties. CPCs have perfect 
adaptability during implantation due to their minimally invasive injectable capability, self-
setting ability in vivo and are bioactive leading to enhanced bone healing. The material is 
resorbed by two different mechanisms: - active resorption (regulated living cells like 
macrophages or osteoclasts) and passive resorption (which takes place via chemical 
dissolution or hydrolysis in the body fluids). However CPCs are dense with weak 
mechanical properties, and may incur microbial contamination during the synthesis 
process, which can lead to problems during implantation [207].  
 
More recently, calcium metaphosphate (CMP) has been proposed as an alternative bone  
substitute material, due to its biocompatibility, degradability and osteoconductive 
properties, provoking specific responses at the interface of the materials resulting in the 
formation of a strong bonds between the tissue and material [221]. Lee & Seol et al 2001 
reported that several authors [222-224] had proposed CMP as a bone implant material 
both in fibre and porous rod form, and could successfully be used as it was 
demonstrated that there was bone growth on calcium polyphosphate CPP structure in 
vitro and in vivo [175, 225]. There are four known crystalline forms (α, β, γ, δ) of CMP 
[226] with β-CMP reported to be the most stable, with high moisture resistance and the 
ability to maintain dimensional and mechanical integrity on exposure to moisture [1]. 
 
Buranawat et al [227] demonstrated the potential of a modified meta calcium phosphate 
construct with mixed porosity as a bone graft that resorbed in vivo within 8 weeks in a 
rabbit model showing new bone formation and complete healing across a critical sized 
defect in a rabbit model. The CMP discs in the study with mixed porosities showed a 
remarkable ability to resorb with rapid bone formation but essentially resulted in a brittle 
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material, not suited for surgical shaping in theatre to fit the anatomy of the bone defect or 
for load bearing applications.  
 
PVA hydrogel has attracted attention in the development of articular cartilage 
replacement due to its high swelling ratio, easy processing [228] and cytocompatibility 
[229]. With the detailed study on the cross linking of PVA using freeze-thaw cycles, 
yielding a porous architecture and the ability to regulate the mechanical properties, 
combined with the bioactive properties of the modified meta calcium phosphate 
constructs and its degradability. 
It was postulated that a composite hydrogel formed of a matrix derived from PVA with 
the dispersed phase as the meta-calcium phosphate would enhance the mechanical and 
osteoconductive competence. Employing a hydrogel as a matrix would also facilitate 
nutrient transport throughout the matrix, absorption of platelet rich plasma (PRP), 
localisation of bioactive molecules or growth factors and enable scaffolds with high 
permeability to support mass transfer requirements whilst providing a 3-D template for 
the cells generating highly compliant scaffolds.  
The scaffolds fabricated in this study were evaluated for their potential use as a bone 











4.2 MATERIALS AND METHODS 
MATERIALS CONCENTRATION 
Poly(vinyl alcohol) (PVA), 145,000 mol. wt. 
hydrolysis ≥ 98% (Merck, Schuchardt OHG) 
10, 20 and 30%wt./v 
CMP (Calcium metaphosphate) ( prepared in 
house, method by Deb et al) 
60%wt with respect to PVA 
MCPM (Monocalcium phosphate 
monohydrate) Ca(H2PO4)2.H2O (M=252,07) 
Scharlab S.L 
 
Table 4-2: Materials used for fabrication of the hydrogel composites. 
 
Filler phase: Monocalcium phosphate monohydrate (MCPM) powder was compressed 
into pellets and sintered using a temperature programme described in Figure 4-1. The 
resultant mass was cooled and milled to a fine powder using zirconia beads. Structural 
changes of conversion of MCPM to CMP were analysed by FTIR, XRD and the particle 
size was determined.  
 
Figure 4-1: Temperature programme for sintering MCPM to CMP, time required by 
thermal process ~36h (including cooling step). 
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Matrix phase:  PVA 10, 20 and 30 % w/v aqueous solutions were prepared by dissolution 
of the appropriate amount of PVA granules in distilled water and magnetically stirred at 
121°C until all the PVA granules dissolved to form a homogenous solution. 
Composite: The aqueous PVA solutions were mixed with CMP powder using ratio 1:1.5 
(40%PVA:60%CMP) so as to obtain a paste like consistency. The amount of CMP was 
kept constant based on a pilot study that was designed to incorporate the highest 
amount of CMP yielding a mouldable paste. This mixture was subjected to centrifugation 
at 3400rpm for 15 minutes after which excess PVA was decanted. The paste was then 
subjected to freeze drying for 24h, and placed in desiccator immediately. All composites 
were prepared by 1 cycle of freeze drying and thawing (1FT). (NB: Hydrogels and 
composites were subjected to freeze drying in the upper chamber of the freeze dryer). 
 
4.3 CHARACTERISATION 
Particle size analysis 
The particle size analysis was carried out using a CILAS 1180 laser diffraction particle 
analyser (Cilas, Orleans; France) operating at an 830nm central wavelength and 7mW 
energy power. The measurement was conducted by introducing approximately 200 mg 
of the powder into the tank of the analysing unit in an aqueous medium. The powders 
were sonicated (frequency 38 KHz for 60 sec) to aid dispersion in the media prior to the 
analysis. The system was cleaned and a background control reading was taken prior to 
each actual measurement. The results were analysed using the standard operating 
parameters by means of a software package provided (Particle Size Expert, Cilas, 
Orleans; France). The results are expressed numerically for the median particle size 
(d50), the 10th percentile particle size (d10) and the 90th percentile size (d90). In 







The infrared spectral analysis was performed to characterise the chemical interaction of 
PVA with CMP. The experimental procedure is detailed in the materials and method 
section of chapter 3.  
 
Raman spectroscopy 
The Raman spectra of the chemical structure of the hydrogel composites were recorded 
on a Renishaw Invia Raman microscope. The experimental procedure is detailed in the 
materials and method section of chapter 3. 
 
DSC analysis 
DSC thermograms of the composite samples were recorded on a PerkinElmer DSC Jade 
analyser, as detailed in the materials and method section of chapter 3. 
 
Equilibrium Water Content (EWC) 
The hydration studies were performed as detailed in the materials and method section of 
chapter 3. 
The degree of swelling in water is defined as the ratio of the water mass of swollen gel to 
the dry gels mass. The swollen gel was measured by allowing gel samples to reach the 
equilibrium state in distilled water at the room temperature while the dry gel mass was 
determined by drying the gel samples to constant weight in a vacuum at 30°C. 
 
Weight swelling ratio (SR) =  
The gel fraction was defined as the ratio of the dried gel mass weight to the initial mass 
weight of the polymer. 
Gel %=    
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Compression & diametral compression 
A universal testing machine (Instron 5569A) with a cell load cell of 50KN and a 
crosshead rate of 0.5mm/min was used to determine the compression carried out on 
cylindrical specimens with dimensions (ϕ=4 mm, h=6 mm). Diametral compression was 
carried out on specimens with dimension d=12 mm and t=6 mm. The load to failure P 
obtained, was used to calculate strength using the formula σT= 2P/πDt. 
Where P is the indirect tensile load, d and t are the diameter and thickness of the 
specimens respectively.  
 
Dynamic Amplitude Scan (DMA) 
Rectangular bars with dimensions (L=34.6mm, W=10mm, and t=4.2mm) were tested 
with a dynamic mechanical analyser (DMA 8000 Perkin Elmer) in three point bending 
over a sweep of physiological frequencies (1–10Hz) at 25°C and displacement amplitude 
0.3mm. To determine best amplitude or force to use when running a multi frequency 
scan, a dynamic amplitude scan was carried out at amplitude 0.001mm-1mm with 
frequency 1Hz at 25°C. Using the damping factor a suitable amplitude region was 
selected to run the multi frequency scans. Multi frequency scans were run at an 
amplitude 0.3mm which was selected to be suitable from dynamic amplitude scans. Prior 
to measurements, the samples were hydrated to equilibrium. The data measured were 
storage (E’) and loss (E’’) moduli. Loss tangent was determined for each frequency as 
the ratio E’’/E’. 
 
SEM 
The morphology of the hydrogel composites were determined using the methodology as 
detailed in the materials and method section of chapter 3. 
 
EDAX 
EDAX of the composites was determined using the methodology as detailed in the 
materials and method section of chapter 3. 
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CYTOCCOMPATIBILITY 
The role of a biomaterial is one in which the properties of the material will facilitate tissue 
regeneration, the key function being their interaction and ability to support cell growth. 
All hydrogels were sterilised by gamma radiation and hydrated for 24hrs before use in 
cell culture. 
 
Human osteoblast (HOB) cell expansion 
The primary HOB cells used were obtained from the femur of healthy patients 
undergoing surgery. The cells were expanded and used at passage 24, after full 
characterisation as previously described by Di Silvio and Gurav (2001)[230]. The growth 
medium was Dulbecco’s Modified Eagle Medium (DMEM; D6046) (Sigma), containing : 
10% Foetal calf serum (FCS) (Sigma), 5% of HEPES, 1% Minimal essential medium 
(MEM) (Sigma), 20 mM L-glutamines, 100 units/ml penicillin, 0.1 mg/ml streptomycin 
(Sigma). The cells were incubated in a humid atmosphere with 5% CO2 at 37ºC.   
 
Cell seeding and counting 
Before seeding cells were counted and viability assessed using 0.1% Trypan blue 
solution in PBS with a haemocytometer. 10µl of cell suspension was added to 10µl of 
trypan blue stain; mixed and transferred to a haemocytometer and cells counted under 
the light microscope using a cell counter. 
Cells were seed at 1x105cells/ml for indirect (elution) studies. For direct studies, rolling 
method was used to seed hydrogels with 3.29x105 cells for each sample, and 
2x104cells/well for the controls. Cells with hydrogels were placed on a rotating mixer for 
1hour at room temperature to allow for cell attachment on either size of the hydrogels, 
after which hydrogels were placed in well plates with HOB media and incubated for 
designated tests. Prior to each test all hydrogel materials were moved to a new well plate 




Cytotoxicity testing (indirect MTT cytocompatibility assay) 
MTT assay was used to determine in vitro cytotoxicity of biomaterials by assessing cell 
metabolic activity. The mitochondrial enzyme succinate-dehydrogenase within the viable 
cells is able to cleave the yellow tetrazolium salt MTT [3-(4,5-dimethylthiazol-2-yl)] and 
reduce it to form insoluble purple formazin crystals, which can be dissolved by addition of 
a detergent such as dimethyl sulfoxide (DMSO). The amount of formazin produced is 
directly proportional to the number of viable cells present, whose colour can be 
quantified by spectrophotometric means [231]. 
Material eluents were obtained by placing hydrogels in 3ml of HOB growth medium 
under sterile conditions in a 7ml bijou vial, then placed onto a rotating mixer at room 
temperature. The supernatants were collected at 24, 48 and 72hour time points and 
transferred into clean bijou vials. 
HOB cells were seeded in 96 well-plates at a density of 1x105cells/ml per well. The cells 
were incubated in HOB media for 24 hours to allow for cell to attach and acclimatisation 
prior to addition of the test eluents.  The following elution times were tested: 24, 48 and 
72 hours with cell exposure times: 24, 48 and 72 hours. At 24 hours post seeding under 
sterile conditions, the HOB media was removed from each well plate and replaced with 
100µl of the leached eluents from the hydrogels, as well as the negative (non-toxic) and 
positive (Toxic) controls, which comprised of  HOB media and HOB media with 10%v/v 
ethanol respectively. The cells were then incubated at 24, 48 and 72 hours and at 
selected exposure times, the elution medium was discarded and replaced with 100µl/well 
MTT solution. 
MTT solution was prepared under sterile conditions with 5%w/v MTT powder (sigma 
UK), dissolved in PBS (Sigma, UK) and filtered using a 0.22milipore filter. The solution 
was added at 1:10 ratio with ascorbic free HOB media. The plates were incubated for 
4hrs (37°C, 95%humidity and 5% CO2), the solution was then removed and replaced 
with DMSO (Sigma) 100µl per well and placed on a shaker for 5mins to ensure 
dissolution of formazan crystals. The absorbance of the calorimetric assay was 
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measured at 570nm test wavelength with 630nm reference wavelength using a DYNEX 
Opsys technologies plate reader. 
 
Live/Dead viability staining 
Viability was analysed using a Live/dead viability/cytotoxicity kit (L-3224) from Invitrogen 
at time points 1, 3, 7, 14, 21 and 28 days. Hydrogels were removed and placed in new 
24 well plates; cells were incubated with 1µM of calcein AM and 2µM of ethidium 
homodimer in phenol free media and placed in CO2 incubator for 20mins. Calcein stains 
the live cells green due to intracellular esterase activity, and ethidium stains the cells red 
as it enters cells with damaged membranes and becomes fluorescent upon binding to 
nucleic acids in the dead cell. The cells were observed and imaged with a fluorescence 
microscope (Olympus IX51) between (x4-x20) magnifications. The live green signal was 
viewed/imaged using a 480nm band pass excitation filter with a 510nm bandpass 
emission filter. The dead (Red) signal was viewed with a 520nm bandpass with a 560nm 
bandpass filter for emission.  
 
Alkaline phosphatase (ALP) concentration 
Cell differentiation of the osteoblastic phenotype was determined by measuring the 
alkaline phosphatase (ALP) production of HOB cells. The activity of the ALP in cell 
culture media was determined by the release of p-nitrophenol from p-nitrophenol 
phosphate (PNPP). A standard curve was prepared from 200 µg/ml 4-nitrophenol stock 
solution to give a range from 0 to 100 µg/ml. 50 µl of cell culture media was transferred 
to a 96 well plate and 50 µl of substrate reagent (p-nitrophenol phosphate, magnesium 
chloride hexahydrate and triton X-100 in Glycine) was added.  The plate was placed on a 
shaker for 2 minutes, absorbance was read immediately; measured 





Protein concentration assay 
The concentration of total protein was determined from culture media collected from 
wells of samples at known time points. A quick start Bradford protein assay was used in 
this study. Standard dilutions of bovine albumin serum were provided in the kit with 
ranges 0.125, 0.25, 0.5, 0.75, 1.0, 1.5, and 2.0mg/ml. 5µl of standards and samples were 
pipetted into 96-well microplate and 250µl of 1x dye provided in the kit was added to the 
5µl of standards and samples. The plate was left to incubate at room temperature for 10 
minutes, and the colour/absorbance changes were measured using a DYNEX Opsys 
technologies reader at test wavelength 590nm. All culture media samples gave 
absorbance readings within the range of the standard curve, and concentration of total 
protein of each sample was calculated. 
 
Quantitative real time polymer chain reaction (qRT-PCR) 
To investigate the cell phenotype mRNA was analysed using quantitative real time PCR. 
At each time point samples were suspended in 0.7ml TRIzol® LS reagent, cells were 
lysed by pipetting up and down several times, solution was transferred to an eppendorf  
and RNA extracted following the standard TRI reagent protocol [232].  
RNA extraction-: 0.2 ml of chloroform was added to each sample, tubes were capped 
and shaken vigorously for 15 minutes, followed by 15minute incubation at room 
temperature. After incubation samples were centrifuged at 12,000xg for 15minutes at 
4°C to enable phase separation (mixture separates into a lower red phenol-chloroform 
phase, an interphase and a colourless upper aqueous phase). The aqueous phase was 
collected and transferred to a fresh tube where RNA was precipitated by addition of 
0.5ml 100%isopropanol and allowed to incubate at room temperature for 10minutes. The 
sample mixtures were centrifuged at 12,000xg for 10 minutes at 4°C. The precipitated 
RNA pellets were washed with 1ml of 75% ethanol and centrifuged at 9000xg for 
8minutes at 4°C. The supernatant was discarded and the RNA pellet was allowed to dry 
for 10-20minutes, and resuspended in 40ul RNAse-free water. RNA concentration and 
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quality was quantified using Nano drop spectrophotometer and purity assessed using the 
260/280nm ratio. 
Preparation of cDNA-: single stranded cDNA was synthesized from total RNA using the 
High capacity cDNA reverse transcription kit and protocol provided (Applied Biosystems). 
Desired input of RNA was 1ug per 20ul reaction (RNA+master mix), volume of required 
RNA for 1ug was calculated with dilution RNAse free water determined for each RNA 
template to equal a total of 10µl. 10µl of the RNA template was combined with 10µl of 
the reverse transcription master mix to give a final volume of 20µl. The master mix was 
prepared with 10X RT buffer (2µl), 25X dNTP Mix(100mM)(0.8µl), 10X RT random 
primers (2µl) and nuclease-free H2O(3.2µl). A thermal cycler was used to perform the 
reverse transcription using optimised settings for High capacity cDNA reverse 
transcription kits [233]. 
 Step 1 Step 2 Step 3 Step 4 
Temperature (°C) 25 37 85 4 
Time (min) 10 120 5 ∞ 
Table 4-3: Optimised thermal cycle conditions for performing reverse transcription. 
 
qPCR-: PCR was achieved using the GoTaq® probe qPCR master mix kit (Promega). 
2µl of CXR reference dye was added to the 1ml tube of GoTaq® probe qPCR master 
mix. 4µl cDNA template was combined with 10µl 2X TaqMan® Gene expression master 
mix, 5µl RNase-free water and 1µl 20X Gene expression assay to make a total volume 
of 20µl mixed into each well of a 96 well plate. The plate was sealed with the appropriate 
cover and centrifuged at 1000rpm for 1minute. The plate was loaded and analysed on a 
Rotor-Gene 6000 series sequence detection system (Corbett). The PCR reaction 
consisted of an initial enzyme activation step at 95°C for 2mins, followed by 40 cycles of 
95°C for 15s and 60°C for 1min. 
 The gene expression assay consisted of the house keeping gene GAPD (X20) (applied 
biosystems), ALP (X60), RUNX2 (X60) (life technologies). 
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SEM cell morphology study 
Cell morphology on hydrogels was carried out at time points 7, 14, 21 and 28 days, each 
sample was fixed with 1.5% glutaraldehyde buffered in 0.1 sodium cacodylate.  The cells 
were stained in 1% osmium tetroxide and 1% tannic acid, and then dehydrated through a 
series of alcohol concentrations (20%, 30%, 40%, 50%, 60%, 70%, 90%, 96% and 
100%).  The final air-drying was in hexamethyl disilazane (HMDS).  The samples were 
gold-palladium sputter coated for 2 minutes to reduce charging and viewed using a JOEL 
scanning electron microscope (SEM). 
 
4.4 RESULTS 
Particle size analysis of the CMP used as the filler phase 
The particle size distribution percentiles (10, 50 and 90 %) of CMP powder are presented 
in Table 4-4, the histogram of particle size distribution and the cumulative percentage of 
the data are shown in Figure 4-2. The histogram of the tested powder exhibited a normal 
distribution with the mean particle size of 49.9µm. 






CMP 6.2 24.1 49.9 
Table 4-4: Particle size distribution of CMP. 
 
 
Figure 4-2: The particle size distribution of CMP powder in cumulative percentage (red 
line) and in frequency percentage (bars). 
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XRD analysis 
The main peaks observed were at 26°, 29° and 32° 2θ angles, which indicated the 
presence of β-calcium metaphosphate. Other broader low intensity peaks characteristic 
of calcium phosphates were observed at 40°, 47° and 50°.   
 
 
Figure 4-3: XRD pattern of CMP filler particles used in fabrication of the PVA-CMP 
particles. 
 
FTIR analysis of PVA-CMP composites 
The FTIR spectra of CMP (Figure 4-4) showed the characteristic absorption peaks of 
PO3¯ at 1061, 1115 and 1241 cm-1. These results are in agreement with published 
studies which report PO3¯  absorption peaks to be in the ranges of (1100-1160 cm-1 and 
1260-1320 cm-1) [234] and (1080-1120 cm-1) [235].  The shoulder at around 790 cm-1 and 
below on the spectrum can be assigned to the covalent bond between non-bridging 
oxygen and calcium ions as P–O–Ca stretching vibration. For PVA-CMP, the FT-IR 




Figure 4-4: FTIR spectra of CMP granules, PVA10-1FT hydrogel and PVA-CMP 
composites fabricated by crosslinking using a single freeze thaw cycle. [A] Is a full range 
spectra and [B] is an expansion of the fingerprint region. 
 
A slight shift of the PO3¯ peaks of PVA-CMP from CMP were observed at 1113 and 1055 
cm-1 from 1115 and 1061 cm-1 on the composites. This minor shift was attributed to the 
presence of PVA in the composite specifically the C-OH bending vibration at 1087 cm-1. 
This may be evidence of intermolecular interaction between PVA and CMP. The 
prominent hydroxyl stretching band (3289 cm-1) and C-H stretching of alkyl groups (2939 
cm-1) of PVA were not observed on the PVA-CMP composites. However absorption 
bands with weaker intensity were observed on the PVA(10 & 20)-CMP composites at 
3289 cm-1, which increased in intensity for PVA30-CMP to 3295 cm-1 with a minor C-H 
stretching alkyl group also observed at 3242 cm-1. This observation was attributed to the 
fact that due to the lower viscosity of PVA10 & 20 fluid phase used in fabrication of the 
composite, more PVA aqueous solution was decanted after the centrifugation phase 




filler particles resulting in a reduced amount that was decanted. However FT-IR spectra 
does not indicate chemical reactions having taken place. 
 
Raman spectra analysis 
No differences were observed between the spectra of the PVA-CMP composites (Figure 
4-5), however prominent peaks attributed CMP were observed in the composites. The 
peaks observed at 681 cm-1 and 1168 cm-1 correlate to the P-O-P and PO3- vibrations 
respectively, which are in agreement with other studies [236, 237]. The peaks at 1000 
cm-1 correlate to the out of plane bending of C-H groups in PVA. 
 
 
Figure 4-5: Raman spectra of PVA-CMP composites fabricated from 10, 20 and 30% 









Thermal analysis (DSC) 
Figure 4-6: Normalised thermogram of PVA10-1FT, PVA10, 20 and 30-CMP composites, 
crosslinked by 1 freeze thaw cycle. 
 
Hydrogel composites fabricated by 1FT 
cycle 




Table 4-5: Glass transition temperatures (Tg°C) of the PVA 10-CMP, PVA20 & PVA30-
CMP composites fabricated by one cycle of freeze thawing.  
 
The glass transition temperature of the composites of PVA-CMP has not been affected 
by the variation in concentration of the PVA (Table 4-5). The Tg was also found to be 
higher than those of PVA matrix hydrogels (70.5 – 73.4°C) obtained by one cycle of 
freeze thawing as reported in (Chapter 3).    
  
Water uptake of the composites  
The EWC of the PVA-CMP composites in SBF, 100% humidity and distilled water in 
Figure 4-7 showed that the EWC decreased with increasing concentration of PVA  
regardless of the immersion medium. 
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Figure 4-7: EWC of the PVA-CMP-1FT composites fabricated with PVA of 
concentrations 10, 20 and 30%. The scatter plot presents EWC of composites in SBF, 
100%humidity and distilled water. (n=3) 
 
The lowest concentration of PVA at 10% used to formulate the composites exhibited the 
highest EWC whilst storing the composites at 100% humidity led to lower EWC’s as 
expected. 
Hydrogel network 
obtained by 1-FT 
EWC (%) Swelling ratio 
(SR) 
Gel fraction, GF 
(%) 
PVA10-CMP 34.3 ± 2.5  1.5 ± 0.1 97.7 ±  0.2 
PVA20-CMP 30.2 ± 1.4  1.4 ± 0.03  96.9 ± 0.9  
PVA30-CMP 21.4 ± 1.4  1.3 ± 0.02 90.9 ± 4.1  
Table 4-6: Equilibrium water content, swelling ratio and gel fraction of PVA-CMP 
composites prepared by one cycle of freeze thawing. Tests carried out in distilled water 
(n=3). 
 
EWC and swelling ratio (Table 4-6) in distilled water decreased with increasing 
concentration of PVA in the composite network. This due to the tighter dense network 
obtained with higher concentration of PVA which in turn limits the amount of water 
absorbed in the network. The gel fraction of the composites was also found to decrease 
with increasing concentration of PVA in the network. This could be attributed to the loss 
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Figure 4-8: Water uptake of the PVA-CMP composites fabricated with PVA of 
concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. [A] 
Represents a full scale plot of water uptake from the initial time point to the final 4weeks 
time point. [B] Represents an expanded version of water uptake within the first 10 hours, 
to highlight the differences in the rate of uptake. (n=3) 
 
Water uptake of the composites (Figure 4-8) indicates a linear trend within the first 2hrs 
after immersion in water. The rapid water uptake of the composites reached equilibrium 
within 8hours and remained relatively constant over the 4 week duration of the test. 
Water uptake values were found to decrease with increasing concentration of PVA with 




Compressive strength and modulus of the hydrogel composites are presented in Figure 
4-9 and Figure 4-10 respectively, which were carried for both dry and hydrated 
specimens in distilled water and SBF. 
  
Figure 4-9: Compressive strength of PVA-CMP composites fabricated with PVA of 
concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. Tests 
were carried out under dry and hydrated specimens (n=6), as well as after 2 and 4 
weeks immersion in SBF (n=4). As the materials are not brittle it should be noted that the 




Figure 4-10: Young’s Modulus of PVA-CMP composites fabricated with PVA of 
concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. Tests 
were carried out for dry and fully hydrated specimens (n=6), as well as after 2 and 4 
weeks immersion time in SBF (n=4). As the materials are not brittle it should be noted 
that the values are comparative within the group.  
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The compressive strength of the PVA-CMP composites were found to increase with 
increasing concentration of PVA. The compressive strength values ranged between 7-
25MPa, 2.5-48MPa and 2.9-17MPa, for the dry, hydrated in water as well as after 
immersion in SBF respectively for the composites respectively. All the composites 
exhibited higher compressive strengths in the dry state, as expected, with the exception 
of PVA30-CMP composite, which exhibited the highest compressive strength even for 
the hydrated specimens. Compressive strength after immersion in SBF was found to 
decrease with increased immersion time for all the composites. The compressive 
modulus of the composites also increased with increasing concentration of PVA and the 
values ranged between 68.3-425.4, 16-725 and 16-180MPa, for the dry, hydrated 
conditions, as well as after immersion in SBF respectively. The modulus of the 
composites after immersion in SBF were found to decrease with increasing immersion 
time. 
 
Diametral compression test 
 
 
Figure 4-11: Diametral compressive strength of PVA-CMP composites fabricated with 
PVA of concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. 
Tests were carried out under dry and hydrated to equilibrium conditions. (n=6) (*, **, *** 
and **** P<0.001); asterisk linked with lines indicate significant difference in values 
between the groups. As the materials are not brittle it should be noted that the values are 





Figure 4-12: Diametral stiffness of PVA-CMP composites fabricated with PVA of 
concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. Tests 
were carried out under dry and hydrated to equilibrium conditions. (n=6), (*, ***, **** 
P<0.001 and ** P=0.004); asterisk linked with lines indicate significant difference in 
values between the groups. As the materials are not brittle it should be noted that the 
values are comparative within the group. 
 
The diametral compressive strength of the dry composite hydrogels ranged between 1.8-
6.4MPa with concentration of PVA influencing the strength but no significant differences 
(P=0.160 & 0.856 for hydrated and dry composites respectively) were found between the 
20 & 30% concentration of PVA. There were significant differences in the stiffness values 
obtained in this mode that ranged between 9.8-38.0MPa. Both diametral compressive 
strength and stiffness values of the hydrated gels were lower in comparison to the dry 
composites. There was no significant difference (P=0.059) between the stiffness values 




















Dynamic mechanical analysis (DMA) 
 
Figure 4-13: Dynamic amplitude scan of PVA-CMP composites fabricated with PVA of 
concentrations 10, 20 and 30% and crosslinked via one cycle of freeze thawing. Tests 






Figure 4-14: Dynamic properties of the PVA-CMP composites vs time. Specimens were 
tested at frequency 1Hz and under hydrated conditions at 25°C for 30minutes. 
 
 
Figure 4-15: Modulus [A] and energy absorbing potential [B], of PVA10,20,30-CMP 
composites at  static temperature 25°C and multi-frequency 1- 10Hz. Multifrequency 
scans were run at amplitude 0.3mm which was selected to be suitable from dynamic 
amplitude scans. (n=3) 
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Storage modulus results indicated a clear trend, with PVA10 exhibiting the lowest 
modulus followed by PVA20 and PVA30. This result is within expectation as stiffness of 
the composites increases with increasing concentration of PVA. Results showing the 
energy absorbing potential of the composites are in agreement with those of loss 
modulus as they indicate that PVA10 has the highest energy absorbing potential which 
reduces with increasing concentration of PVA. This would be expected as low amount of 
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Figure 4-16: SEM micrographs showing the morphology of the freeze-thawed PVA-CMP 
composites starting with PVA10, 20 then 30 from top to bottom respectively, at 
magnifications 100X, 500X and 2500X from left to right respectively. 
 
SEM micrographs of the PVA-CMP composites shown in Figure 4-16 clearly 
demonstrated the variation of microstructure of the composites, with visible micro-pores 
and in some cases randomly scattered macro-pores. 
 
EDAX analysis 
PVA-COMPOSITES Wt.% ELEMENT VALUES 
Polymer enriched zone  Inorganic enriched zone 
C O  C O P Ca 
51.8 ± 10.1 46.8 ± 8.7  3.1 ± 0.8 64.2 ± 2.5 25.2± 1.4 7.6 ± 0.6 
Table 4-7: Wt. % of elemental values in the composites, taken from identified polymer 
areas and spindle crystals. 
 
 
Figure 4-17: EDAX of PVA-CMP composite, [A ] represents spectra obtained from the 




X ray micro-analysis of elements present in the PVA-CMP composite networks are 
presented on Table 4-7 and Figure 4-17. EDAX confirmed the presence of both the 
polymer and ceramic phase in the composites, indicating the presence of polymer rich 
and polymer poor phases/areas. 
 
CYTOCOMPATIBILITY 
Cell viability study using MTT assay 
Figure 4-18 shows the viability of HOB cells seeded on the elusion extracts of the VA-
CMP composites, tested by MTT assay at 24, 48 and 72 hour exposure time of eluents 
collected after 24, 48 and 72 hours. Results indicated that the PVA-CMP composite 











Figure 4-18: MTT assay test showing the response of human osteoblast cells following 
exposure to eluents from PVA30 hydrogel and PVA30-CMP composite. Cells were 
exposed for 24, 48 and 72hrs to a [A]. 24hr elusion wash time [B]. 48hr elusion wash 
time and [C] 72hr elusion wash time. (n=4) 
 
Live/dead cell analysis 
Live cells were observed on all the hydrogel composites over a period of 28 days, 
indicating good cell attachment, proliferation and migration on the surface as well as 


















































Figure 4-19: Images of live/dead staining of HOB cells (x4, 10 and 20 magnification) on 
the PVA30 hydrogel and PVA30-CMP composite  at day 3, 7, 14 and 28. 
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Figure 4-20: SEM micrographs showing HOB cell attachment on PVA30 hydrogel and 
PVA30-CMP composite after 7 and 14 days in culture. 
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The results showed that the cells adhered well to the surface of the scaffolds, confirmed 
by the flat stretched morphology of the cells. It was also observed that on the PVA-CMP 
composites the cells were able to spread across the pores of the composites, eventually 
entirely covering the pores. 
 
HOB cell differentiation by alkaline phosphatase activity and protein concentration 
The ALP/Protein concentration production of cells seeded on the hydrogels is shown in 
Figure 4-21. A peak in alkaline phosphotase activity was observed after 14 days in 
culture. 
 
Figure 4-21: The alkaline phosphatase activity in balance with the protein concentration 
of human osteoblast cells (HOB) on the PVA30 hydrogel and PVA-CMP composite, with 
the tissue culture plate as the control. Tests were carried out on culture media 
supernatant of hydrogels composites at different time points day (7, 14, 21 and 28). Data 
represents as mean±SD. (n=4) 
 
Real time quantitative PCR: Molecular quantification of osteoblastic phenotype  
RUNX2 & ALP 
Relative expression of RUNX2 and ALP of HOB cells on the PVA30 hydrogel and PVA-
CMP composite is shown in Figure 4-22 and Figure 4-23. RUNX2 results indicate an 
increase in expression from day 7 to day 14 followed by a decrease on the control, whilst 
the PVA-CMP composite showed down regulation at day 21 followed by and up 
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regulation at day 28. ALP results showed a peak in expression at day 14 for the control 
and PVA-CMP composite. The results indicate differentiation of HOB cells towards 
mature osteoblasts. 
 
Figure 4-22: Relative expression of Runx2 of the HOB cells cultured on the  PVA30 
hydrogel and PVA-CMP composite, analysis was carried out at time points (7,14, and 28 
days). (n=3). NB: data presented is relative to day 7. 
 
 
Figure 4-23: Relative expression of ALP of the HOB cells cultured on the  PVA30 
hydrogel and PVA-CMP composite, analysis was carried out at (7,14,21 and 28 days). 
(n=3). NB: data presented is relative to day 7. 
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4.5 DISCUSSION 
In designing bone substitutes, one of the main strategies is to create a 3D environment 
that enables osteogenesis. A 3D matrix mimicking the extracellular matrix, which allows 
the attachment of osteoprogenitor cells to proliferate and differentiate into osteoblasts 
whilst simultaneously providing the requisite mechanical integrity which is key in bone 
regeneration. Calcium phosphate based biomaterials promote osteogenic differentiation 
through several mechanisms. The ability to sequester osteoinductive factors such as 
bone morphogenetic proteins and regulate calcium and phosphate ions imbibes an 
osteoinductive effect. However, calcium phosphate scaffolds are limited by their 
brittleness thereby limiting their clinical use. Three-dimensional (3D) porous PVA-CMP 
hydrogel composite scaffolds were successfully developed to overcome the weak 
mechanical properties, poor cell adhesion and low osteogenic ability of hydrogels that 
limit their capability for bone regeneration in vivo.  
In this study the filler phase was obtained by milling CMP with a mean particle size of 
~50µm.  The filler phase was selected on the basis of a previous study [227] which 
confirmed that porous blocks of CMP when placed in critical sized defects in a rabbit 
model were able to completely close the defect site. The histological findings suggested 
a natural healing process with no signs of inflammation, and also showed that a 
significant amount of graft resorption occurred within four weeks, which is in contrast to 
other xenografts used in the same model [238]. The porous block of CMP was seen to 
resorb totally at 8 weeks and vascularised bone was formed within the defect. The 
addition of osteogenic protein-1 (OP-1) within these scaffolds showed that bone 
formation occurred earlier, however even without the inclusion of OP-1, there was 
excellent bone growth and full coverage of the defect. With the resorbability of the CMP 
and cytocompatibility established, it was incorporated as the filler phase in aqueous PVA 
polymer solutions to create bone plugs suited for use in maxillofacial and other bone 
defects. Three different concentrations of PVA (10, 20 and 30 %) were used to prepare 
the precursor paste because the resultant viscosities varied and the degree of 
crosslinking would vary due to the different concentration of the hydroxyl groups in the 
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mileu thereby influencing the resultant properties. With an aim to incorporate a high 
concentration of the filler, a pilot study indicated that a maximum of 60% by weight of 
CMP could be incorporated as higher concentrations led to only partial wetting of the 
filler phase by the aqueous PVA solutions due to increased viscosity of the mix. Although 
higher concentration could be included in 10% PVA solutions, results on the study of the 
matrices showed that the lower concentration of PVA yielded fragile matrices. Hence a 
concentration of 60% of CMP was used for all the PVA concentrations. These 
composites were designed to be able to act as a bone plug, having the ability to absorb 
bodily fluids and retain them and the inclusion of PVA in the network was postulated 
inherently reduce the degradation and resorption rate of the CMP filler phase in the 
composite. The composites obtained were characterised to understand the effect of 
incorporation of CMP filler particle as well as the effect of variation of PVA concentration 
on the properties of the composites, whilst surgical handling was a parameter of 
influence that was based more on the opinion of the surgeon’s handling and the ability to 
insert in a bone defect. 
 
FTIR and Raman analysis of the PVA-CMP composite scaffolds 
FTIR and Raman analysis 
results presented in  
Figure 4-4 and Figure 4-5 
respectively indicated that 
CMP was successfully 
incorporated within the PVA 
polymer phase. This was demonstrated by the characteristic peaks of  at 1061 and 
1241 cm-1 in the FTIR spectra, and 681 cm-1 and 1168 cm-1 on the Raman spectra,  
which are in agreement with those obtained from other studies [234, 236]. The PO3 units 
in CMP (Ca(PO3)2) are structurally linked through the -P-O-P- bonds to form chains that 
have lengths of about 10,000 units i.e. in the beta form of CMP [1]. The FTIR spectra of 
Figure 4-24: Schematic 
structural representation of 
CMP, depicting its 
polymeric structure with 
covalently bound PO3 units 
whose chains are ionically 
bound to Ca between the 
chains. Adapted from 
Antonucci et al [1] 
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the composites showed the main characteristic peaks associated with PVA and calcium 
meta phosphate. The strong absorption peak arising due to hydroxyl groups (3289 cm-1) 
and C-H stretching of alkyl groups (2939 cm-1) of PVA (observed on the PVA-1FT 
spectra) were not as prominent and much weaker in the PVA-CMP composites. This was 
attributed to the low ratio content of PVA (6:4) in the composite network, combined with 
the fact that excess PVA was decanted after the centrifugation process, during 
fabrication of the composites. However, the absorption peak for the hydroxyl group had 
an increased intensity with the PVA30-CMP composites, this difference could be 
attributed to the highly viscous nature of aqueous PVA30 which directly impacted the 
binding ability between PVA and CMP filler particles, resulting in a lower amount of PVA 
decanted after centrifugation and hence observation of higher intensity of hydroxyl bands 
as compared to PVA (10&20)-CMP composites. The fingerprint region of the composites 
fabricated from the varying concentrations of PVA displayed no changes or shifts in the 
spectra, this was expected as all composites were crosslinked through the PVA when it 
was subjected to one cycle of freeze thawing.  
  
Thermal analysis of composites 
A vast difference was observed between the DSC thermograms (Figure 4-6) of PVA and 
PVA-CMP composites. The Tg area of PVA can be clearly observed whereas that of the 
PVA-CMP can hardly be seen, however when zoomed in it is clear that the Tg of the 
PVA-CMP composite have shifted. The Tg (Table 4-5) values obtained were found to be 
between 104-105.5°C for all composites. The increase from Tg of PVA reported in 
chapter 3 (observed ~70°C) to that of the composites can be accounted by the 
incorporation of CMP particles within the polymeric structure, reinforcing the resultant 
composite. The limited variation in Tg indicates that the formed composites incurred the 
same level of crosslinking. This observation is accurate and is in agreement with 
observations reported in the FTIR and Raman analysis, as all composites were 
crosslinked in the same manner which was by subjecting it to one cycle of freeze 
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thawing. The loss of the prominent melting peak of PVA in the composites indicated 
incorporation and interaction of PVA with the CMP filler particles. 
 
Water uptake of composites 
Although in vitro simulation of water uptake is essential for an understanding of the 
anticipated in vivo behaviour of bone substitutes and their long term performance, it is 
difficult to draw a direct correlation. However, the in vitro behaviour of biomaterials is 
beneficial to understand the in vivo swelling and interaction with fluids, which can provide 
some useful information for guidance for the design of biomaterials. Hence three 
different biologically relevant environments were selected. 
 EWC of the composites were determined in distilled water, simulated body fluid and 
100% humidity as shown in Figure 4-7. Swelling behaviour of the composite network is a 
process that is mainly related to the amorphous region and the free hydroxyl (OH) 
groups of the compound, therefore incorporation of CMP should improve network 
stability of the composites. 
The decrease in water content with the increasing concentration of PVA in the 
composites is caused by two factors; the interaction between Ca2+ ion and the matrix of 
PVA gel leading the matrix to become denser, and the CMP particles occupy the space 
to squeeze out water from the hydrogel. Therefore the higher the concentration of PVA 
the denser the network and the smaller the space to support water. For all PVA10-CMP 
had significantly (P≤0.032) the highest EWC (29.4, 34.3 and 26.6%) as compared to 
PVA20-CMP (30.5 and 25.1%) and PVA30-CMP (27.0, 21.4 and 21.7%) respectively for 
SBF, DW and humidity, with the exception of PVA20-CMP in SBF. This trend was due to 
the dense nature (increase in viscosity) of PVA formed at higher concentrations, which 
results in hindered mobility of the polymer chains, when expanding during hydration, 
resulting in a limit to the amount of fluids that can be absorbed by the hydrogel network. 
This results was found to be in agreement with results obtained earlier and reported in 
Chapter 3 on PVA polymers hydrogels formed from different concentrations. Comparison 
of results also indicated that EWC in DW was significantly higher than in 100% humidity 
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and SBF for PVA10-CMP (P=0.003 and 0.017), and PVA20-CMP (P=0.001 and 0.042) 
respectively, with the exception of PVA30-CMP where the highest EWC was in SBF 
(P=0.001). Therefore for all PVA concentrations, overall EWC under humid conditions 
was significantly lower than in SBF and distilled water. These observations were justified 
by the fact that under humid conditions the composites are not immersed in aqueous 
solution, but are placed on moist cotton in a sealed glass vial, thus there is no direct 
diffusion via the surface initially, resulting in reduced overall amount of water molecules 
absorbed. The EWC in distilled water was higher than in SBF due to the fact that, SBF 
contains an ion concentration similar to that of human plasma, while DW in essence has 
been purified of ionic salts and molecules. The osmolarity of the medium in which the 
hydrogel is hydrated can affect the overall EWC of the hydrogel in a transient manner, 
thus a shift in the hydration of the hydrogel with changes in osmolarity of hydrating 
solution can be expected. When soaked in water, because of the lower osmotic pressure 
inside and outside of the gel, a large number of water molecules spread into the gels and 
therefore the quality and volumes of the hydrogel and water are both increased. A higher 
salt concentration Na+ in SBF would tend to promote hydrogel de-swelling. A high salt 
concentration implies that more Na+ ions are available to bind with the gel, thereby 
resulting in increased osmotic pressure which results in deswelling of the hydrogel. 
Water uptake plots presented in Figure 4-8 indicate that the composites reached 
equilibrium had a linear uptake profile and was reached within the first 8hours, and 
remained at a steady point for 4 weeks. This result indicated that the composites do not 
undergo hydrolysis and disintegration over prolonged periods of time in water. 
Contrastingly studies from literature have reported relatively high water uptake values for 
three-dimensional polymer/ceramic composites. Examples include a study on PVA/HA 
cryogels fabricated by three cycles of freezing and thawing which reported that they 
found similar values between the water content of the PVA/HA composites (215.5-
234.8%) as compared to the PVA hydrogel (229.1%) [239]. Another study on poly(lactic 
acid)(PLA)/HA 3D porous scaffolds,  reported that in comparison with their pure PLA 
scaffolds the mean water absorption rate of PLA/HA scaffolds increased significantly 
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from 65.2 to 159.3%, and scaffolds did not undergo hydrolysis. The authors went further 
to justify their results by stating “Existence of HA can drastically improve the 
hydroscopicity of PLA scaffolds; however, because HA is enshrouded in PLA matrix, this 
improvement of water absorption ability is not evidently varied within the certain range 
[240].” It should also be noted that the PLA/HA scaffolds had a higher level of porosity as 
compared to the composites reported in this study. However the bone plugs in this study 
were designed with the aim of having lower swelling ratios as excessive fluid uptake can 
lead to excessive swelling, thus compromising the bone plug, which in turn would exert 
pressure on the wound defect edges resulting in cell death and necrosis of the tissue. 
However a small amount of swelling assists in fitting of the bone plug within the wound 
without exerting too much pressure on the edges. 
 
Compression analysis 
Biomechanical properties help to guide surgeons in use of bone plugs and guide the 
rehabilitation programmes of those patients who have had augmentation procedures with 
bone plugs. TruFit CB plugs (Smith and Nephew) are resorbable material composed of 
polylactide-co-glycolide (PLG) copolymer, calcium-sulfate, polyglycolide (PGA) fibres 
and surfactant. A study was carried out by JTK Melton et al (2010) to evaluate the 
material properties of the new cylindrical scaffold plug licensed for the treatment of 
osteochondral defects. It was found that the maximum compressive stresses at failure 
for the dual layer implants occurred at 5.5MPa (7mm), 5.8MPa (9mm) and at 8.5MPa 
(11mm) plugs of different diameter. The modulus of elasticity was calculated at 50 MPa 
(7mm), 60 MPa (9mm) and 80 MPa (11mm). The larger the plug size, the higher the 
strength shown under test conditions at all strain rates. The Young’s moduli of the 
implants were reported to be in keeping with previous estimated values for successful 




Figure 4-25: Image of PVA-CMP 
composite before compression (left) 
and after compression (right). 
In this study the compressive strength of the dry 
and hydrated PVA-CMP composites was found to 
increase with increasing concentration of PVA, 
which was expected as previous studies (Chapter 
3) showed that strength of PVA single network 
hydrogels increases with increase in 
concentration. The dry composites had 
significantly higher (P≤0.006) compressive strength than the hydrated composites of 
PVA10&20-CMP (7.0 and 25.4MPa respectively), with the exception of PVA30-CMP. 
The hydrated PVA30-CMP composite was found to have a significantly higher (P≤0.005) 
compressive strength of 48.0MPa than all the groups tested. This was due to the fact 
that the higher concentration of PVA results in a dense elastic network which provides 
enhanced reinforcement in combination with CMP filler. This network when hydrated 
results in a higher resistance to larger loads of compression as compared to PVA10 and 
20 concentration which are less dense. The elastomeric nature of the composite means 
that the composites do not shatter or break down completely when compressed under 
hydrated conditions, but they undergo compaction as the pores collapse and the 
moisture is released, this is demonstrated in Figure 4-25. The compressive stiffness of 
the composites was also found to increase with increasing concentration of PVA, with 
PVA30-CMP displaying the highest stiffness values of 425.4 and 725.8MPa (P=0.003) 
under dry and hydrated conditions respectively. Composites tested under dry conditions 
were found to have higher modulus values than those tested under hydrated conditions 
with exception of PVA30-CMP. However only PVA10-CMP was found to have a 
significant difference P≤0.001. These values are higher than those of the commercially 
available TruFit CB plugs (Smith and Nephew) by a factor of over 5 (comparison of 
PVA30-CMP vs TruFit 11mm) indicating that the PVA-CMP bone plug composites are in 
keeping with previous estimated values for successful regeneration of cartilage within a 
synthetic scaffold as reported by JTK Melton et al (2010). Other comparisons (non-
commercial) include a study on fabrication of three-level hierarchical CaP/Collagen/HA 
148 
reported compressive strength values of 6.2MPa with stiffness of 352MPa, these values 
are relatively comparable to the PVA10 and 20-CMP composites which had stiffness 
values of 16.0 and 215.9MPa respectively. They were however not comparable to the 
PVA30-CMP composite which had strength and stiffness which was 7 and 2 times higher 
respectively [242]. Another study by Gonzalez et al, (2014) reported their PVA/HA 
composite’s highest  compressive properties to be 16.3MPa and 120MPa for strength 
and stiffness respectively, for 15%wt concentration of PVA and 6%wt HA content in the 
composite [239]. 
 
The compressive strength after immersion in SBF was found to decrease with increasing 
immersion time in SBF, for all the composites. These values were found to be 
significantly lower (P≤0.037) than the strength obtained under hydrated conditions. This 
decrease in strength indicated that the composites undergo some level of polymer 
degradation and/or  CMP dissolution resulting in the weakening  of the interaction link 
between the polymer and ceramic phase, this due to the interaction of the composite 
with ions in SBF. This notion was reinforced by further reduction in strength and stiffness 
of the composites after 4weeks immersion in SBF. Bohner et al, (2012) reported that a 
potential approach to understand the mechanism of degradation or resorption in vivo is 
to look at the materials solubility in vitro in physiological fluids. The authors went further 
to state that “ The material should not be soluble in physiological fluids at pH 7.4, 
because spontaneous rather than osteoclastic dissolution would occur, but should be 
soluble at a slightly lower pH value, typically between the pH value present at the 
osteoclast interface (pH 4–5) and pH 7.4. [217]”. This statement is agreement with the 
fact that the composites do undergo some dissolution but do not undergo complete 
dissolution as the polymer phase acts as a binder and protective barrier to the CMP 
particles. The reduction in strength and stiffness also indicates that there is no deposition 
of minerals on the composites during immersion in SBF, as would occur in the case of 
bioglass, this notion is in agreement with results obtained from a study on surface 
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Figure 4-26: Image of hydrated PVA-CMP 
composite before compression (left) and after 
diametral compression (right). 
 
modification of CMP fibres, where they found that no products were formed on the 
surface of CMP fibres that were soaked in SBF for 30 days at 37°C [236]. 
 
Diametral compression analysis 
Diametral compression tests (Figure 4-11 and Figure 4-12) were carried out on the 
composites, using the same bone plug shape that would be used clinically such as in 
tooth extraction cases. This is an indirect tensile test via induction of the local tensile 
stress in the transverse direction of the applied compressive stress, estimating the 
strength of materials as they undergo elastic deformation. Results indicated that 
diametral compressive strength (P<0.001) and elastic modulus (P≤0.004) under dry 
conditions were found to be highest with PVA20 (6.3 and 38.0MPa) and 30-CMP (6.4 
and 28.0MPa) respectively. Under 
hydrated conditions strength and 
stiffness increased with increasing 
concentration of PVA, where 
PVA30-CMP had significantly 
(P≤0.001) the highest strength and 
stiffness (0.9 and 2.8MPa) 
compared to PVA10-CMP (0.3 and 0.8MPa) and PVA20-CMP (0.4 and 0.9MPa) 
respectively. Deformation of the hydrated specimens resulted in a barrel shape without 
rupture whereas dry specimens showed a typical brittle fracture however without total 
failure of the composite. Results obtained were significantly higher under dry conditions 
as compared to hydrated conditions. However these values were not as high as those 
reported by Gay et al, 2009 whose  PLLA synthetic bone graft substitutes incorporated 
with 50% nHA had an elastic modulus of close to 6GPa [243]. These values were 
significantly higher than those obtained in this study, due to the variance in particle size, 
polymer and ceramics used. Bone Plugs have been used clinically as bone grafts for 
ridge maintenance and socket preservation after tooth extractions, examples include; EZ 
Cure™ plug composed of MBCP™ a biphasic calcium and phosphate with collagen 
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[244], OsteoGen® Bone Grafting Plug composed of bovine collage and calcium apatite 
[245]. Other applications of bone plugs include clinical applications for cartilage repair, 
filling of bony voids or gaps caused by trauma or surgery that are not intrinsic to the 
stability of the bony structure e.g TRUFIT™ CB Plug synthetic osteochondral graft [246, 
247]. However diametral compression properties of these bone plugs have not been 
published and therefore cannot be compared with those of this study. 
 
DMA analysis 
Dynamic mechanical analysis was used to explore the viscoelastic properties of the 
composites. Time dependant plots of tanδ and E’ (Figure 4-14) carried out at 1Hz 
showed no apparent differences between the 3 groups with the exception of the change 
in moduli values. A steep decline in both tanδ and E’ was observed within the first 5 
minutes and remained relatively constant by 30 minutes. These results are contradictory 
to those obtained in a study on DMA analysis to assess the viscoelastic properties of 
bone where changes in E’ were opposite to the trends exhibited by tanδ where for E’ a 
steep increase was detected in the first 20 minutes, followed by a slower rise [248]. 
Testing was also performed over a frequency sweep covering the normal physiological 
frequencies from 1 to 10Hz simulating the walk to fast running. Results displayed on 
Figure 4-15 indicated that storage modulus increased with increasing PVA concentration 
in the composites with 3.6, 8.7 and 16.5MPa for PVA(10, 20 and 30)-CMP respectively 
which is significantly lower than the 9.4GPa obtained on cortical bone [248]. The storage 
modulus in this case referred to the measurement of how a material resists stress (the 
measure of elastic moduli). The loss tangent i.e. damping factor gives a measure of 
viscous energy loss within a material under conditions of dynamic loading. In this study 
the loss tangent was found to decrease with increasing concentration of PVA. This result 
was within expectation as low amount of energy lost or irrecoverable would directly 
translate to high absorbing potential. Values were in the ranges 0.13, 0.12, and 0.11 for 
PVA(10, 20 and 30)-CMP composites respectively, values reported in literature range 
from 0.04 for wet cortical bone [248], the same study also reported values from other 
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studies to be 0.01 for human tibial bone (Lakes et al.) and 0,02 for bovine bone 
(Ramaekers et al.), a variation which may have been due to the analytical techniques 
employed (studies were conducted under shear loading). A study on composites 
comprised of CaP and L-lactide/D-lactide copolymers, which conducted DMA analysis on 
their hydrated scaffolds under similar conditions as in this study reported values of E’ at 
~2GPa and tanδ at ~0.1 [249], while the PVA/HA study reported their highest E’ to be 
5.2MPa [239].  
 
SEM and EDAX analysis 
SEM micrographs displayed in Figure 4-16 highlight the morphology of the PVA-CMP 
composites. The composites were characterised by a dense network structure with 
micropores. It was observed, exposed crystal spindles of CMP as well as polymer like 
areas. EDS micro-analysis confirmed the elements on the crystal and polymer areas 
and, the Ca/P ratio of the CMP in the composite was found to be 0.3, similar 
observations on the EDS of CMP were reported elsewhere [236]. It was noted that the 
Ca/P ratio measured in human mineral for cortical bone is 1.71. The dense polymer 
phase was observed to increase more with increasing PVA concentration, where on 
PVA30-CMP spindle crystals of CMP were not clearly observed as in PVA10 and 20-
CMP composite. This explained the water uptake behaviour of the composites reported, 
where EWC decreased with increasing PVA concentration due to the dense nature of the 
PVA30 polymer resulting in a tight network structure. It was expected that the dense 
PVA30-CMP composite observed on the micrograph would result in higher mechanical 
properties, due to the tightly bound link between the CMP filler particles and polymer 




Ideally, a bone graft should possess properties similar to natural bone and have clinically 
relevant structure to remodelling and regeneration of the native tissue. CMP is a novel 
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scaffold material for tissue engineering and has been demonstrated to possess excellent 
biocompatibility, osteoconductivity, osteoinductivity and degradability in vitro and in vivo, 
features of which are detrimental to the process of new bone formation. Biocompatibility 
and functionality tests were carried out to enable an understanding of how osteoblasts 
cells would behave in vitro on the formed PVA-CMP composites. 
MTT assay is based on the reductive capacity of living cells to metabolize the tetrazolium 
salt, 3-(4,5-dimeththizaol-2yl)2,5-diphenyl tetrazolium bromide to a blue formazin 
product.  Results displayed on Figure 4-18 indicated that there was a decrease in cell 
proliferation with increased exposure time to eluents. Calculations of the RGR confirmed 
that the degradation products of the PVA and PVA-CMP composite became moderately 
cytotoxic at increased osteoblast cell exposure times on eluents obtained after 48 and 72 
hours sample wash time periods.  
Hydrogel 
System 
Eluents (hr) Relative growth rate (RGR) (%) 
24 exposure 48 exposure 72 exposure 
PVA30-1FT 24 82.3 68.2 76.8 
48 72.7 49.3 55.8 
72 72.0 49.2 47.0 
PVA30-CMP-
1FT 
24 72.5 66.6 92.4 
48 53.0 49.8 68.6 
72 52.7 41.2 56.8 
Figure 4-27: Relative growth rate percentage of PVA30-1FT hydrogel and PVA30-CMP-
1FT composite demonstrating viability of HOB cells within the hydrogels. Eluents were 
obtained after 24,48 and 72hr sample wash times, osteoblast cells were exposed 
(cultured) to the eluents for 24, 48 and 72 hours each. 
 
CMP has been reported in a previous study by Buranawat et al, 2013 to be relatively 
nontoxic [227], the toxicity levels observed in this study could therefore be attributed to 
the presence of high concentration of PVA in the composite, reflected by the osteoblast 
RGR of 48 and 72hr eluents at 48 and 72 hour exposure or culture periods with 
osteoblast cells. 
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Live/Dead Staining of the HOB cells cultured on the hydrogel and composite for up to 
28 days (Figure 4-19) showed cell attachment and proliferation on all the scaffolds. Cell 
attachment was observed on the PVA30 hydrogels, difficulties were encountered when 
imaging cells on the hydrogels as it was observed that some cells had penetrated and 
migrated into the internal structure of the hydrogel. When observed at low magnification 
of x4 cells appear to be at the same dimension however at high magnifications of x20 
and even x10 it was difficult to image cells at different depths as most of the cells would 
go out of focus depending on the depth level being imaged. In all cell attachment 
proliferation and migration within the PVA30-1FT hydrogel was observed throughout 28 
days of culture. 
A large volume of cells was observed on the PVA-CMP composites from day 3. Cells 
were observed to have lodged within the micropores of the scaffolds. From 7 to 28 days 
in culture, the HOB cells were observed to grow and proliferate within the pores of the 
composites, this growth and expansion within the pores is observed to become 
interconnected with cells in the surrounding pores at 21 days in culture, and finally 
forming what resembles a sheet layer of cells on the outer surface of the composite (this 
is clearly observed after 28days in culture). These observations indicate that the PVA-
CMP composite is not only biocompatible, but allows for excellent cell proliferation and 
migration on the composite with minimal cell death they can be accounted to the 
micropores and lack of interconnected porosity. 
SEM HOB cell morphology on the hydrogels and composites was observed after 7 and 
14 days in culture.  Cell attachment was observed on both the hydrogel and composite, 
results displayed in Figure 4-20. On the PVA30 hydrogel, the osteoblast cells appeared 
to have fully spread with a flattened morphology, with visible large extensions and a 
raised nucleus. After 14 days in culture, very thin capillary like filopodia extensions were 
observed and the cells appeared to have been scattered on the surface with no regular 
orientation. On the PVA30-CMP composites, cells were observed to have spread all over 
the surface of the composite with no oriental direction, cells also appeared to be three 
dimensional and connected to each other, bridging micropores around them forming a 
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three dimensional web. The surface of the composite seemed to be undergoing some 
early degradation, as granular particles that were assumed to be CMP were observed, 
exposed on the surface of the composite. It has been reported that on a cellular level, it 
could be possible that roughened surfaces promote the differentiation of osteoblasts and 
provides the possibility to form a three-dimensional cellular network [250], this explaining 
the 3D appearance of the HOB cells. A review on failures and hopes of calcium 
phosphate bone grafts stated that “ The presence of dissolution pits or etched crystals 
are indicative of cell mediated resorption, and when a ceramic is dissolved in vitro or in 
vivo, resorption takes place preferentially at the grain boundaries [217]."  In this study 
dissolution could account for the granular particles observed on the composite indicating 
that PVA-CMP scaffold underwent some degradation in vitro. 
ALP assay showed peak levels at 14days in culture, indicating bone formation activity, 
with PVA-CMP composite showing a higher concentration than the PVA30 hydrogel. 
ALP results obtained via qPCR analysis confirmed results obtained for PVA-CMP 
composite indicating peak expression at 14 days in culture. 
Runx2 transcription factors contribute to regulatory mechanisms that are operative 
throughout osteoblast differentiation and are required to modulate expression of target 
genes at key developmental transitions. This protein is first detected in pre-osteoblasts. 
The expression is upregulated in immature osteoblasts, but down regulated in mature 
osteoblasts. Runx2 regulates the expression of major bone matrix genes during the early 
stage of osteoblast differentiation, but it is not essential to maintaining these gene 
expressions in mature osteoblasts. Runx2 is downregulated in mature osteoblasts during 
bone development. Therefore Runx2 expression increases during osteoblast 
differentiation validating involvement in maturation of osteoblasts.  Expression of RUNX2 
showed an increase at 7 and 14 days in culture indicating osteoblast differentiation, 
showing maturation of osteoblast. A decrease from 21 to 28 days in culture on the PVA-
CMP composite, with a down regulation at 21 days indicated bone development and 
maturation of osteoblasts.  
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These results together with data reported by Buranawat et al, 2014 indicate that CMP 
grafts developed in this study are biocompatible with good potential to allow for 
resorption at a reduced rate than that previously reported by Burnawat, as well as 
improved hydration and mechanical properties. 
 
4.6 CONCLUSION 
The key to successful bone regeneration is to provide the wound site with suitable 
delivery vehicle that allows for sufficient cell infiltration and attachment to ensure 
osteoblastic differentiation and optimal cellular functions.  
3D PVA-CMP composite scaffolds were successfully fabricated and obtained by 
crosslinking via freeze drying technique. The composites demonstrated mechanical 
properties suitable for bone tissue engineering applications, where they can be applied in 
medium to low load bearing bone defects. Mechanical properties of the composites can 
also be varied to meet desired needs by simply changing the concentration of polymer 
content used in fabrication. 
The present results also indicated that the PVA-CMP matrices provide excellent 
osteoconductivity and biocompatibility. Live/dead staining as well as SEM cell 
morphology results showed that the osteoblast cells attached well and proliferated on the 
surface of the composite displaying the characteristic cell morphology. The efficacy of 
these scaffolds can be improved by entrapping growth factors within the scaffolds, which 
could be achieved either exogenously by swelling the scaffold in the patient’s own PRP 
during surgery before implantation or endogenously whereby the scaffold would absorb 








Chapter 5  
Fabrication and optimisation of 
dual networks as potential 
biomaterials 
5.1 BIOMATERIALS BASED ON HYDROGELS 
Synthetic hydrogels form the basis of several soft tissue and wound healing products 
and are increasingly being researched for tissue engineering applications due to their 
similarity to natural tissues.  The ability to tune their chemical properties to respond to 
environmental cues, e.g. temperature, pH and light and diffusion of not only low 
molecular solutes but also macromolecules and cells, allows the potential to impart 
biochemical and biophysical cues into the biomaterial for regenerative medicine, to 
achieve optimal clinical outcomes.  
 
There are currently a variety of hydrogel based products commercially available for soft 
tissue grafting and wound treatment.  These products differ in species source (e.g., 
human cadaveric, synthetic, bovine, porcine, equine, a combination of several types, 
etc.), tissue source (e.g., dermis, pericardium, intestinal mucosa, etc.), additives (e.g., 
antibiotics, surfactants), delivery formats (e.g., wet packaged, freeze-dried), and 










Description and applications of soft tissue 
hydrogel products currently available in the 
market 
Image of the Hydrogel 
products 
Mucoderm® is a collagen 3D porous tissue matrix 
derived from porcine dermis, supports 
revascularization and fast soft tissue integration and 
is a valid alternative to patients own connective 
tissue. Others include Mem-Lok® Pliable, Bio-Gide® 
which are collagen barrier membrane manufactured 
from highly purified porcine tissue[251].  
 
Collagen fleeces are natural collagen products with a 
hemostatic effect with a short-term barrier function 
which are used for wound dressing. Zimmer alongside 
Botiss produce collagen products as tapes, patches 





Botiss soft tissue biomaterials derived from porcine, 
acellular pericardium, include: 
 
Duraheal® is a dura substitute, adhesion prophylaxis 
(neuro, gastro, intestinal, cardio), scaffold for cellular 
guidance. 
 
Xenogaurd® used in orbital floor reconstruction, ENT 
e.g. tympanum substitute & rhinoplasty, as well as 
reconstruction of smaller defects e.g. paediatrics, 




TransCyte™ a temporary burn wound covering made 
of human cells and a silicon mesh-like material. It is 
typically used to treat second degree burns that are 
not expected to heal on their own.  
ALGISITE a calcium alginate dressing, (Smith and 
Nephew) intended for use in wounds where there is a 
moderate to heavy level of exudate such as pressure 




full thickness wounds, arterial, venous and diabetic 
leg ulcers, pressure sores, post-operative wounds 
and fungating lesions.  
 
Hydrocolloid dressings such as, Tegasorb, Tegadem 
etc. combine moisture vapour permeability with 
absorbency and conformability, and its transparency 





Apligraf® from Organogenesis, the graft is a living cell 
based product for chronic venous leg ulcers and 
diabetic foot ulcers it is supplied as a living, bi-layered 
skin substitute. The lower dermal layer combines 
bovine type 1 collagen and human fibroblasts (dermal 
cells), which produce additional matrix proteins. The 
upper epidermal layer is formed by promoting human 
keratinocytes (epidermal cells) first to multiply and 




Dermagraft®, Composed of human fibroblasts, an 
extracellular matrix, and a bio-absorbable polyglactin 
mesh scaffold. It is used in treatment of ulcers such 




GORE-TEX® Soft Tissue Patch has a material 
strength of ~1MPa. It is a soft and conformable 
microporous sheet material. It is made from solid 
nodes, connected by thin fibrils of expanded 
polytetrafluoroethylene (ePTFE). Its applications are 
varied ranging from Chest Wall Reconstruction, 
Diaphragmatic Hernia, Ventral Hernia, Gastroschisis 
and Omphalocele.    
 
[261] 
GORE® BIO-A® Tissue Reinforcement is a synthetic 
product is composed of [co]polymer (polyglycolic acid: 
trimethylene carbonate [PGA:TMC]) that is gradually 
absorbed by the body. The device has a three-
dimensional matrix consisting of open, interconnected 
pores and like ECM, the matrix serves as a scaffold 
for tissue regeneration, but consists of polymer fibres 
instead of decellularized tissue [262]. 
 
[262] 
Table 5-1: A variety of soft tissue grafts commercially available for   tissue augmentation 
and wound healing. All images were adapted from the denoted references provided next 
to the images. 
 
The grafts listed in the Table 5-1 have certain limitations both in terms of their biological 
and mechanical performance and often lead to rejection, due to limited of resorbability 
and inadequate mechanical properties required for the applications. To overcome the 
shortcomings of the current materials used mainly in soft tissue applications, advances in 
material design and polymer chemistry have allowed for incorporation of advanced 
dynamic features in biomaterials such as controllable degradability and stimuli 
responsiveness. Hydrogels, are particularly useful in soft tissue applications, however 
have been limited by weak mechanical properties. Structural and mechanical load of 
tissues vary as behaviour is optimised for their respective physiological functions, thus 
engineered tissue constructs should exhibit stress–strain responses comparable to the 
tissues they are intended to replace or provide structural support [263, 264]. Thus 
strategies to toughen hydrogels, which include formation of hydrogels from a 
combination of synthetic and natural polymers, development of inter penetrating 
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networks (IPN) networks and double networks (DbN) are being explored for biomedical 
applications. 
 
Inter Penetrating Networks (IPN) 
The International Union of Pure and Applied Chemistry (IUPAC) has defined IPNs as; 
polymers comprising of two or more networks that are at least partially interlaced on a 
molecular scale but not covalently bonded to each other and cannot be separated unless 
chemical bonds are broken (Figure 5-1) whilst semi IPNs are; polymer comprising of one 
or more polymer networks and one or more linear or branched polymers characterized 
by the penetration on a molecular scale of at least one of the networks by at least some 
of the linear or branched macromolecules (Figure 5-1). This means semi IPNs consists 
of only one crosslinked component within the network structure and one of the linear or 
branched macromolecules can in principle be separated from the integral/elemental 
polymer network without breaking the chemical bonds [138]. 
Preparation and formation of IPNs can be classified as simultaneous or sequential, 
where with simultaneous reactions, the polymers or monomers of both networks are 
mixed together and the two networks are synthesized together at the same time by 
independent, noninterfering routes such as chain or stepwise polymerisation. Sequential 
reactions are formed by swelling a 1st single polymer network hydrogel in a solution of 
the second polymer, forming a semi IPN and if the 2nd polymer is crosslinked then this 
forms a full IPN [139, 140].  
The combination of favourable properties of each composing polymer used to prepare 
the IPNs often leads to a new system with improved properties  considerably divergent 
from those of the individual polymer, that have  resulted in the successful use of IPNs in 
pharmaceutical and biomedical applications [141]. Smart hydrogels that are stimuli 
responsive i.e. temperature, pH and a combination of both temperature/pH responsive 
hydrogels, which achieve their properties by exploiting the properties of at least one of if 
not both polymeric component of the network. The network structures have led to 
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improvements in bioadhesion recently shown by formulation of photocrosslinkable 




Figure 5-1: Schematic representation of the semi-IPN and IPN formation. Polymer A and 
Polymer B are generic polymers (such as linear, comb or grafted).  
 
Double networks (DbN) 
Double network were first reported by Gong laboratories [68], that are characterised as 
tough IPN matrices in which a relatively high  molecular mass neutral polymer network is 
incorporated within a swollen heterogeneous polyelectrolyte network.  The difference 
between the DbN and conventional IPN are based on the contrasting structures of the 
polymers in use, the following principles are essential features/parameters used to attain 
DbN hydrogels and can be adjusted and varied to achieve a wide range of mechanical 
performance of the final networks: 
- A first network, being a brittle polymer such as a polyelectrolyte; a second network, 
being a soft and ductile polymer such as a neutral polymer. 
Sequential Pathway Simultaneous Pathway 
Polymer  A 
solution 
Crosslinked  








Solution of polymer 
A+B + crosslinkers 
IPN 
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- The molar concentration of the second network is 20 – 30 times the first network. 
- The first network is tightly crosslinked, whilst the second network is loosely crosslinked, 
which requires a high molecular weight second polymer. 
DbN are reported to contain up to 90% by weight of water, with tensile strengths of 
1~10MPa at 1000 – 2000% strain, compressive stress of 20-60MPa at 90 – 95% strain, 
elastic modulus of 0.1 – 1.0MPa and toughness ( tearing fracture energy) of 100 – 
1000Jm-2. The toughness of the hydrogels and its large fracture energies has been 
described to be attributed to the necking phenomenon, where polyelectrolyte polymer 
(first network) breaks into small clusters that efficiently disperse the stress around the 
crack tip into the surrounding damage zone, thus serving as sacrificial bonds, the ductile 
polymer (second network) is believed to extend extensively thereby sustaining the large 
deformation [69, 266, 267]. However it has been reported that fragmentation of the first 
network is accumulative and irreversible. Following the work by J. Gong on the 
development of poly(2acrylamido-2methylpropanesulfonic acid) (PAMPS) and 
poly(acrylamide) (PAAm) [68],  further novel DbN were developed by other groups 
examples include; bacterial cellulose/polyacrylamide (BC/PAAm) [268], poly(ethylene 
oxide) (PEO) and poly(acrylic acid) (PAA) [269], thermoresponsive DbN of poly(N-
isopropylacrylamide) (PNIPAAm) and N-isopropylacrylamide (NIPAAm)[270], a review of 
other DbN hydrogels has been reported by Haque et., al 2012 [266]. Some of these DbN 
hydrogels exhibit good biocompatibility and low friction resistance, making them 
desirable with a promising perspective in a wide range of biomedical applications such 




Sodium alginate (SA) is a naturally occurring polysaccharide widely used as a 
biomaterial for tissue engineering due to its biocompatibility, ability to undergo gelation 
under physiological conditions and non-thrombogenic nature. It is also a naturally 
abundant material and can be used solo or in combination with other bio or synthetic 
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polymers in formation of hydrogels [232]. SA is derived mainly from brown seaweed 
through treatment with aqueous alkali solutions typically with NaOH, thereby after which 
the extract is filtered and mixed with calcium chloride so as to precipitate the alginate. 
Treatment with dilute hydrochloric acid (HCl) can convert the alginate salt to alginic acid 
[232]. Alginates are composed of β-D- mannuronic acid units (M units) and α-L-guluronic 
acid (G units) monomers linked together by -β(1,4) and –α(1,4) glycosidic bonds, which 
vary in amount and sequential distribution along the polymer chain (MM, GG OR MG) 
depending on the source of the alginate [233]. Due to their physical and chemical 
properties alginates have been widely used in food, textile, medical and pharmaceutical 
industries. Even though alginates are readily dissolved in water, they can be rendered 
insoluble by allowing them to gelate in the presence of divalent cations, where these ions 
interact ionically with blocks of guluronic acid residues. An example on how the gelation 
occurs is by the interaction of Ca2+ ions with the G block units leading to the formation of 
an egg box structure, where CaAlg is formed by the G components enclosing the 
calcium ions; resulting in the formation of a three-dimensional network structure shown in 
Figure 5-2. Alternative di- as well as tri-valent cations may also be used in gelation of 
alginates such as Fe2+, Cu2+ and Al3+ [273, 274]. Ionically crosslinked alginates are weak 
and lose mechanical properties and stability over time in vitro, therefore stable covalent 
cross-links may be introduced to the alginate hydrogels using bifunctional crosslinkers 




Figure 5-2: Egg box structure demonstrating G units enclosing calcium ions during 
gelation. Adapted from Marriott et al. [275]. 
 
The biocompatibility and facile crosslinking to gelate alginate make them versatile 
biomaterials for drug delivery, cell encapsulation, cardiac tissue engineering [276] and 
bone tissue engineering [232]. Alginates are considered not to degrade but on gelation 
the process can reverse with time to allow an erodible matrix via dissolution. 
 
The aim of this study was to develop tough interpenetrating (IPN) dual network hydrogel 
system by adopting the concepts and principles of double network hydrogels, where the 
1st network is a dense tightly structured poly electrolyte, which is swollen in a second 
ductile loosely crosslinked monomer. However, in this study a neutral base polymer of 
PVA was selected to form the 1st dense network mesh and 2nd polyelectrolyte polymer 
network of sodium alginate was selected to form the interpenetrating network within the 
1st mesh and the first network of PVA was also obtained by a physical process of 
crosslinking. Hydrogel blends of PVA and alginate [182], and IPN’s of PVA and alginate 
have  been reported all developed by various methods, but none fabricated via 
techniques proposed in this study. This unique, simple and nontoxic method of 
fabricating hydrogels gives rise to prospects of developing  tough hydrogels with ability to 
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be tailored for various applications of interest and further to utilize these systems as 
matrices for elastomeric biocomposite formulation. In this study the following steps were 
implemented as to optimise the study and determine the levels of crosslinking required to 
yield tough hydrogels. 
 Due to the mechanism of PVA gelation via physical crosslinking it was critical to 
analyse the effect of freeze thawing cycles on the 1st network. 
 The effect of incorporation of alginate in the network structure was determined by 
analysing the physico-chemical properties of the hydrogels. 
 The biocompatibility of the optimised hydrogels was assessed. 
 Drug release from dual network hydrogels. 
 
5.2 MATERIALS AND METHODS 
 Chemical structure 
PVA as described 











Table 5-2: Materials used in the synthesis of dual network hydrogels. 
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Based on the results detailed   in Chapter 3, a 10% wt./vol concentration was used to 
make the solutions of PVA in water(PVA10), which exhibited good handling properties, 
hence  used in the  synthesis of dual network hydrogels. 
 
PVA hydrogel films 
PVA10 solutions were prepared as previously reported in chapter 3. Polymer solutions 
were cast into moulds to form thin hydrogel sheets and subjected to different (1, 2 and 3) 
cycles of freeze drying for 24 hours and allowed to thaw for 12 hours before repeating 
the next freeze drying process to obtain PVA1FT, PVA2FT and PVA3FT gel films, (NB: 
All xerogels fabricated from here on were subjected to freeze drying in the upper 
chamber of the freeze dryer). The PVA xerogels were characterised to identify the 
effects of different cycles of freeze thawing on the formed networks before the xerogels 
were further used to form interpenetrating dual networks with SA. 
 
Synthesis of PVA/SA interpenetrating dual hydrogel networks 
The PVA10 xerogels films were immersed in 2%wt./vol. SA till equilibrium uptake, to 
allow for penetration of SA into the PVA gel. The   PVA gels swollen in sodium alginate 
were   then immersed in 10% CaCl2 to allow for chelation to occur.  The hydrogels were 
then separated into two groups for further crosslinking by (a) 1 freeze-thaw cycle and (b) 
air-drying (AD) + 1 cycle of freeze thawing (1FT). All xerogels formed were placed in a 
desiccator until physiochemical characterisation.    
 
5.3 CHARACTERISATION 
Attenuated Total Reflectance- Fourier Transform Infrared spectroscopy (ATR – 
FTIR) 
The infrared spectral analysis was performed to characterise the chemical structure of 




Differential Scanning Calorimetry 
The experimental procedure is detailed in chapter 3.  
The crystallinity of PVA10 xerogels were determined by calculations from the thermal 
curves of the freeze-thawed hydrogel films. The heat required for melting the sample ΔH 
was determined by integrating the area under the peak over ranges 180 – 250°C. The 
peak representing heat required for the evaporation of water at around  100°C was 
analysed and used to obtain the corrected value of ΔH [154, 278].  
%Crystallinity= [ (ΔHm – ΔHw) / ΔHm°] x 100% 
ΔHm = heat of melting 
ΔHw = heat of vaporisation of water 
ΔHm° = heat of melting polymer at 100% crystallinity 
ΔHm° PVA = 138.6J/g  [154] 
 
Water uptake  
Hydration studies to obtain EWC were performed as detailed in the material and method 
section of chapter 3 and 4. 
The following equations were used to determine the nature of diffusion of water into the 
hydrogels. 
 
Where Mt and M∞ denote the amount of solvent diffused into the gel at time t and an 
infinite time (equilibrium) respectively. The slope s is obtained from the slope of a straight 
line of the plot Mt/M∞ against t1/2 where l is the thickness and D is the diffusion coefficient. 
 
 
For absorption Mt = Wt - Wi and M∞=Ws – Wi 
For desorption Mt = Ws – Wt and M∞=Ws - Wd 
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Where weight of hydrogels Wt = at time during swelling, Wi =initial weight, Ws =weight at 
equilibrium, Wd = dry weight after dehydration. 
 
Ultimate Tensile Strength 
Tensile strength measurements were performed as detailed in the material and method 
section of chapter 3. 
 
Trouser tear test 
This test method covers the determination of the force necessary to propagate a tear in 
the hydrogel films. Fracture energies were obtained using the trouser tear test on a 
rectangular shaped specimens (50mm x 17mm) with a 33mm long initial notch. The 
fracture energies of the hydrogels were calculated as  
G=2Fave/w    
Where Fave is the average tearing force and w is the thickness of the tested samples. 
 
Hydrolytic degradation 
Hydrogels were fabricated as previously described and solutions of phosphate buffered 
saline (PBS) of concentration 0.1M with pH 7.4 was used as the immersion medium. 
Samples were weighed and their dimensions taken before immersing them in 3ml of the 
PBS solution at 37ºC. The samples were removed at timed intervals and then wiped 
gently with soft paper to remove surface water. The samples were dried under vacuum 
at room temperature and weighed after complete drying. All experiments were done in 
triplicates. 
 
Drug release studies 
Hydrogels were loaded with a total of 1% vancomycin hydrochloride (Sigma Aldrich): to 
fabricate the drug loaded hydrogels, a solution of PVA was mixed with 1% vancomycin at 
300rpm until the drug was homogenously incorporated in the solution. The PVA solution 
was allowed to settle to allow the release of all bubbles before casting onto moulds and 
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subjecting to cycles of freeze thawing as previously described. For formation of the dual 
network hydrogels, 1% vancomycin was added to the 2%sodium alginate solution to 
prevent diffusion of the drug from PVA to sodium alginate. Once fully swollen with 
alginate the hydrogels were chelated with CaCl2 before subjecting to one more cycle of 
freeze drying. 
Drug release studies were conducted in phosphate buffered saline solution (PBS), pH 7 
at 37ºC. Dimensions of the specimens and weights were recorded before immersing in 
2ml PBS. 200µl solution of samples was withdrawn at recorded time points and diluted 
with 500µl distilled before reading on a UV spectrophotometer (Cecil 9000 series) at 
wavelengths 281nm, the extracted 200µl was replenished with exactly 200µl at each 
time point. Tests were carried out in triplicates. The calibration curve was constructed 
using vancomycin solutions in PBS with concentrations of 5-100µg/ml. To determine if 
the absorbance of vancomycin changed with each day an intra-day precision on the 
assay was carried out by processing and analysing three individual vancomycin 
standards at concentrations of 40, 50 and 60µg/ml respectively, for the duration of the 
study. 
 





Scanning electron microscopy (SEM) 
The experimental procedure is detailed in chapter 3. 
 
CYTOCOMPATIBILITY 
MTT, Live/Dead Staining, Cell morphology (SEM), Protein concentration, qPCR 
Cytocompatibility of the hydrogels were determined using the methodology as detailed in 
the materials and method section of chapter 4.  
 
5.4 RESULTS 
Effect of different freeze thaw cycles on PVA10 
PVA subjected to freeze thawing induces crosslinking of the PVA chains by hydrogen 
bonding and crystallite formation. In this study the effect of different freeze thaw cycles 
on PVA10 were investigated. PVA xerogels were fabricated by subjecting a PVA10 
aqueous solution which was cast onto a mould, to consecutive 24hr cycles of freeze-
drying; 1, 2 and 3 freeze thaw cycles. These xerogels were characterised to determine 
the effect of freeze drying on the hydrogels under the same processing conditions prior 
to formation of interpenetrating dual networks. 
 
Figure 5-4: Images of the dry PVA10 xerogels subjected to different cycles of freeze 







ATR-FTIR spectra of PVA10-FT xerogels 
 
Figure 5-5: A comparison of the FTIR spectra of 10%(w/v)PVA hydrogel films after 1,2 
and 3 freeze thaw cycles respectively. All three spectra were normalised to allow for 
comparison. 
 
The characteristic peaks of PVA were observed with vibrations corresponding to the OH 
groups (~3292 cm-1) due to the intermolecular and intramolecular hydrogen bonds, C-H 
stretching (~2940 cm-1) from the alkyl groups, C-OH(~1088 cm-1) related to the 
symmetric C-C stretching mode or C-O stretching where an intramolecular hydrogen 
bond is formed between two neighbouring OH groups on the same side of the plane of 
the carbon chain. The weak vibration at 1659 cm-1 assigned to C=O is due to acetal 
residual in PVA [182, 279].  
 
Thermal analysis and degree of crystallinity 
The crystalline structure of PVA10 hydrogels subjected to different cycles of freeze 
thawing were examined in terms of the overall degree of crystallinity as obtained from 
DSC thermograms. 
OH 




































Figure 5-6: DSC thermogram for PVA10 hydrogel prepared by one cycle of freeze 
thawing. 
 
A typical DSC thermogram for PVA10 subjected to consecutive cycles of freeze thawing 
is shown in Figure 5-6. The sharp peak at 227°C corresponds to the melting of PVA10 
and at approximately 100°C there is the change due to the evaporation of residual water 
present in the hydrogel. The degrees of crystallinity were calculated by analyzing the 
DSC thermograms for each of the PVA10 hydrogels subjected to different cycles of 
freeze thawing. A known mass of each of the hydrogels was subjected to a constant rate 
of heating. The heat required for melting the sample, ΔH,  was determined by integrating 
the area under the melting peak over a range of 190-240°C. The residual water present 
in the sample was calculated by analysing the heat required for evaporation of water on 
an area approximately at 100°C, this was used to correct the ΔH value. The degree of 
crystallinity was calculated by dividing the corrected ΔH with the heat required for melting 
100% crystalline PVA sample ΔHm°= 138.6J/g.  
 
Table 5-3: Shift in the crystallinity and glass transition (Tg) of the PVA10 hydrogel films 
as a function of freeze thaw cycles. 
 
Cycles of freeze thawing % Crystallinity Glass transition Tg(°C) 
1 67.4 70.9 
2 69.0 73.4 
3 68.9 72.5 
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Table 5-3 shows the crystallinity and glass transition values obtained from analysis of 
thermal scans of PVA10 hydrogels after different cycles of freeze thawing. Results 
indicated that 2 cycles of freeze thawing led to a higher Tg and degree of crystallinity 
than 1 and 3 freeze thaw cycles. No further increase in either Tg or crystallinity was 
observed with 3 freeze thaw cycles, an increased number of freeze thaw cycles does not 
necessarily increase the overall initial degree of crystallinity in the PVA sample, it is 
apparent that repeated cycles of freeze thaw only reinforce the crystals that already exist 
[154]. 
 
Interaction with water 
Hydrogels have the ability to take up and retain water as well as biological fluids, this 
behaviour is highly dependent on the composition of crosslinking. To investigate the 
effect of different cycles of freeze thawing on the hydration dynamics of the PVA10 
hydrogels, equilibrium water content, swelling ratio, gel fraction and diffusion coefficient   
of hydrogel were calculated. 
Cycles of 
freeze thawing 







1 83.2 ± 0.1 7.3 ± 0.2 82.0 ± 3.0 1.9 
2 81.3 ± 0.4 6.0 ± 0.1 89.0 ± 3.4 1.6 
3 79.2 ± 0.7 5.5 ± 0.1 87.2 ± 1.5 2.0 
Table 5-4: Equilibrium water content, swelling ratio, gel fraction and diffusion coefficient 
of PVA10 hydrogels prepared by different cycles of freeze thawing (n=3). 
 
Table 5-4 displays the effect of different cycles of freeze thawing PVA10 hydrogels on 
the EWC, swelling ratio and gel fraction obtained from the hydration study. Both EWC 
and SR were found to decrease with increasing number of freeze thaw cycles, and no 
significant difference were found between different cycles of freeze thawing. 
The solubility or remaining hydrogels content after initial hydration (Gel fraction) was 
determined by dividing the dry insoluble part of the hydrogel with the initial dry weight of 
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the sample, the gel fraction was found to increase with increasing cycles of freeze 
thawing. There was no significant difference between the diffusion coefficient of the 
PVA10 hydrogels subjected to different cycles of freeze thawing, however the diffusion 




The ultimate tensile strength (σT) and Young’s modulus (E, tensile modulus) of PVA10 
freeze thawed hydrogels shown  in Table 5-5 ranged between  0.3 – 0.4MPa and 0.5 - 
0.8MPa respectively for the hydrated gels. 
 
Cycles of freeze thawing σT (MPa) E (MPa) 
1 0.3 ± 0.1 0.5 ± 0.1 
2 0.4 ± 0.1 0.5 ± 0.1 
3 0.4 ± 0.1 0.8 ± 0.3 
Table 5-5: Tensile strength and modulus of the hydrated to EWC, PVA10 hydrogels 
subjected to different cycles of freeze thawing, (mean ± standard deviation) n=6. 
 
Tensile strength of the hydrogels were found to increase with increasing number of 
freeze thaw cycles, but was not statistically significant (p=0.161). The Young’s modulus 
of PVA10-3FT was found to be the highest and   statistical analysis showed that PVA10-
3FT was only significantly higher (p<0.05) than PVA10-2FT, and no difference was found 
between PVA10-1 and 2FT. 
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Figure 5-7: Stress strain curve of hydrated PVA10 hydrogels prepared by different cycles 
of freeze thawing. 
 
The typical stress strain curve in tensile mode of the hydrated PVA10 hydrogels in Figure 
5-7 indicate that there is an effect of the freeze-thawing cycles.  The stress strain curves 
also highlight the ductile behaviour of the PVA hydrogels, with a high capacity for 
deformation however with the ability to   withstand relatively low stresses. 
 
Dual network hydrogels of PVA-Alginate  
With the optimization and characterisation of the effect of freeze thaw cycles on PVA10 
hydrogels; the hydrogel systems were taken further to develop interpenetrating dual 
networks of PVA with sodium alginate (SA). The objective being to create a network 
system that constitutes of a robust synthetic 1st polymer network in conjunction with a 
weak natural polymer, interpenetrating within the 1st network to form a 2nd network, 
forging the creation of biocompatible mechanically enhanced network system. 
The dual network (DN) hydrogels were prepared via: 
I. 1st crosslinking by freeze thaw cycles previously reported for PVA10 
II. Allowing SA to penetrate the PVA10 hydrogel by swelling them to equilibrium in 
SA 
III. Chelation of the SA in a solution of calcium chloride 
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IV. 2nd crosslinking by either subjecting the interpenetrating network (IPN) hydrogels 
to 1 cycle of freeze thawing or air-drying prior to freeze thawing (AD+1FT). 
The two different final crosslinking methods used for the 2nd crosslink were undertaken to 
determine or identify if AD+1FT could have a significant improvement on the strength of 
the hydrogels.  
 
PVA-FT                              SA                              DN
 
Figure 5-8: Schematic representation of the formation of a dual network formed from a 
1st network of PVA crosslinked by freeze thawing, which is allowed to swell in a 2nd 
network of alginate and chelated with Ca2+ followed by a second crosslinking by freeze 
thawing.  
 
Development of the dual network hydrogels 
Dual network hydrogels were synthesized by swelling the 1st PVA xerogel network in a 
solution of sodium alginate until equilibrium was reached. Table 5-6 presents values of 
the calculated percentage of sodium alginate absorbed before chelation and after 













Cycles of Freeze 
thawing 
% Sodium alginate 
absorbed in PVA 
Hydrogel at 
equilibrium 
% of alginate in 
the Hydrogel after 
one cycle freeze 
thawing 
10 1 76.3 ± 1.5 39.6 ± 0.6 
 2 75.4 ± 0.4 34.9 ± 0.2 
 3 74.7 ± 1.6 33.9 ± 2.3 
20 2 63.6 ± 1.1 23.3 ± 0.4 
Table 5-6: Percentage of sodium alginate absorbed by the PVA hydrogels formed by 
different numbers of freeze-thawing cycles (n=3). Mass of PVA xerogels was measured 
before and after swelling to equilibrium in SA as well as after freeze drying, values of 
which were used to calculate percentage of alginate in the networks. 
 
 
Determination of concentration of calcium chloride (CaCl2) 
When sodium alginate solution is immersed in a solution of calcium chloride a rapid ion 
exchange process takes place. Sartori et al. 1996 reported that more than half the ion 
conversion between sodium and calcium occurs within the first 30 seconds, where there 
is an exchange of approximately two Na+ by one Ca2+; the expected ion exchange 
between a monovalent and a divalent cation. When left for longer immersion times in 
CaCl2 there is a greater ion exchange and it is reported that full ion conversion is 
obtained after ~300 minutes, when  1%wt sodium alginate and 0.8%wt CaCl2 [280] was 
used. 
A sodium alginate solution of 2%(w/v) was used, and from calculations only 1.8%(w/v) 
concentration CaCl2 would be required for full ion conversion in 5 hours. However 
considering the sodium alginate solution will require to penetrate within the PVA hydrogel 
and as well as considering reducing the immersion time of SA in CaCl2 to obtain 
maximum ion conversion; interpenetrating hydrogel networks of PVA and SA were 
formed by immersing in 10% CaCl2 for 3 hours to allow for maximum ion conversion 
throughout the depths of the hydrogel network. 
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Optimisation of freeze thaw cycles to be used for 2nd crosslinking 
Thermal analysis was used to determine the number of freeze thaw cycles 
required/necessary to form the 2nd crosslinking that would provide sufficient crosslink 
density in the hydrogels, yielding superior mechanical properties and stability. 
Hydrogel Network system Number of freeze-thaw 
cycles for dual networks 
Glass transition (Tg) 
DN10-2FT-1FT 1 163.6 ± 2.8 
DN10-2FT-2FT 2 167.1 ± 3.1 
DN10-2FT-3FT 3 167.5 ± 0.2 
Table 5-7: Variation of Tg from the effect of different cycles of freeze thawing to form a 
2nd crosslinking on the PVA10-2FT hydrogels. 
 
The glass transitions (Tg) reveal that there was no significant increase in Tg of the 
hydrogels when subjected to a further 2nd crosslinking of more than two freeze thaw 
cycles. The data in Table 5-7, made it evident that the second crosslinking of only 1 
freeze thaw cycle after swelling of PVA10 hydrogels in SA provided sufficient 
crosslinking density present in the final hydrogel network. The Tg values of the three 
dual networks formed via different cycles of crosslinking showed no significant 




Figure 5-9 : Photographs of dual network hydrogels, hydrated to equilibrium prepared via 




Figure 5-10 : Photographs of dual network hydrogels, hydrated to equilibrium prepared 
via a second crosslink of air drying and 1 freeze thaw cycle. 
 
FTIR spectra 
Assignments of Sodium alginate Frequency cm-1 
-OH stretching 3258 
-C-H stretching 2133-2377 
-COO- asymmetric 1594 
-COO- symmetric 1403 
-C-O-C stretching 1027 
Table 5-8: Peak assignments for the FTIR spectra of sodium alginate granules. 
 
 
Figure 5-11: A split layer FTIR spectra   of PVA10 after 1 cycle of freeze thawing and 
sodium alginate granules. 
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A comparison of the FTIR spectra of sodium alginate and PVA10-1FT is shown in Figure 
5-11, with the peak assignments of raw sodium alginate summarised in Table 5-8. A 
broad band centred peak at 3258 cm-1 is assigned to O-H stretching and a weak signal 
2377-2133 cm-1 due to the C-H stretching vibrations. The asymmetric stretch of the 
carboxylate COO- vibrational peak arises at 1594 cm-1 and the band at 1403 cm-1 is 
assigned to C-OH deformation vibration with contribution of the COO- symmetric 
stretching vibration of the free carboxyl group. The C-O stretching vibrations were seen 
at 1027 cm-1 [281]. The fingerprint region is represented by the mannuronic acid residues 
at 811 cm-1 and the guluronic acid residues at 686 cm-1 [281, 282]. Studies have shown 
that when sodium alginate contains high guluronic units, the bands or shoulders around 
the 1027 cm-1 absorbance peak would have a greater intensity than those of alginates 
with medium or low guluronic units. From Figure 5-11 it is evident that the sodium 
alginate used in this study is of low guluronic unit content as the shoulder peak reported 
to appear (in literature) on the C-O-C peak are not visible  [280]. 
 
  
Figure 5-12: An overlay of the FTIR spectra of sodium alginate granules, and dual 
network hydrogels chelated with calcium chloride and subjected to further crosslinking. 
 
A comparison of the FTIR spectra of the dual networks with sodium alginate (Figure 
5-12) showed that a sharp  O-H stretching peak (~3290 cm-1), which increased in 
intensity as compared to the low broad peak of the SA granules, which is due to the 
intramolecular bonding in the dual network hydrogel. The C-H (~2940 cm-1) 
corresponding to intermolecular binding is more defined on the dual network hydrogels 
and does not change with the different second crosslinking of the dual network 
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hydrogels. The COO- symmetrical peak (~1400 cm-1 highlighted in blue) in SA granules 
shifts to higher wavenumbers (~1420 cm-1) in the DN with a decrease in intensity due to 
the ionic binding, as the calcium ions replace sodium ions in the alginate blocks, 
therefore the charge density, radius and atomic weight of the cation are changed, 
creating a new environment around the carbonyl group. The blue highlighted area shows 
the change in the peak arising at ~1300 cm-1, which becomes more pronounced in the 
DN as compared to the granules, suggesting a strong binding of the calcium to the G 
blocks. Within the red highlighted region, a new peak arises at around 1150 cm-1, which 
corresponds to a partial covalent bonding between calcium and oxygen atoms. New 
peaks at ~1070 and ~1026 cm-1are associated with the guluronic blocks and indicate a 
change in the binding within these blocks as calcium is introduced [280]. 
 
   
Figure 5-13: A comparison of infrared spectra (overlay) of PVA10-2FT, PVA10-2FT dual 
network hydrogels subjected to a further crosslinking of one freeze thaw cycle and air-




Figure 5-14: A split layer FTIR spectra comparing PVA10-1FT, PVA10-2FT dual network 
hydrogels subjected to a further crosslinking of one freeze thaw cycle and air-drying prior 
to freeze thawing, and PVA20-2FT dual network subjected to a further crosslinking of 1 
freeze thaw cycle. 
 
Figure 5-13 and Figure 5-14  show the comparison of the FTIR spectra of the dual 
network hydrogels and PVA-2FT only hydrogel. The peak arising at 1600 cm-1 (green 
block) is assigned to the carboxylate groups present in both guluronic and munnoronic 
acids units in alginate, which confirms the incorporation of the alginate in the dual 
network. A slight shift in the carboxylate peak highlighted in the blue region indicates an 
interaction between PVA and sodium alginate. The C-O stretching at 1027 cm-1 (pink) in 
PVA,  is replaced by a double peak in the dual networks (at 1058-1081 and 1023-1026 
cm-1) which can be attributed to the ether (C-O) and acetal ring (C-O-C) formed due to a 
crosslinking between PVA and SA (or due to the antisymmetric stretch of C-O-C 








Differential scanning calorimetry – Thermal analysis 
 
Figure 5-15: Normalised thermograms of PVA10-2FT, PVA20-2FT, PVA10-2FT dual 
network hydrogels subjected to a further crosslinking of one freeze thaw cycle and air-
drying prior to freeze thawing, and PVA20-2FT dual network subjected to a further 
crosslinking of 1 freeze thaw cycle. 
 
 
Hydrogel network Cycles of PVA10 freeze 
thawing 
Glass transition, Tg (°C) 
 
DN10-(x)-1FT 
1 155.2 ± 3.0 
2 163.6 ± 2.8 
3 169.1 ± 3.2 
 
DN10-(x)-AD+1FT 
1 169.3 ± 2.2 
2 176.6 ± 2.6 
3 177.4 ± 2.3 
PVA20-(x)-1FT 2 75.9 
DN20-(x)-1FT 2 139.0 
Table 5-9: Glass transition of PVA10 and PVA20 dual network hydrogels prepared by 
different cycles of freeze thawing. (x=1, 2 or 3 FT as shown in column 2). 
 
The Tg values of the dual networks ranged from 139-1770C and were found to show a 
correlation to the number of FT cycles as expected. The single network of PVA exhibited 
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a Tg at ~750C (Table 5-3) and this large difference also confirms the formation of a new 
network that reinforces the matrix. The Tg values of the dual networks also showed a 
relationship with the concentration of the PVA used with the higher concentration of 20% 
PVA yielding a lower Tg, which may be attributed to the reduced uptake of the alginate 
















DN10-(x)-1FT 1 69.1 ± 0.9 4.6 ± 0.1 70.6 ± 2.2 0.3 
2 69.8 ± 0.5 4.7 ± 0.1 71.0 ± 1.3 0.1 
3 71.8 ± 0.8 4.5 ± 0.1 78.4 ± 3.2 1.0 
DN10-(x)-
AD+1FT 
1 70.7 ± 1.4 4.7 ± 0.1 70.2 ± 1.2 0.4 
2 72.6 ± 0.7 5.1 ± 0.1 72.1 ± 0.7 0.9 
3 72.4 ± 0.7 4.7 ± 0.1 76.3 ± 1.0 0.8 
PVA20-(x)-
1FT 
2 66.3 ± 0.7 3.0 ± 0.1 99.0 ± 1.7 1.0 
DN20-(x)-1FT 2 55.0 ± 0.5 2.7 ± 0.01 83.4  1.3 
Table 5-10: Equilibrium water content, swelling ratio and gel fraction of PVA10 and 
PVA20 dual network hydrogels prepared by different cycles of freeze thawing (n=3). 
(x=1, 2 or 3 FT as shown in column 2). 
 
The results of EWC, SR, GF and diffusion coefficients of the different hydrogel groups 
are summarised in Table 5-10. EWC  and SR of dual networks subjected to a 2nd 
crosslinking of 1 FT cycle exhibited lower values than those subjected to a 2nd 
crosslinking of AD+1FT, both networks of which were found to be significantly lower 
(p<0.001) that of the PVA only hydrogels. This indicates the formation of a tighter more 
compact and rigid network structure. The concentration of PVA to form the dual networks 
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had a significant effect on both EWC and SR with the higher concentration of 20% 
yielding lowest values. The variation of the diffusion coefficient of water on the hydrogels 
showed a similar trend, where the average water diffusion into hydrogels decreased as 
crosslinking density increased, with the exception of the DN20 dual network hydrogel. 
 
Figure 5-16: A comparison of the hydration of PVA10 and 20 subjected to 2 freeze thaw 
cycles, as well as their dual network hydrogels. 
 
 
Figure 5-17: A comparison of the dehydration curve of PVA10 and 20 subjected to 2 
freeze thaw cycles, as well as their dual network hydrogels. 
 
Figure 5-16 and Figure 5-17 are typical plots of the behaviour of water absorption and 
desorption versus t1/2 for the different PVA10 and 20 hydrogel groups and their 
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Degradation studies on hydrogels bring to view the rate at which structural integrity of 
hydrogels is compromised / lost in time whilst immersed in a solution of known pH and 
temperature. 
 




Figure 5-19: Expanded plot representing a comparison of the degradation curves for the 





Figure 5-20: Expanded plot representing a comparison of the degradation curves for the 
the dual networks subjected to different methods of crosslinking in the 1st 50h. (n=3) 
 
Figure 5-18, Figure 5-19 and Figure 5-20 show a comparison between the degradation 
of the PVA only hydrogels and their respective dual network gels. The plots are 
presented as %weight loss from hydrogels as a function of time. The results that dual 
network hydrogels undergo a higher weight loss percentage as compared to the parent 
PVA only hydrogels. 
 
Tensile strength 
Tensile strength tests were carried out to elucidate the effect of the different forms of 
crosslinking as well as the integration of SA into the PVA network, on the mechanical 
properties of the hydrogels. 
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Figure 5-21: A comparison of tensile strength of the freeze-thawed PVA hydrogels with 
PVA/alginate dual network hydrogels prepared via various methods. (n=6) (* P<0.001); 
asterisk linked with lines indicate significant difference in values between the groups 
 
  
Figure 5-22: A comparison of the Young’s modulus of the of the freeze-thawed PVA 
hydrogels with PVA/alginate dual network hydrogels prepared via various methods. (n=6) 
 
Fully hydrated hydrogels were used to determine the tensile strength and modulus, 
shown in Figure 5-21 and Figure 5-22. The PVA only hydrogel exhibited lower tensile 
strengths compared to dual network hydrogels, whilst DN10-2FT-1FT exhibited a 
significantly higher ultimate tensile strength of 0.7Mpa as compared to the other dual 




Figure 5-23: A comparison between stress strain curves of PVA10 and dual network 
hydrogels subjeccted to two freeze thaw cycles before a further crosslinking by either 1 
freeze thaw cycle or air drying prior to freeze thawing.  
 
The modulus values of the hydrogelas showed that the dual networks exhibited higher 
values in comparison to the PVA only networks with the exception of the PVA 10 that 
was subjected to three cycles of freeze-thaw. Typical strees-strain curves shown in 
Figure 5-23, indicates the ductile nature of the ductility of the hydrogels hydrogels. 
 
From the optimisation study it was apparent that PVA10-2FT hydrogels yielded dual 
network hydrogels with superior mechanical properties only with a second crosslinking of 
1FT. To obtain dual network hydrogels with tensile strength greater than 1MPa, PVA of 





Figure 5-24: A comparison of tensile strength of the PVA (10, 20)-2FT and DN (10, 20)-
2FT-1FT hydrogels. (n=6) (* P≤0.033 and ** P<0.001); asterisk linked with lines indicate 
significant difference in values between the groups 
 
  
Figure 5-25: A comparison of Young’s modulus of the PVA (10, 20)-2FT and DN (10, 
20)-2FT-1FT hydrogels. (n=6) (* and ** P<0.001); asterisk linked with lines indicate 
significant difference in values between the groups 
 
Tensile strength and Young’s modulus PVA 10, 20 only and their respective dual 
network hydrogels formed from two cycles of freeze thawing are presented on Figure 
5-24 and Figure 5-25 respectively. The results showed that tensile strengths of the dual 
network hydrogels could be increased by increasing the concentration of PVA to 20%, 
which were three orders of magnitude higher than most hydrogels.    
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Figure 5-26: A comparison of the stress strain curves of PVA10 and 20 and their 
respective dual network hydrogels subjected to two freeze thaw cycles before a further 
crosslinking by  1 freeze-thaw cycle. 
 
The modulus values of the dual networks indicated that they were dependent on the 
initial concentration of the first network, namely PVA. It can also be extrapolated that the 
stiffness of the single network hydrogels increases when SA is included in the network to 
form an IPN dual network. 
 
Fracture toughness 
A trouser tear test was performed on hydrogels with PVA base fabricated by two freeze 
thaw cycles. 
Tearing tests are used as a measurement of fracture energy to qualify the mechanical 
strength of hydrogels. Fracture energies of the hydrogels (Figure 5-27) Showed that 
PVA20 dual network hydrogel had a significantly higher fracture energy of 6.5KJ/m2 in 
comparison with all the other hydrogels. PVA10 dual network however had lower fracture 




Figure 5-27: Fracture energy values of PVA10, 20-2FT and dual network hydrogels 
obtained from using a trouser tear test. (n=6); asterisk linked with lines indicate 
significant difference in values between the groups 
 
Drug release 
A preliminary study of these dual networks as potential drug carriers were evaluated 
using vancomycin, a widely used antibiotic. Vancomycin hydrochloride hydrate (Mw 
1485.71 anhydrous basis) was incorporated within the hydrogels and its release rate 
calculated. FTIR spectra was recorded to determine the incorporation of the antibiotic 
drug within the hydrogels prior to release. 
 
 
Figure 5-28: An overlay comparison of infrared absorbance peaks of PVA only hydrogels 




The spectra of the gels with and without vancomycin are shown in Figure 5-28, and the 
increase in the intensity of absorbance peaks between 1800-1600 cm-1 and 1500-1200 
cm-1 confirmed the presence of vancomycin. 
  
 
Figure 5-29: An overlay comparison of infrared absorbance peaks of dual network 
hydrogels incorporated with and without vancomycin, subjected to different cycles of 
freeze thawing. 
 
The FTIR spectra of the dual networks with and without vancomycin in Figure 5-29 
showed the increase in intensity of the peaks between 1700-1500 cm-1 due to amide 
groups of the vancomycin as well as 1500-1200 cm-1 indicating the presence of 
vancomycin the base PVA network structure. As the concentration of the drug used is 
low in comparison to the dual network, the overlapping bands of the base components 
predominate hence it is difficult to assign the peaks, however the comparison of the 
spectra with and without the drug can be used to confirm the presence of vancomycin.  
 
 
Figure 5-30: A split layer infrared absorption peak comparison of PVA10-2FT hydrogel 




Figure 5-31: Percentage drug release as a function of time of the PVA only hydrogels 




Figure 5-32: Expanded (first 600 mins) percentage drug release plot as a function of time 
representing [A]PVA only hydrogels subjected to different cycles of freeze thawing and 
their respective [B]dual network hydrogels. (n=3) 
 
Figure 5-31 and Figure 5-32 display the percentage drug release plots of the hydrogels 
incorporated with vancomycin. Results show a linear drug release profile in the early 
stages, of up to between ~40-45% within the first 500 minutes the plateauing at ~60% 
release of the drug within 7000 mins. The dual networks exhibited a slower release in 
comparison to the single network ~17-25% of the drug being released within the first 500 
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Figure 5-33: SEM micrographs of PVA10-(1,2,3)FT, DN(10,20)-2FT-1FT, DN-2FT-
AD+FT,  at different magnifications 100x, 500x and 2500x, as well as tensile specimens 
of the dual network hydrogels after tensile testing, presenting the different morphologies 
seen on the area of the tensile break. 
 
The micrographs of PVA10 xerogels showed a microporous structure on the surface, 
with what appears to be crystallite domains, whereas the PVA20 xerogel showed a 
dense smooth surface with little to no visible porosity. The dual network hydrogels had a 
rough non-ordered surface area, this was attributed to the presence of alginate within the 
PVA network structure, of which was confirmed by FTIR results. The micrographs of the 
fractured surfaces of the tensile specimens show stretched elongated fibres of the 
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hydrogels indicating that the hydrogels are ductile, which is in agreement with tensile test 
results obtained from the study. 
 
Cytocompatibility of hydrogels 
Cell viability study by MTT assay 
Human osteoblast like cells were used to test their viability in presence of the elutions of 
the hydrogels using  MTT assay at 24, 48 and 72 hour exposure times of eluents 
collected after 24, 48 and 72 hours. The results showed that eluents from single 
networks of PVA and the dual networks did not have any toxicity, however DN hydrogels 
expressed a higher level of cell viability than the PVA hydrogels within the 24 and 48h 









Figure 5-34: MTT test showing the response of human osteoblast cells following 
exposure to eluents from PVA10-2FT and DN10-2FT-1FT hydrogels. Cells were 
exposed for 24, 48 and 72h to a [A]. 24h elution time [B]. 48h elusion time and [C]. 72h 
elusion time. 
 
Live dead assay 
HOB cells were stained with calcein AM and ethidium bromide solution, with the live cells 
displaying a green nucleus and dead cells fluorescing a red colour. Live cells were 
observed to be dispersed throughout the hydrogel networks. After 28 days in culture 
cells are observed to have a flattened morphology on the PVA10-2FT hydrogels, and 
observed to have formed something resembling a sheet cover on the surface of the dual 





























Figure 5-35: Images of live/dead staining of HOB cells (x4, 10 and 20 magnification on 






















Figure 5-36: Images of live/dead staining of HOB cells (x4, 10 and 20 magnification on 










HOB cell differentiation by alkaline phosphatase activity and protein concentration 
 
Figure 5-37: The alkaline phosphatase activity in balance with the protein concentration 
of humanosteoblast cells (HOB) on PVA10-2FT and DN10-2FT, with the tissue culture 
plate as the control. Tests were carried out on culture media supernatant of hydrogels at 
time points day (7, 14, 21 and 28). Data represents as mean±SD as n=4 
 
 
HOB cells cultured on the PVA and DN hydrogels (Figure 5-37), expressed a peak in 
ALP concentration after 14 days culture period, which then decreased at 21 and 28 days 
in culture. The DN hydrogel had higher production of ALP than the PVA only network, 
indicating that more HOB cells in the dual network were progressing towards 
differentiation to mature osteoblasts. 
 
Real time quantitative PCR: Molecular quantification of osteoblastic phenotypes, 
ALP and RUNX2 
The expression of RUNX2 on the cells seeded within the PVA and dual network 




Figure 5-38: Relative expression of Runx2 of the HOB cells cultured on the  PVA10-2FT 
and DN10-2FT-1FT hydrogels, analysis was carried out at time points day(7,14,21,28). 
NB: data presented is relative to day 7. 
 
Relative expression of RUNX2 shown in Figure 5-38 indicated an increase in expression 
from day 7 to day 14 followed by a decrease, with exception of PVA10-2FT hydrogel 
which showed down regulation at day 14. 
 
5.5 DISCUSSION 
Hydrogels are able to provide a microenvironment for cells to adhere, proliferate and 
differentiate whilst providing exchange of nutrients, thus enabling their use in tissue 
engineering applications. The properties or design variables of hydrogels in biomedical 
applications are specified by the intended clinical scaffold application and the 
environment into which the scaffold is to be placed, hence tough networks with high 
water absorbency are expected to find applications in soft tissue engineering and wound 
dressing applications. Hydrogels possess a 3 dimensional matrix and constitutes of 
linear or branched hydrophilic networks that are either physically or chemically 
crosslinked with high water absorbency. Poly (vinyl alcohol)/PVA, is a synthetic 
biocompatible  polymer that is water soluble due to its hydroxyl groups and is easily 
degradable in the environment, where the degradation depends on the amount of 
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hydroxyl groups. Alginate, on the other hand is an anionic linear polysaccharide 
composed of two saccharides composed of α-I-guluronic acid (G) and β-d-mannuronic 
(M) that are covalently bonded through 1,4-glycosidic linkage and arranged into either 
homopolymeric block (MM and GG) or alternating block (MGMG) along the polymeric 
backbone. Polymer blends and crosslinking of alginate with PVA have been reported to 
overcome the limitations of the individual polymers, however these still lead to fragile 
structures with low cell adherence due to the high water absorbency. With the aim of 
creating tough hydrogel networks, PVA was chosen as the base polymer for formation of 
dual networks due to its ability to form insoluble networks via hydrogen bonding and 
crystallite formation. The effect freeze drying on crystallite formation and the resultant 
consequences of freeze thaw cycles on the hydrogel was first investigated before 
incorporation of alginate into the network structure to form dual networks.  
In this study the physical properties that were deemed appropriate for both soft tissue 
applications and to form tough, elastomeric matrices for composite formulation were 
evaluated:  
 Mechanical strength at a macroscopic level must bear loads to provide stability to 
the tissue as it forms as well as fulfil its volume maintenance function. 
  Fluid diffusion and degradation properties, which will directly translate to mass 
transport properties of the hydrogel and at a microscopic level influence cell 
growth, differentiation and ultimate tissue formation.  
 Along with biocompatibility and nontoxicity, incorporation of drugs or growth 
factors, which can be released in vitro or in vivo as the gel degrades, aiding and 
facilitating in the process of new tissue formation. 
 
Effect of different freeze drying and thawing cycles on the PVA single hydrogel 
network 
It is known that freeze thawing produces stable PVA hydrogels that are physically 
crosslinked in the presence of crystallite regions. At a molecular level PVA chains 
present as a layered structure with a simple zig zag configuration where the double layer 
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of molecules is held together by hydroxyl bonds whilst weaker van der Waals forces 
operate between the double layers as shown in Figure 5-39.   
 
 Figure 5-39: Zig zag configuration of hydrogen bonding in PVA structure. Adapted from 
Courtney et al [285]. 
 
A folded structure of PVA chains leads to small ordered regions called crystallites, 
scattered in a disordered amorphous polymer matrix. The increase in size of crystallites 
is directly proportional to increase in size of molecular weight [142] and the degree of 
crystallinity as well as the size of crystallites depends on drying conditions [192]. The 
molecular weight of PVA was not varied in this study and the crystallite formation was 
thus only dependent on the freeze-thawing cycles. The results (Table 5-3) showed that 
two freeze-thaw cycles led to a slightly more stable crystalline structure,  indicated by the 
Tg and % crystallinity calculated,  73.4°C and 69.0% respectively, however the 
differences were not statistically significant, nevertheless they were different, considering 
DSC measurements are accurate This data was supported by an earlier study by 
Hassan et al. 2000 where a similar trend in crystallinity values of PVA 15 wt.% was 
observed when  subjected to three, five and seven cycles of freeze thawing at 
approximately 60% [154]. It was noted that, increased number of cycles of freeze 
thawing does not necessarily increase the overall initial degree of crystallinity but 
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however reinforces the crystals that already exist, therefore enhancing stability of the 
hydrogels [154]. 
FTIR spectral analyses revealed crosslinking occurred when the PVA 10% solution was 
subjected to 1, 2 or 3 cycles of freeze-thawing, however only minor changes could be 
detected between the spectra with increasing number of freeze-thaw cycles as expected. 
The main difference was the decrease in the intensity of the O-H band due to loss of 
water from the consecutive cycles and the sharp intense peak of C-OH absorption band 
indicated an increase in the crystallinity. 
  
Figure 5-40: Diffusion Coefficient and Gel fraction as a function of number of freeze thaw 
cycles, carried out in distilled water at 37°C. (n=3) 
 
When a hydrogel is placed in contact with water, it diffuses into the hydrogel resulting in 
swelling and saturation with water. Diffusion involves migration of water into pre-existing 
or dynamically formed spaces between the hydrogel polymer chains, whereas swelling of 
a hydrogel involves a larger scale segmental motion resulting in a bigger separation 
between the hydrogels. Hence, a critical analysis of the swelling process aids in 
revealing the underlying molecular processes of hydration and subsequent dehydration. 
Diffusion coefficients as well as gel fractions were determined to provide further insight 
on the hydration dynamics of the PVA10 hydrogels, relating directly to the effect of 
cycles of freeze thawing on the crystalline structure.  The lowest diffusion coefficient was 
observed with two freeze thaw cycles, indicating less diffusion of water ions into the 
PVA10 hydrogel structure due to the presence of more crystalline regions.  The gel 
fraction of the hydrogels were calculated, therefore PVA chains that were not 
incorporated into the overall crystalline structure dissolved in solution and thus the 
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resulting gel fraction indicated percentage of crosslinked regions within the overall PVA 
structure. Results showed that there was initial dissolution of PVA with all cycles of 
freeze thawing, due to the PVA chains that did not participate in the crystallite formation 
process, however the highest gel fraction retained was with two freeze thaw cycles at 
89.0%. This supports the findings of the thermal analysis, that enhanced stability is 
obtained when PVA is subjected to an increased number of freezing thawing cycles 
(observed with 2FTcycles), but once the limit is reached to which crystallinity can be 
reinforced, further cycles of freeze thawing impact and reduce the stability of the 
hydrogel (observed with 3FT cycles).  
 
Synthesis and development of the dual network Hydrogels 
Double network gels essentially consist of two interpenetrating networks with contrasting 
structures, one a densely cross-linked, brittle network of low concentration and the other 
a lightly cross-linked ductile network of high concentration. The first network is  rigid with 
cross-linked short chains whilst the second network is soft and ductile as illustrated in 
Figure 5-41, adapted from Gong et al [286]. However one of the requirements to form 
such networks is that the first network needs to be a strong polyelectrolyte that limits the 
polymers that maybe used, especially in tissue engineering applications.  
 
Figure 5-41:  A double network with blue strands indicating the first network and pink the 
second ductile network [286].  
 
More recently, a molecular stent method has been reported by Gong et al [287], 
proposing a more general method of toughening hydrogels. Unlike DbN gels, the method 
of synthesis involves using a neutral hydrogel to create the first network and then by 
swelling it in a linear polyelectrolyte they expand the first network akin to stent. This 
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occurs as the polyelectrolyte functions as a dangling chain that produces a high osmotic 
pressure, which leads to high swelling and rigidity of the neutral gel.  Our approach of 
forming  ‘Dual networks’ is analogous to double networks, but use two water soluble 
polymers where the first network is crosslinked and this is allowed to entrap the second 
linear polymer, which can be gelated and then subjected to crosslinking.  The first 
polymer is essentially allowed to swell in the second water soluble polymer and chelated 
followed by crosslinking. Hence, two polymers are used and a new polymer is not 
synthesized by entrapping the monomers in the first network unlike the double or 
molecular stent networks.  
Dual networks of PVA as a 1st network and alginate as a second network were 
successfully formed by first forming the PVA network and then the second polymer was 
allowed to ingress in the network. Dilute solutions of alginate were used such that the 
high viscosity did not impede diffusion within the polymer network. PVA could be swollen 
substantially in the second network component due to the ionizable carboxylate groups 
present in sodium alginate and due to porosity of the PVA network that was formed 
through freeze-drying. The percentage of alginate within the PVA networks post 
chelation with CaCl2 and one cycle of freeze drying was obtained by the difference in 
weight of the PVA xerogel and the xerogel weight of dual network formed. The average 
overall amount of alginate present was found to be 36% and 23% respectively for PVA 
10 and 20 dual networks. 
 
FTIR spectra 
The FTIR spectra (Figure 5-12) showed the ionic binding as calcium ions replaced the 
sodium ions in the alginate blocks, by the shift in the SA peak at 1400 cm-1 to 1420 cm-1 
in the dual network, as well as the development of a more pronounced peak at 1300 cm-
1. This indicated that calcium ions were able to penetrate and chelate the alginate within 
the PVA structure. The second network post cross linking did not show variation in the 
spectra with the main difference being an increase in the intensity of the 1FT second 
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crosslinking as compared to the AD+1FT (absorbance range at 1700 – 800 cm-1) in the 
spectra.  
The FTIR spectra of  the dual networks also confirmed the presence of the alginate 
within the network due to the appearance of the ~1600 cm-1 carboxylate peaks of SA 
units and the interaction of PVA and SA molecules as can be observed from the  shift in 
the COO- peaks from 1418 to 1426 cm-1. Crosslinking between PVA and sodium alginate 
was indicated by the anti-symmetric stretch of the C-OH in PVA forming a doublet peak 
in the dual network observed at 1080 and 1026 cm-1 revealing the presence of alginate 
within the structure as well as crosslinking of the PVA, indicating that there may be some 
interaction between the two polymers. 
 
Thermal analysis 
One of the most commonly used methods to estimate polymer–polymer interaction is the 
determination of the Tg of the polymer networks. The Tg of PVA hydrogels increased 
from an average of ~72.3°C (Table 5-3) for all the 3 cycles of FT to an average of 
162.6°C and 174.4°C (Table 5-9) for DN with a second crosslinking of just 1FT and 
AD+1FT respectively. A similar finding was reported where blends of PVA and alginate 
showed a single Tg that increased with alginate concentration. However, the onset of Tg 
obtained for the dual networks were considerably higher, which was dependent on the 
concentration of the alginate in the network and a repression in the degree of crystallinity 
of the crystallizable component was observed due to the presence of the alginate. This 
increase in glass transition indicates that indeed SA was incorporated within the PVA 
network structure, as SA has been reported to have and decomposition endothermic 
peak of close to 200°C [282]. It can be reported that increase in the Tg was due to 
formation of a tighter network structure on the DN than the PVA only hydrogels. These 
results were found to be in agreement with data obtained from studies by Kulkarni et al 
[288] who developed interpenetrating network hydrogel membranes of SA and PVA by 
solvent casting, and observed a shift in the endothermic peaks of their IPN hydrogels 
towards a higher temperature. They reported that their observations could be due to “the 
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formation of more rigid polymeric network as a result of increasing crosslinking and 
formation of IPN structure due to chain entanglements”. Kim et al [143] developed blends 
of PVA and SA for wound dressing applications via freeze thawing method. They 
reported that the melting temperature of their hydrogels increased with increasing SA 
proportion. The dual networks in this study were obtained either solely by a 2nd 
crosslinking of one cycle of freeze-thawing or subjected to air drying followed by freeze-
thawing. The Tg values showed higher values for the latter, which can be attributed to 
the hydrogels incurring a combination of physical chain entanglements by air-drying in 
addition to the hydrogen bonding that occurs on freeze drying of the network structures. 
The DN20-2FT-1FT hydrogel presented with a lower Tg than the DN10 hydrogels, this 
could be due to limited penetration of SA into the tight and dense network structure of 
PVA20 single network hydrogel. 
 
Water uptake of hydrogels 
Hydrogels have the ability to retain water in their network structure and their affinity to 
water varies with composition and the polymer architecture. The EWC of the PVA10 
hydrogels subjected to 1,2 and 3 FT cycles decreased from an average of ~80.2% to 
~70.2 and 71.9% for the dual network hydrogels networks with a second crosslinking of 
1FT and AD+1FT respectively (Table 5-4 and Table 5-10). This decrease in EWC was 
found to be significant enough (P<0.001) to indicate that addition of SA to the network 
structures followed by the different forms of second crosslinking resulted in hydrogels 
with a tighter network structure than the base single network PVA hydrogels, which 
would in turn lead to less swelling of the hydrogels in fluids due to the hindered mobility 
of polymer chains as compared to hydrogels with a loosely cross-linked network 
structure.  
Swelling ratio is negatively related to crosslink density and as with EWC the swelling 
ratio decreased with addition of SA into the PVA network structure. PVA is known to form 
hydrogels through freeze-thawing methods that result in porous architecture and it has 
been reported with PVA-gelatine blends that the swelling ratio decreases with increasing 
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PVA content, which is explained by the fact that with an increase in PVA concentration, 
the volume fraction of polymer in the cryogel increases, which enhances the degree of 
interaction between the PVA–PVA and PVA–gelatine molecules [182]. It was observed 
that the swelling ratio of the dual networks decreased with addition of SA into the 
network structure, which can be attributed to both the hydrophilic nature of PVA and the 
enhanced interaction between the SA and PVA [289]. However, in the dual network SA 
is first ionically crosslinked with Ca2+ ions  followed by further crosslinking by either 1FT 
or AD+1FT, which lead to the rise in crosslink junctions resulting in lower EWC and SR. 
In agreement with these results is a study by Hua et al. 2010 [283] who reported that 
their dual crosslinked PVA/SA beads exhibited a lower swelling rate than the PVA/SA 
beads crosslinked by CaCl2. Also Chhatri et al. 2011 [144], fabricated PVA and alginate 
blends via freeze thawing and reported that swelling ratio of their hydrogels decreased 
with increase in concentration of PVA within their blends, which is in agreement with 
results from this study where the water uptake of the PVA and DN hydrogels decreased 
with increase in PVA concentration. 
Figure 5-16 and Figure 5-17 present typical plots of the behaviour of water absorption 
and desorption versus t1/2 for the PVA10, 20 and DN10, 20 hydrogels subjected to two 
FT cycles. The initial stages of absorption and desorption conformed well to a linear t1/2 
relationship, the slope of which enabled the calculation of the diffusion coefficients. 
Diffusion coefficient of the hydrogels indicated that there was limited migration of water 
molecules into the pre-existing spaces of the dual network hydrogels as compared to the 
PVA base hydrogel. These values decrease from an average of ~1.8 (10-6cm2s-1) in PVA 
to ~0.5 and 0.7(10-6cm2s-1) for the DN networks with 1FT and AD+1FT second 
crosslinking. 
The influence of addition of SA to the network on gel fraction was also investigated, the 
average gel fraction in the absence of SA was found to be ~86.1% for all the cycles of 
FT, this being relatively high suggesting PVA was almost completely crosslinked. With 
incorporation of SA the average gel fraction was found to be ~73.3% and 72.3% for the 
DN networks with 1FT and AD+1FT second crosslinking respectively. This result on 
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reduction of gel fraction with incorporation of SA may be due to the loss of unchelated 
and unreacted alginate within the network structure, this trend in results was found to be 
in agreement with results reported in a study by Kim et al. 2008 [143] on PVA alginate 
blends. Furthermore the cycles of FT did not show a significant difference in gel fraction 
within the different groups. Generally, with a decrease in gel fraction, hydrogels are weak 
and less flexible, however the EWC, SR and diffusion coefficient in this study indicated 
that this is not the case. 
Increase in concentration of PVA from 10%(w/v) to 20%(w/v)  resulted in decreased 
EWC and SR as well as increase in gel fraction as compared to the PVA10 and DN10 
hydrogels. This is can be attributed to the increase in the interaction between the 
alginate and PVA due to the presence of higher number of hydroxyl groups available for 
interaction. 
 
Hydrolytic degradation of hydrogels 
Hydrogels can slowly degrade under physiological conditions due to hydrolytic or 
enzymatic chain breakages occurring within the network chains of the hydrogels, but 
under controlled in vitro conditions degradation is mainly due to breakdown of weak 
crosslinks between polymer chains. PVA, crosslinked by physical means can undergo 
dissolution with time via the breakdown of the crosslinks. Likewise calcium alginates 
breakdown fairly rapidly as the process of chelation is reversible and in presence of 
sodium ions this can slowly be reversed resulting in the dissolution and elimination of the 
product by the renal pathway.  
Weight loss in phosphate buffer saline was monitored to determine the disintegration of 
the networks and evaluate the effect of the dual network formation. Figure 5-18, Figure 
5-19 and Figure 5-20 show typical plots of weight loss (%) as a function of time, with the 
dual network hydrogels exhibiting a higher weight loss than the PVA10, 20 hydrogels. 
This is attributed to the presence of the calcium alginate chains, which probably begins 
to go through the reversible reaction forming sodium alginate that is subsequently lost. 
However the DN20-2FT-1FT hydrogel exhibited lower degradation values as compared 
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the to all the dual network hydrogels, this is attributed to the higher concentration of PVA 
that leads to the interaction of carboxylate groups of the alginate to form more H bonded 
links with the hydroxyl groups of the PVA due to their higher abundance in the network 
structure, which is also in agreement with the EWC and swelling ratio obtained 
Generally hydrogels with lower crosslinking density undergo degradation at a faster rate 
while those with higher crosslink density degrade at a slower rate.  Higher overall 
degradation of the dual networks is attributed to the early degradation of alginate in the 
network structure, although the alginate has been crosslinked twice ionically and 
covalently by either FT or AD+FT, these crosslink junctions are weaker than those of the 
OH bonds within the PVA hydrogels. Similar observations were reported in studies on 
PVA-Alginate blends by Hau et al. 2010 [283], Kamoun et al. 2015 [162]  and IPN 
networks by Thankam et al. 2013 [284].  
 
Tensile strength and modulus 
The hydrogels obtained by freeze-thawing 10% PVA exhibited statistically significantly 
lower tensile strength (P<0.001) than all the dual networks irrespective of the number of 
FT cycles. The presence of alginate in the PVA network to form a dual network led to 
significant improvement in the tensile strength of the hydrogels, which is attributed to the 
interpenetration of alginate into the PVA structure, followed by its chelation and 
subsequent crosslinking within that structure. This crosslinked interpenetration within 
PVA by alginate may have led to the formation of hydrogen bonds between the hydroxyl 
groups of PVA and the hydroxyl groups of the alginate network, this resulting in 
enhanced tensile properties of the dual network hydrogels.  
When evaluating the effect of the different types of the second crosslinking on the tensile 
properties, it was found that AD+1FT did not significantly enhance the tensile strength as 
compared to only 1FT crosslinking. Analysis on the effect of number of FT cycles within 
each group of the individual groups (PVA only network, DN-1FT, DN-AD+1FT), showed 
that PVA and DN-AD+1FT hydrogels were found to have tensile strength values with no 
significant difference between freeze thaw cycles within each group, whereas two FT 
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cycles of DN-1FT hydrogels yielded superior tensile strength (0.73MPa) significantly 
higher (P<0.001) than all the hydrogels. It would be expected that increasing the number 
of freeze thaw cycles (degree of crosslinking in the networks) would result in higher 
ultimate tensile strength, however it has been observed from the results that a higher 
degree of crosslinking i.e. cycles of FT greater than 2FT results in a more brittle network 
structure, hence the lowered UTS. PVA-alginate blends for wound dressings have been 
reported by Kim et al. 2008 [143] where they found the addition of SA into blends 
resulted in decrease in tensile strength of their hydrogels with  UTS values of 0.07MPa 
with E of ~0.009MPa for 5%(w/w%)  and 3%(w/v) of SA. Xie et al. 2012 [289]  reported a 
similar observation with a drop in tensile strength of their PVA-SA blends  with addition of 
SA to PVA. Their highest recorded tensile strength was with blends containing 25 % SA 
with 4FT cycles 0.2MPa. A comparison of the blends with the dual networks also clearly 
indicate that the formation of a dual network has a significant effect on the tensile 
properties and it is the first brittle network that has a bearing on the tensile properties as 
is evident with the higher concentration of PVA. Kulkarni et al. 2010 [288]  formed IPN’s 
of PVA and SA for drug release and found that tensile strength improved with the 
formation of IPN networks with maximum UTS values of ~0.4MPa, whilst 
Gnanaprakasam et al. 2013 whose study on growth and survival of cells on biosynthetic 
PVA and SA reported  a similar trend with tensile values of semi IPN and IPN hydrogel 
network of 0.8 MPa (disodium hydrogen phosphate and Ca2+ crosslinks) and 1.2MPa 
(3% glutaradehyde crosslink) respectively [284]. These values were significantly lower 
than that obtained for the dual networks in this study that were above 4MPa. 
Stiffness of the hydrogels was found to increase with formation of the dual networks, with 
no significant difference between the two methods of the second crosslinking used in 
formation of the dual networks. The typical stress strain curve of the hydrogels illustrated 
in Figure 5-23 indicates that hydrogels had the ability to undergo strains of ~≥1 
(mm/mm). Figure 5-24  Figure 5-25 and Figure 5-26 demonstrate that hydrogels with 
higher tensile strength and stiffness can be achieved by increasing concentration of 
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PVA, however there is a limitation of increasing the concentration that yields high 
viscosity solutions not conducive for handling. 
 
Fracture toughness 
Fracture properties are related to specific material parameters such as critical fracture 
toughness, energy release rate, fracture energy and crack propagation resistance which 
can be determined using a fracture mechanical test method such as a trouser tear test. 
Tearing energy includes surface energy, energy dissipated in plastic flow processes, and 
energy dissipated irreversibly in viscoelastic processes. 
Fracture energies of the hydrogels showed that (Figure 5-27), the PVA 20 dual network 
(DN20-2FT-1FT) had a statistically significantly (P<0.001) highest fracture energy (6.3 
KJ/m2) in comparison to its base PVA20 hydrogel as well as the PVA10 hydrogel and 
their corresponding dual network. This was within expectations as tensile strength tests 
indicated that increase in concentration of PVA lead to significantly higher strengths as 
well as incorporation of SA into the PVA base network structure. The opposite result 
however was observed with the PVA10 dual network where a lower fracture energy was 
obtained than its parent base PVA10 hydrogel. This could be attributed to the fact that 
more alginate is absorbed in the PVA10 network structure as compared to the PVA20, 
and with alginate being weaker than PVA in turn resulted in a decreased fracture 
toughness. Fracture toughness energies obtained in this study were compared with 
those obtained from double network hydrogels and the toughness values of the dual 
networks were ~≥ 2 fold than those reported in literature [290, 291]. 
 
In vitro drug release study 
The dual networks developed exhibited properties that ere suited for potential wound 
dressing applications, hence a preliminary study using vancomycin was carried out. 
Vancomycin is a commonly effective antibiotic, recommended for chronic wounds, 
including those with moderate to severe osteomyelitis, is highly effective against gram 
positive bacteria and used in hospital epidemics as a first line of defence against deadly 
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resistant streptococcal and staphylococcal strains such as Staphylococcus aureus, 
which are becoming resistant to penicillin, methicillin and other b-lactam antibiotics[163-
165]. 
  
Figure 5-42: Molecular structure of vancomycin hydrochloride and FT Raman spectra 
[Source: Sigma Aldrich]. 
 
 
Drug and polymer Interaction  
Vancomycin has a complex structure consisting of a seven membered peptide chain 
linked to two unique sugar moieties. The drug is known to bind to peptides and polymer 
surfaces, as well as act at a chelator. Vancomycin has also been reported to dimerize 
with itself specifically due to amide-amide hydrogen bonding, hydrophobic and ionic 
interactions, therefore it is expected to have hydrogen bonding as well as hydrophobic 
interactions with alginate. The drug and polymer interaction was studied by FTIR 
analysis represented on Figure 5-28 and Figure 5-29, where it was observed than not 
only was vancomycin incorporated into the network structures of the hydrogels, there 
were also some interactions as shifts in the intensity of the C=O, C-H symmetric peaks in 
PVA were observed along with the COO- symmetric and C-O-C stretching in the dual 
networks. 
 
In-vitro drug release profile 
Figure 5-31 and Figure 5-32  illustrate the release profile of entrapped vancomycin within 
the hydrogels. A linear (high) release rate is observed with the PVA10 single network 
hydrogels with up to 59% vancomycin being released from the hydrogels within the first 8 
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hours. This linear release is attributed to the porous structure of the PVA10 hydrogels 
attained during the sublimation process of water ice crystals within the network. This 
then in turn led to a large surface area of the hydrogel exposed to dissolution of the 
vancomycin drug into the PBS solution. Increase in concentration of PVA10 to PVA20 
led to a decrease in total drug released (27%) after 500 minutes, this due to the dense 
network structure of PVA formed off higher concentrations. 
DNs presented with lower  drug release rate with a maximum of ~27% after 500minutes, 
this attributed to the tight interpenetrating network structure attained in formation of the 
dual networks as well as reduced porosity within those networks, thereby hindering the 
transport of drug molecules through the membrane. It was observed that drug release 
rate is closely related to EWC and SR of the hydrogels, therefor the higher the swelling 
ratio of the hydrogel the higher the %drug release and vice versa. Similar observations 
have been reported in other studies,  where Kulkarni et al reported that their PVA 
hydrogels loaded with prazosin hydrochloride showed a maximum release of ~ 99.3% 
after 12 h, with a high release rate observed in the initial hours, where as their PVA/SA 
IPN membranes had an extended drug release for up to 24 h. They also reported that 
the drug release in their hydrogels decreased with increase in PVA concentration [288]. 
Hau et al reported that their dual crosslinked beads (chelated blend of PVA/SA subjected 
to 2 cycles of freeze thawing) showed a lower initial drug release profile of diclofenac 
sodium as compared to the PVA/SA CaCl2 crosslinked beads [283]. Variation of freeze 
thaw cycles in this study did not show a significant difference in drug release rates within 
the individual groups. 
It has been reported that high initial linear drug release profiles are useful for immediate 
irradication of bacteria while slower release profiles are appropriate for preventing 
infection or recolonisation of the wound by bacteria [163]. Therefore the initial linear 
followed by slower drug release profile of the DN hydrogels would prove suitable for 
simultaneously irradicating an existing infection while preventing recolonisation of the 
wound by bacteria. 
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Figure 5-43: picture image of freeze thawed 
PVA hydrogels with 10 and 20%w/v 
concentration, demonstrating the difference in 
final appearance of the hydrogels. 
 
SEM analysis 
SEM (Figure 5-33) identified crystallite domain in the PVA 10 hydrogels post freeze-
thawing, which is expected and in agreement with literature as PVA forms crosslinks via 
hydrogen bonding and crystallite formation. The higher magnification identifies fibrous 
strands in the PVA10 hydrogels as well as micropores. This observation supports the 
high EWC and SR results obtained in the hydration studies. PVA20 micrograph displays 
a dense network structure with no to much lower porosity, which is in agreement with the 
low EWC and SR results. The dual networks in contrast show a fibrillar morphology, with 
entwined fibrils and there is appearance of a difference in the morphology within the 
network. The fracture tensile surfaces of the dual networks indicate a ductile fracture 
compared to PVA networks that show a brittle fracture. This observation is in agreement 
with results obtained from tensile test where strains of the hydrogels were >1 mm/mm 
The differences in the appearance of 
the PVA10 and 20 hydrogels is that 
(this may not be clearly visible with 
SEM images but is demonstrated with 
images of the hydrogels), PVA10 
hydrogels appear to be more opaque 
in nature whereas the PVA20 
hydrogels appear to be translucent. This difference in appearance was also reported in 
another study[200], which can be explained by the fact that  the polymer solution is less 
viscous with low concentration of PVA therefore there is less restriction on the movement 
of the PVA chains in solution thus making it easier for them to crystallise more 
effectively. This results in a hydrogel with large crystallites that scatter more visible light 
which makes the hydrogels look opaque (will however have a lower crystallinity than 
hydrogel of higher polymer content). Increase in PVA concentration results in an 
aqueous solution with high viscosity and more PVA chains to form crystallites, however 
the crystallite size decreases as there will be  restricted growth and therefore scatters 
less visible light which translucent hydrogels [200]. 
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Cytocompatibility 
Cell proliferation and viability of seeded cells on the elusion extracts the hydrogels was 
quantitatively assessed by MTT assay. Relative growth rate of the HOB cells was 




Eluents (hr) Relative growth rate (RGR)(%) 
24 exposure 48 exposure 72 exposure 
PVA10-2FT 24 65.6 45.4 45.2 
48 63.5 45.2 42.6 
72 84.2 52.4 59.8 
DN10-2FT-1FT 24 98.2 58.9 47.7 
48 75.9 50.7 37.0 
72 97.9 54.2 38.6 
Table 5-11: Relative growth rate percentage of PVA10-2FT and DN10-2FT-1FT 
demonstrating viability of HOB cells within the hydrogels. 
 
Where:  
Non-cytotoxic >90% cell viability; 
Slightly cytotoxic = 60–90% cell viability; 
Moderately cytotoxic = 30–59% cell viability; 
Severely cytotoxic ≤30% cell viability 
24hr exposure to 24, 48 and 72hr eluents indicated that the HOB cells found the 
degradation products of the hydrogels to be slightly toxic increasing to moderately toxic 
with 48 and 72 hour exposure. These results are contradictory to those obtained in a 
study by Gnanaprakasam et al. 2013 [284], where they reported a higher viability of 
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fibroblast cells on their hydrogel extracts indicating that the degradation products for their 
PVA-alginate IPN were not toxic. 
However live/dead staining over a period of 28 days (Figure 5-35 and Figure 5-36) 
showed that HOB cell were able migrate from the surface into the internal structure of 
the hydrogels. Difficulty was encountered when imaging, as cell were at different depths 
within the hydrogels and change in focus and magnification led the cells at different 
depth going out of focus. This illustrates and confirms the ability of the hydrogels to not 
only present as biocompatible, with good cell adhesion and attachment, but also the 
ability of the cells to migrate and proliferate within the hydrogel networks. Earlier time 
point observation (day 1-14) of the cell morphology showed cells aggregating to form 
bollus shape, cells of which later spread out along the surface of the hydrogel, beginning 
to form a sheet like structure over the surface as observed with the DN on Figure 5-36 
x20magnification. Literature reports that surface aspects of a biomaterial such as, 
topography, chemistry and surface energy determine cell behaviour upon contact. Cells 
in contact with a surface will first attach, adhere and spread, the quality of adhesion will 
influence their morphology and their capacity to proliferate and differentiate [166]. 
Active proliferation of HOB cells occurs within the first 10-12 days, from 12 to 18 days 
the extra cellular matrix undergoes a series of modifications in composition and 
organisation that renders it competent for mineralisation. During this matrix maturation 
phase, every cell becomes alkaline phosphatase positive (ALP) [169, 170].  Hence ALP 
concentrations on cell supernatants were determined and presented on Figure 5-37. 
Control and hydrogel samples indicated a sharp increase in ALP at day 14. The dual 
networks presented with a higher increase in ALP production than the PVA10 only 
hydrogels. This indicates that the HOB cells in culture were on the onset of progression 
to the next phase being mineralisation. This observation is a reflection of functional 
activities of the HOB cells necessary for the progressive formation of bone tissue. 
Runx2 is down regulated in mature osteoblasts during bone development, meaning that 
Runx2 expression increases during osteoblast differentiation validating involvement in 
maturation of osteoblasts. Results (Figure 5-38) were found to be inconclusive however, 
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results indicated an increase in expression of DN10-2FT-1FT from day 7 to 14, which 
indicated an increase in osteoblast differentiation, this was followed by a decrease after 
day 21 indicating that the osteoblast on the hydrogels may be maturing. 
 
Applications of the formed hydrogels 
Given the properties of the fabricated dual network hydrogels, various applications are 
proposed where the hydrogels can integrate with surrounding tissues and induce new 
tissue formation: hydrogels can be loaded with soluble signalling molecules such as 
bone morphogenetic proteins or platelet rich plasma as well as antibiotics, and be used 
in areas such as wound dressing.  
 
Figure 5-44: Picture images illustrating the nature and flexibility of the dual network 
hydrogels. 
 
With addition of a calcium phosphate filler and increase in PVA concentration dual 
network hydrogels can be used for osteochondral defect applications, as well as in areas 
of bone repair where stimulation of bone regeneration is required. It can also be noted 
that to allow for enhanced cell attachment and proliferation, peptide-coupled alginates 
can be used for the formation of dual network hydrogels [292]. 
 
5.6 CONCLUSION 
The present study demonstrated that dual network hydrogels of PVA and alginate can be 
successfully and easily fabricated as well as be tailored to desired tensile strength and 
stiffness. 
The methodology was optimised and showed that two cycles of freeze-thawing yielded 
optimum properties of DNs demonstrated by higher UTS than their base PVA hydrogel 
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or counterpart AD+1FT hydrogels, also confirmed by their lower EWC and higher Tg. 
The hydrogels were also characterised by FTIR and SEM. SEM images of the hydrogels 
showed a clear difference in their morphologies. This approach in fabricating dual 
network hydrogels could be useful and properties tailored for applications in different 
biomedical fields such as drug delivery or soft tissue engineering purposes. Additionally 
this hydrogel network system can be incorporated with fillers such as calcium 
phosphates and bioglass to further advance their development for applications in wider 





















Chapter 6  
Dual network composite bone 
grafts 
6.1 INTRODUCTION  
Single network hydrogels have been studied extensively for biomedical applications [9], 
however the focus in the last decade has been on enhancing the mechanical properties 
to favour cell based applications. The mechanical properties of hydrogels formed solely 
via physical interactions are usually too weak for application in load bearing tissues, thus 
new platforms are required to create hydrogels with diverse chemical composition and 
physical properties to satisfy the demands of different cell types and tissues.  
This has led to the synthesis of a range of different type of smart hydrogels that have 
different interpenetrating polymer architectures. Double networks are being increasingly 
investigated as a convenient method of synthesizing tougher hydrogels.  The mechanical 
properties of hydrogels can be enhanced by the generation of a double-network and this 
approach can produce hydrogels that are considerably tougher than the corresponding 
single-network gels, with optimised double-network hydrogels that are hard (0.1–1 MPa), 
strong (tensile stress 1–10 MPa, compressive stress 20–60 MPa), tough (tearing fracture 
energy 100–9000 J m−2), and the ability to be stretched up to 20 times their own length 
[293, 294]. Double-network combinations including poly(2-acrylamido-2-
mehtylpropanesulfonic acid), alginate, or poly(ethylene oxide) (PEO) as the highly cross-
linked first network with poly(acrylamide) or poly(acrylic acid) (combined with PEO) as 
the loosely cross-linked second network have been reported for cartilage repair due to its  
tissue like properties [68, 293, 295]. Double networks as described earlier (Chapter 5) 
utilize two interpenetrating networks with contrasting structures; one which is a densely 
crosslinked polyelectrolyte to imbibe the brittle characteristics which is then 
interpenetrated with second ductile network having a low degree of crosslinking. In our 
approach, we use the same concept but use two water soluble polymers where the first 
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network is crosslinked and this is allowed to entrap the second linear polymer that can 
be crosslinked under physiological conditions, hence we term it as a ‘dual network’. 
Based on this concept, novel dual hydrogel networks formed using PVA and sodium 
alginate were designed to form for the first time novel composites for bone regeneration. 
A totally novel approach has been used to form composites with bioactive fillers  
specifically using 45S5Bioglass®  as the filler due to the established ability of this glass 
to bond with bone [296].  
 
Bioactive glass: The composition of bioactive glasses typically includes, Na2O-CaO-
SiO2 with addition of P2O5, MgO and CaF2 in the system. The glass compositions are 
denoted with names that signify the wt. % of silica in the network for example the ratio of 
Ca/P in Bioglass® 45S5 is 5 to 1. These compositional features make the surface highly 
reactive when exposed to an aqueous medium and therefore lead to in vitro and in vivo 
bioactivity [297]. All the bioactive materials developed form mechanically strong bonds 
with bone however the rate of bone bonding depends on the composition of the material 
as lower molar ratios do not bond to bone. Examples of common bioactive glass 





















SiO2 45 52 55 60 53 34 
P2O5 6 6 6 4 4 16.2 
CaO 24.5 21 19.5 36 20 44.7 
CaF2     0 0.5 
MgO     0 4.6 
Na2O 24.5 21 19.5  23 0 




A    A B 
Table 6-1: Composition of bioactive glasses and glass-ceramics (wt. %) used clinically 
for medical and dental applications. 
 
Class A bioactivity is reported to lead to both osteoconduction and osteostimulation as a 
consequence of rapid reactions on the bioactive glass surface. Therefore, compositions 
of bio active glass such as 45S5 are reported to have the highest rate of bioactivity, 
hence result in the fastest rate of bone bonding as well as bonding to soft tissues [298]. 
This mechanism of bonding is attributed to the formation of a hydroxycarbonate apatite 
(HCA) layer on the surface of the glass, following glass dissolution [299, 300]. 
Bioactive bioceramic materials have found many clinical applications in orthopaedic and 
dental areas, where they have been used as bone grafts as well as powders to fill 
various types of bone defects, and implant coatings.  It has been reported that Bioglass® 
45S5 has been used in more than a million patients to repair bone defects in the jaw and 
orthopaedic application [301]. Bioglass® currently finds use in a number of clinical 
applications and more than a dozen commercial products either solely composed of 
bioglass or adapted with binders (i.e. Perioglass® [302] and NovaBone® [303]). The use 
in tooth pastes such as Novamin (2004) [300] which are designed to occlude dental 
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Using bioceramics as a reinforcing phase in polymeric composites was first introduced 
by Bonfield et al [304], wherein polyethylene was reinforced with hydroxyapatite to form 
bone analogue materials. The inclusion of Bioglass® 45S5 to form composites was later 
investigated due to the bioactivity conferred, however there were concerns related to the 
glass particles being smeared by the polymer during processing that would hamper 
bioactivity. The inclusion of Bioglass® in polymers can increase the stiffness and 
compressive strength to an extent, since polymeric scaffolds usually tend to have low 
strength and bioactivity. Bioglass® on the other hand has low fracture toughness, is 
brittle when used alone. In order to mitigate this structural weakness various methods 
have been employed for fabricating porous composite scaffolds with tuned pore sizes 
and interconnectivity. Some of the common methods used in fabrication of porous 
Bioglass® scaffolds include particulate leaching, Solid free form (SFF) and replication 
technique (Sponge method) [305] as these provide more reproducible scaffolds with 
control over structural properties. 
Bioglass® has been reported in composite formulations with polymer matrices such as 
polylactide (PLA), polyglycolide (PGA) and their copolymers (PLGA), as well as poly -
caprolactone (PCL) [306]. Cannillo et al, fabricated PCL-Bioglass® 45S5 composites via 
salt leaching technique and to develop scaffolds with good interconnected porosity, 
suited for bone regeneration and vascularisation, however due to the porogen removal 
process in water, these composites had supressed development of HA in vitro [307]. 
Another study on Bioglass® nano particles (5–20wt.%) with PCL fabricated via particle 
leaching and freeze extraction using polyethylmethacrylate (PEMA) beads as a porogen, 
resulted in porous composites with 0.04 - 0.12MPa strength in compression, and with 
low Bioglass content exhibited higher yield strength but a larger filler content resulted in 
decrease in yield strength, which was  lower than that of the parent polymer [264]. 
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Ryszkowska et al, fabricated porous polyurethane composites containing 5-20wt. % of 
Bioglass® via polymer coagulation and salt leaching method. Their composites showed 
a higher storage modulus (0.12 – 0.81 MPa) than the parent polyurethane foams, and 
they were able to achieve good formation of HCA layer in SBF [308]. 
 
Limitations of current Bioglass® materials and composites 
Bioglass® 45S5 remains the gold standard within the class of bioactive glasses but as a 
material it has limitations in that: 
 They cannot be made into amorphous bioactive glass scaffolds because they 
crystallize during sintering, due to the narrow window between Tg and onset of 
crystallisation for 45S5, this makes it difficult to fabricate porous structures by 
sintering which would bond particles into a strong glass phase creating inter 
connected porous 3D structures. 
 Glass devitrification during sintering results in the formation of a predominantly 
crystalline phase (Na2O-2CaO-3SiO2), which results in reduced rate of 
conversion to HA. Slow degradation rate and conversion to an HA like material 
makes it difficult to match the degradation rate of the scaffold with the rate of new 
tissue formation [298]. 
 
The rationale for this study is to develop an osteoconductive bone substitute with good 
structural properties that can be combined with an osteoinductive biological stimulus. 
Thus, to enhance the elastic and expandable properties of the composites, in addition to 
localising orthobiologic factors with controlled swelling, dual networks were selected as 
the matrix and 45S5Bioglass® was the filler to form bone substitutes.   The dual network 
was established to be a tough interpenetrating polymer network as detailed in Chapter 5 
provides an added advantage to the continuous phase of the composite. The type of filler 
that can be incorporated in the hydrogel network is not limited to just Bioglass® but 
encompasses the various forms of calcium phosphates as well as bioactive glasses but 
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the current study was limited to the use of 45S5 Bioglass® to understand the mechanical 
and physical features of these novel composites  
 
Objectives of the study 
 To develop a biocompatible and bioactive dual network Bioglass® composite with 
an interconnected porous structure, designed to allow fluid flow, cell migration, 
bone ingrowth and vascularisation. 
 To characterise the mechanical properties and understand the physical features 
of these novel systems prior to in vivo testing. 
 The ability to promote osteogenic cell attachment and osteogenesis. 
 
  
6.2 MATERIALS AND METHODS 
MATERIAL CONCENTRATION 
PVA 10 & 20wt./v 
Sodium alginate 2%wt./v 
Bioglass® 45S5 30%wt with respect to PVA 
Porogen 10%wt with respect to PVA 
Table 6-2: The concentration of the precursors for fabrication of the experimental 
composites. 
 
Hydrogel composites were prepared by thoroughly mixing a solution of PVA with 
Bioglass® 45S5 using a magnetic stirrer for at-least an hour until a homogenous mixture 
with a slurry like consistency was obtained. This was then subjected to 1, 2, and 3 cycles 
of freeze thawing at -59.4°C, vacuum 17mT for 24hrs. The physically crosslinked 
hydrogels were swollen in a solution of sodium alginate until equilibrium was reached 
and chelated with a 10% solution of calcium chloride. The hydrogel composites were 






Description of formulation composition of the composites 
DN10-(1, 2 or 
3FT)BG 
PVA10 network incorporated with Bioglass® subjected to a 1st 
crosslinking of either 1, 2 or 3 cycles of FT followed by a 2nd 




PVA10 network incorporated with Bioglass®, subjected to a 1st 
crosslinking of 2 FT and a 2nd crosslinking of 1FT after swelling in 
alginate and chelation with CaCl2. The composite contains 10% 
porogen with respect to PVA content. 
DN20-BG-
10%Porogen 
PVA20 network incorporated with Bioglass®, subjected to a 1st 
crosslinking of 2 FT and a 2nd crosslinking of 1FT after swelling in 
alginate and chelation with CaCl2. The composite contains 10% 
porogen with respect to PVA content. 
Table 6-3: Description of formulation composition ascribed to the acronyms used for 
different composite formulations in this chapter. 
 
6.3 CHARACTERISATION 
Particle size analysis 
The particle size of the ceramic 45S5 Bioglass® phase was analysed. The experimental 
procedure is detailed in the materials and method section of chapter 4. 
 
FTIR spectroscopy 
FTIR was used to characterize the presence of specific chemical groups in the 
PVA/Bioglass® hydrogel composites, reflecting the effectiveness of the method used to 
fabricate them. FTIR spectra were obtained within the range between 4000 and 400 cm−1 
(Perkin–Elmer, Paragon 1000), using diffuse reflectance spectroscopy method (DRIFTS-
FTIR). The experimental details are similar as detailed in the materials and method 




The Raman spectra of the hydrogels composites were recorded on a Renishaw Invia 
Raman microscope. The experimental procedure is detailed in the materials and method 
section of chapter 3. 
 
DSC analysis 
DSC thermograms of the composite samples were recorded on a PerkinElmer DSC jade 
analyser, as detailed in the materials and method section of chapter 3. 
 
Equilibrium Water Content (EWC) 
The hydration studies were performed as detailed in the materials and method section of 
chapter 3 and 5. 
 
Ultimate Tensile Strength 
The tensile strength was determined using the methodology as detailed in the materials 
and method section of chapter 3. 
 
Trouser Tear test 
The toughness of the hydrogel composites was determined using the methodology as 
detailed in the materials and method section of chapter 5. 
 
Compression & cyclic compression 
Compression tests were carried out on samples that were hydrated to equilibrium. 
Cylindrical specimens with dimensions d=8, h=5 were tested in compression using a 
universal testing machine (Instron 5569A) with a 500N load cell and cross head speed of 
1mm/min. 





The morphology was determined using the methodology as detailed in the materials and 
method section of chapter 3. 
 
BIOACTIVITY OF COMPOSITES (MINERALISATION) 
The simulated body fluid (SBF) solution was prepared by following the recipe reported by 
Kokubu and co-workers [309], which was used to conduct mineralisation studies of the 
composites due to its similarity in ionic concentration to that of human plasma. 
Briefly reagents from 1 to 8 were dissolved one by one in distilled water at 37°C, 
reagents 9 and 10 were dissolved in small amounts with care taken not to exceed pH 
7.45. Samples were then placed in SBF solution which was maintained at 37°C. At 
periodic intervals samples were removed from the solution and analysed for desired 
characterisations i.e. tensile, cyclic compression, FTIR, Raman SEM and EDAX. The 
immersion medium, SBF was refreshed weekly to better simulate in vivo conditions by 
maintaining the ionic concentration of the solution. 
 
Order Reagent Amount (g) 
1 NaCl 8.035 
2 NaHCO3 0.355 
3 KCL 0.225 
4 K2HPO4·3H2O 0.231 
5 MgCl2·6H2O 0.311 
6 1.0M HCl 39ml 
7 CaCl2 0.292 
8 Na2SO4 0.072 
9 Tris 6.118 
10 1.0M HCl 0-5ml 




MTT, Live/Dead Staining, Protein concentration, qPCR 
Biocompatibility of the hydrogel composites was determined using the methodology as 
detailed in the materials and method section of chapter 5. 
 
6.4 RESULTS 
Particle size distribution 
The particle size distribution percentiles (10, 50 and 90 %) of Bioglass® 45S5 powder 
are presented in Table 6-5, whilst the histogram of particle size distribution and the 
cumulative percentage of the data are shown in Figure 6-1. The histogram of the tested 
powder exhibited a normal distribution. 
 Diameter at 10% 
(µm) 
Diameter at 50% 
(µm) 
Diameter at 90% 
(µm) 
Bioglass 45S5 1.4 7.2 17.1 
Table 6-5: Particle size distribution of bioglass® 45S5 powder. 
 
 
Figure 6-1: The particle size distribution of 45S5 Bioglass powder in cumulative 






FTIR analysis  
 
Figure 6-2: FTIR spectra comparing Bioglass® powder with the non-porous dual network 
bioglass composites fabricated by 1,2 and 3 freeze thaw cycles and the porous dual 
network composites of PVA concentration (10 and 20)wt.%, fabricated  by two cycles of 
freeze thawing. 
 
The FTIR spectra of the dual network Bioglass® composites with and without the 
porogen showed strong absorption peaks at 1004 and 915 cm-1, attributed to Si-O-Si and 
Si-O stretching modes respectively. The Si-O-Si bending mode and the amorphous 
phosphate is not apparent in this spectra as the scales were till 650 cm-1 but are 
expected at 480 and 600 cm-1 respectively [310]. The characteristic absorption bands of 
PVA at 3280 cm−1, 2946 cm−1, 2908 cm−1, was attributed to the stretching of OH, 
asymmetric stretching of -CH2 and symmetric stretching of -CH2. Absorption bands also 
arising from PVA in the composites were identified at 1416-1447 cm−1 (wagging of CH2 
and bending of OH), 992-1019 cm−1 (stretching of -CO and bending of -OH from 
amorphous sequence of PVA), 914-928 cm−1 (bending of -CH2) and 846-868 cm−1 
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(rocking of -CH). Characteristic peaks of alginate at 1639 and 1423 cm-1 corresponding 
to –COO- group were prominent for the porous DN20 Bioglass® composite in 
comparison to the rest of the composites. Minor shifts in the Si-O and C-O peaks were 
observed on the spectra of DN10BG composites, where they decreased in intensity with 







Cycles of FT 
 
Tg 1 (°C) ± SD 
 
Tg 2 (°C) ± SD 
DN10BG 1 74.2 ± 9.1 169.0 ± 5.5 
2 75.0 ± 3.7 211.1 ± 10.8 
3 81.1 ± 1.0 202.7 ± 9.5 
DN10BG-
10%Porogen 
2 80.0 ± 12.8 218.5 ± 1.5 
DN20BG-
10%Porogen 
2 85.6 ± 8.6 167.0 ± 5.5 
Table 6-6: Glass transition temperature (Tg°C) of the dual network bioglass composites 
fabricated by different cycles of freeze thawing and porous dual network composites with 
a composition of PVA at 10 and 20%wt./v concentration. (n=3). DNBG: Dual network 
Bioglass® composites. 
 
DNBG composites as shown in Table 6-6, were found to display two glass transition 
temperatures, the first between 74-85°C,  corresponds to the Tg of PVA whilst the 
second between 167-218°C, corresponds to the Tg of the presence of alginate in the 
network. The inclusion of a porogen did not have a significant effect on the Tg as 
expected, however it was noted that the increasing concentration of the PVA led to an 
increase in Tg for the porous networks.  
 
Equilibrium Water Content (EWC) 
The water uptake of the DNBG composites over a period of 4 weeks (Figure 6-3) clearly 
demonstrated that the porous networks had a significantly higher uptake due to the  
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larger surface area.    
 
Figure 6-3: Water uptake of the non-porous DNBG composites fabricated by 1,2 or 3 
cycles of freeze thawing and porous DNBG composites fabricated with PVA of 
concentrations 10 and 20wt./v%. A represents a full scale plot of water uptake from the 
initial time point to the final 4weeks time point. B represents an expanded version of 
water uptake in the first 10 hours. (n=3) 
 
All the composites attained equilibrium uptake within 8 hours and as expected the rate of 
water uptake was highest for the porous networks, which was also dependent on the 
starting concentration of PVA.  
 
NON-POROUS DUAL NETWORK COMPOSITES 
Ultimate Tensile Strength 
The ultimate tensile strength and Young’s modulus of non-porous DN10BG composites 
shown in Figure 6-4,  indicated that fabrication using 2 freeze thaw cycles resulted in the 
A 
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highest ultimate tensile strength, whilst further freeze–thaw process had no discernible 




Figure 6-4: Tensile strength [A] and Young’s modulus [B] of DN10BG composite 
networks fabricated   using 1,2 and 3 cycles of freeze thawing. (n=6) (* P≤0.017 and ** 
P=0.004). The horizontal lines relate the groups and the asterisk shows the level of 
significant difference. 
 
Trouser Tear test 
 
Figure 6-5: Fracture energies of the hydrogels and hydrogel composites obtained using 
the trouser tear method. The fracture energies of PVA10, DN10 with 2 cycles of freeze 
thawing and DN10BG fabricated by 1, 2 and 3 freeze thaw cycles. (n=6) (* and ** 
P<0.001, *** P=0.030). The horizontal lines relate the groups and the asterisk shows the 






DNBG composite gels were found to have fracture energies higher than those of the 
PVA10 and DN10-2FT hydrogels (Figure 6-5) and amongst the DN10BG composites, 
fabricated by 2 cycles of freeze thawing yielded the highest fracture energy. 
 
POROUS DUAL NETWORK COMPOSITES 
The DN20BG composites exhibited significantly higher tensile strength and modulus in 
comparison to the DN10BG-1FT networks, clearly indicating that the initial concentration 
of PVA played a significant role. The strength and stiffness porous composites, however 
was lower than that obtained from the non-porous composites. 
 
  
Figure 6-6: Tensile strength [A] and Young’s modulus [B] of porous DN10, 20BG 
composites fabricated via 2 cycles of freeze thawing. (n=6) (* = P<0.001). The horizontal 
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Testing in Compression  
 
Figure 6-7: Compressive stress-strain curve of porous DNBG (10 and 20% PVA 






Young’s modulus  (MPa) 
DN10BG-2F-1FT 0.2 ± 0.02 0.8 ± 0.1 
DN20BG-2FT-1FT  0.3 ± 0.04 * 1.5 ± 0.4 * 
Table 6-7: Compression and Young’s modulus values of hydrated porous DN10, 20BG 
composites fabricated via two cycles of freeze thawing. (n=3) (* = P≤0.045) 
 
The stress-strain curves of the porous DNBG composites are shown in Figure 6-7 and 
the values in Table 6-7. DN20BG was found to have higher compressive stress and 
stiffness values than the DN10BG composite, which was found to be able to undergo 
higher strain values than the DN20BG composite. 
 
Uniaxial Cyclic compression 
Figure 6-8 illustrates the repeated compressive force on the hysteresis and mechanical 
integrity of the composites of the porous DN10 and 20 BG composites. The experiments 
were performed with identical parameters, where loading and unloading cycles were 
carried out without allowing the composites to undergo a relaxation period. 
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Figure 6-8: Cyclic compression 
showing stress vs strain plots 
of porous DN10BG [A] and 
DN20BG[B] composites for 5 
cycles at 40% strain, 
calculated from maximum 
compression data. 
 
The stretching and relaxation 
curves of both at low strain 
(40%) were superimposable 
and little to no hysteresis was 
observed, suggesting high 
resilience for both materials at 









100X 500X 2500X 
DN10BG-NO POROGEN 










100X 500X 2500X 
DN10BG-10%POROGEN 







100X 500X 2500X 
DN20BG-10%POROGEN 
   
 
Figure 6-9: SEM microstructure images at magnification x100 500 and 2500, as well as 
EDX spectra of non-porous DN10BG composite and porous DN(10 and 20)BG 
composites fabricated via 2 freeze thaw cycles. 
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Scaffold microstructures and energy dispersive X-ray microanalysis of elements present 
in the DNBG composite networks shown in Figure 6-9, indicate that the non-porous 
DN10BG composite presents a compact structure with a rough surface area, whilst the 
porous DN(10 and 20)BG composites were found to have an interconnected porous 
structure, with varying pore sizes ranging from 1mm to < 20µm. EDX spectra confirmed 
the presence of silicon, calcium, phosphorus and sodium oxides in the composites as 
well as the presence of carbon due to the polymer content. 
 
IN VITRO BIOMINERALISATION STUDY 
The interaction of the selected hydrogel composites with simulated body fluid were 
studied in vitro by analysing the ability of the composite networks to form an apatite layer 
over a period of 4 weeks. The formation of an apatite layer is essential in assisting 
favourable intracellular and extracellular responses promoting rapid bone formation in 
vivo. DN hydrogels fabricated via 2 freeze thaw cycles and their respective DNBG 
composites were selected according to optimisation studies to be taken further and 
analysed for the level and effect of mineralisation on surface, tensile and stiffness 
properties on the hydrogels and hydrogel composites results are presented below. 
 




Figure 6-10: Tensile strength and Young’s modulus  changes after immersion in SBF at 
7, 14 and 28 days, of the DN hydrogel, non-porous DN10BG and porous DN10, 20BG all 
fabricated via two cycles of freeze thawing. (n=4) 
 
The effect of mineralisation on the tensile strength and Young’s modulus of the 
hydrogels and composites (Figure 6-10) indicated that for all DNBG hydrogel composites 
there was an initial decrease in tensile strength and Young’s modulus in the first 7 days, 
which was, then followed by a steady increase up to 28 days.  The DN hydrogel itself 
however did not show and increase in tensile strength and stiffness when immersed in 


















Figure 6-11: Cyclic compression showing 
stress vs strain plots of porous DN10BG 
composites for 5 cycles at 40% strain after  









Figure 6-12: Cyclic compression showing 
stress vs strain plots of porous DN10BG 
composites for 5 cycles at 40% strain after  
7[A], 14[B] and 28[C] days immersion in 




The DN10 and 20BG composites demonstrated hysteresis which was attributed to the 
effect of mineralisation on the porous composites after 7, 14 and 28 days immersion in 
SBF (Figure 6-11 and Figure 6-12).The change in the loading and unloading curves of 
the DN10BG composites was found to increase with increasing immersion time in SBF. 
The DN20BGcomposite exhibited multiple fracture points which increased with 







FTIR analysis  
The FTIR spectra of DNBG composites before exposure to SBF and after 7, 14 and 28 
days are shown in Figure 6-13, highlighting the changes on the composites due to 
formation of apatite on the surface layers. The formation of HCA layer on the composites 
was identified and characterised by appearance of absorption bands at ~604 and ~565 
cm-1 attributed to the P-O bending vibrations, as well as the P-O asymmetric stretching 
vibration bands between 1000 and 1150 cm-1. The P-O stretching is superimposed on 
the Si-O stretching band corresponding to bioactive glasses, but however became more 
visible on the porous composites after 28 days immersion in SBF. The peak centred at 







Figure 6-13: FTIR spectra non-porous DN10BG and porous DN10, 20BG composites  
fabricated by two cycles of freeze thawing, after 0, 7, 14 and 28 days exposure in 
simulated body fluids.  
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Figure 6-14: Raman spectra DNBG composites after 0, 7, 14 and 28 days immersion in 
SBF. [A] Represents non-porous DN10BG composite, [B] & [C] represent porous DN10, 
20BG composites respectively. 
 
Raman spectroscopic analysis of the DNBG composites after 7, 14 and 28 days in SBF 
is presented on Figure 6-14. Major differences in the spectra of the composites were 
observed at day 28 after immersion in SBF, with the exception of the porous DN20BG 





943 and 958 cm-1 for non-porous and porous composite respectively. The asymmetric 
bending  and the asymmetric stretching peak were identified at ~424 and 
1085cm-1 respectively [296, 311]. 
 
SEM analysis 
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Figure 6-15: SEM micrographs of mineral deposition on both the non-porous and porous 
DNBG composites soaked in SBF over a period of 28 days. 
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The formation of HCA crystals on the DNBG composites is demonstrated in Figure 6-15. 
Results indicated that there was formations of crystallites on all the composites due to 
immersion in SBF.  
 
CYTOCOMPATIBILITY 
Cell viability study by MTT assay 
Human osteoblast like cells were seeded on the eluents obtained from the composites in 
tissue culture medium for 24, 48 and 72 hours.  An MTT assay was carried out at 24, 48 







Figure 6-16: MTT assay test showing the response of human osteoblast cells following 
exposure to eluents from PVA10-2FT and DN10-2FT-1FT hydrogels. Cells were 
A 
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exposed for 24, 48 and 72hrs to a [A]. 24hr elusion wash time [B]. 48hr elusion wash 
time and [C] 72hr elusion wash time. 
 
The results indicated that prolonged exposure caused a drop in cell viability, which is 
likely to be related to the alkaline environment caused by the presence of Bioglass®. 
 
LIVE/DEAD STAINING 
Figure 6-17 displays superimposed live and dead staining images of the porous and non-
porous DN10BG composites. 






















Figure 6-17: Images of live/dead staining of HOB cells (x4, 10 and 20 magnification) on 
the non porous and porous DN10BG-2FT-1FT hydrogel at day 1, 3, 7, 14 and 28 in 
culture. 
 
Live cells were observed on all the hydrogels over a period of 28 days. This was also 
observed as a positive indication of good cell attachment, proliferation and migration of 
cells on the surface and within the internal structures of the composites. 
 
Cell Morphology analysed via SEM 
The adherence and morphology of the HOB cells on the surface of the composites was 
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Figure 6-18: SEM micrographs showing HOB cell attachment and coverage on DNBG 
composites after 7 and 14 days in culture. 
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The results showed that the cells adhered well to the surface of the scaffolds. This was 
confirmed by the flat stretched morphology of the cells. It was also observed that on the 
porous composites the cells were able to spread across the pores of the composites, 
eventually entirely covering the pores entirely. It was noted that there seemed to be a 
deposition of a mineral layer on the surface as the cells were spreading and proliferating 
resulting mineral deposition over the cells. 
 
HOB cell differentiation by alkaline phosphatase activity and protein concentration 
The ALP/Protein concentration is used as a bone marker and has been implicated in the 
initiation of mineralisation. A peak in alkaline phosphatase activity was observed at 14 
days in culture indicating early cell differentiation, after which ALP levels declined. This 
indicates differentiation of HOB cells and the onset of mineralisation. 
 
Figure 6-19: The alkaline phosphatase activity in balance with the protein concentration 
of human osteoblast cells (HOB) on non-porous and porous DN10BG composites, with 
the tissue culture plate as the control. Tests were carried out on culture media 




Dual networks were successfully fabricated based on the principles of double networks 
using 2 water soluble polymers (PVA and sodium alginate) that are FDA approved and 
have been widely used in the biomedical field. This resulted in achievement of a tough 
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interpenetrating polymer network with potential for further development for applications in 
reinforcing long segmental bone defects. It is known that brittle, rigid bone substitutes 
often induce micro-movement at the bone-bone substitute interface, consequently 
interfering with bone regeneration. In contrast elastic materials that can exhibit controlled 
swelling have the ability to evoke an intimate contact with the wound bed edges under 
pressure. This alleviates the problems that can occur due to micro-motion of 
grafts/substitutes providing an environment favourable for bone formation.  In this 
chapter the DN network system was taken forward to develop composite networks with a 
view to create a composite that would be suitable for applications in bone augmentation.  
Scaffolds fabricated from inorganic materials such as calcium phosphate based 
bioceramics and Bioglass® possess higher mechanical strength than polymeric 
scaffolds, however such materials have been found to be very brittle and in most cases 
result in failure of the scaffold material on application of service   loads. To overcome the 
common problems of brittle ceramics and weak hydrogels, several options have been 
developed to combine polymers with ceramics or glasses to form composite materials. 
This strategy has proved to be attractive as it combines the controlled degradation 
kinetics of the polymer phase with the high bioactive potential induced by the 
incorporation of ceramic or glass particles, which promote the formation of mineralisation 
sites. Additionally this combination allows for the mechanical properties of the 
composites to be improved as compared to the parent hydrogel networks, the brittle 
behaviour directly ascribable to the ceramic phase can be softened when coupled with a 
polymeric phase. This therefore offers valid and viable solution to mimic the composite 
behaviour of natural tissue response to external stimuli. 
 
Bioglass® 45S5 was chosen as a filler for the formation of the dual network bone 
substitutes, as the 45S5 formulation of Bioglass® is known to bond rapidly with bone in 
vivo as well as stimulate bone growth away from bone implant interface. Bioactive glass 
has been used clinically in bone repair and regeneration in orthopaedics, alveolar ridge 
augmentations, maxillofacial reconstruction and spinal surgery. The novelty of this work 
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is that for the first time, a dual network that was also developed in this study was being 
used to create a tough, elastomeric hydrogel composite with the inclusion of a bioactive 
component within the system. Although the hydrogel composites were fabricated by 
using different cycles of freeze thawing, the high tensile strength and toughness of the 
dual networks (Chapter 5) obtained after two cycles of freeze-thawing process was 
anticipated to yield optimum properties, for the Bioglass® composites. The bioglass 
composites were also taken further to develop porous composites with a structure 
mimicking cancellous bone. 
 
The effect of incorporation of Bioglass® into the dual network hydrogel system 
The idea in this study was to incorporate a bioactive phase within the tough dual network 
hydrogel matrix without compromising the mechanical properties. The inclusion of 
Bioglass® would impact the amounts of fluids absorbed in that, higher concentrations of 
Bioglass® filler in the network would result in reduced water uptake of the composite, 
which would directly impact the ability of the composite to absorb biological fluids which 
would aid in enhancing regeneration and repair of the bone tissue. The particle size 
selected was optimum as larger particles would disrupt the mechanical integrity of the 
networks. 
Therefore based on this 30% wt. Bioglass® with particle size 17µm was incorporated 
within the dual network hydrogel systems formulated with a PVA base of 10%w/v. This 
concentration of PVA had easy handling properties and low viscosity allowing for ease of 
fabrication when conducting optimisation studies.  
 
FTIR analysis 
The PVA, alginate and Bioglass® absorption bands were identified in the final composite 
structures. The spectra in Figure 6-2 compares Bioglass® powder with the non-porous 
DN10BG composites fabricated by 1, 2 and 3 cycles of freeze thawing and the DN10 
and 20BG composites fabricated by 2 cycles of freeze thawing. The spectra revealed 
characteristic broad peaks of –OH stretching at 3280 cm-1, -CH- stretching of alkanes at 
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~2946 cm-1 indicating the presence of PVA. Peaks at ~1602 and ~1420 cm-1 
corresponding to –COO- group reveal the presence of alginate in the network structure. 
Broad peaks at ~1003 and ~846 cm-1 corresponding to Si-O stretching and Si-O-Si 
bending respectively [127, 312, 313]. This indicated that Bioglass® was successfully 
incorporated within the network structure of the DN hydrogel structure. Minor shifts 
observed in the Si-O-Si and Si-O peaks of the non-porous composites suggest that 
cycles of freeze thawing did not have a significant effect on the overall composite 
formulation. Similar observations in the spectra of PVA-alg-BG composites have been 
observed and reported on biocomposite foams [314], composite coatings on stainless 
steel [313] and PVA sol gel derived foams [315]. Trace elements of the porogen used to 
fabricate the porous composites were detected on the DN20BG composite as compared 
to the DN10BG composite. This may have been attributed to the fact that as PVA of 
20%wt/v is more viscous than 10%wt/v, thus resulting in a denser and tighter network 
structure which makes it difficult to eliminate all remnants of the porogen due to the 
limited diffusion of water molecules within the polymeric network. However it was noted 
that the porogen used in this study is a biocompatible FDA approved material, and 
therefore these remnants were not of any consequence and the biocompatibility of the 
composites was not compromised. 
 
DSC analysis 
The effect of addition of Bioglass® into the DN hydrogel system resulted in the 
composite systems displaying two distinct glass transitions (Table 6-6). In the case of 
non-porous DN10BG composites fabricated by various cycles of freeze thawing, the first 
Tg was observed in the range of temperatures between 81.1 – 74.2°C which 
corresponds to the Tg of PVA. The second Tg was found in range of temperatures 202.7 
– 169°C, corresponding to the temperature range where alginate has been reported to 
undergo decomposition (Amorphous polymers show only softening point which could not 
be considered as thermodynamic transition. It's a chain "slipping “of polymers chains that 
becomes possible at some thermal agitation). The Tg of Bioglass® has been reported to 
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be ~500°C [316], thus it was not observed in this study. The Tg of the non-porous 
composites increased with increasing cycles of freeze thawing. The porous composites 
exhibited the same trend of two Tg’s, which increased with increasing concentration of 
PVA in the case of the first Tg, however there was a decrease in the case of the second 
Tg due to the fact that higher concentrations of PVA required more  energy to change 
from a semi crystalline to amorphous state. These results clearly indicated that alginate 
was successfully incorporated in the PVA-BG network. 
 
Equilibrium Water Content (EWC) 
When developing dual network bioglass composites, it was vital to produce scaffolds that 
would be able to absorb biological fluid and retain them, allowing for their local delivery 
at the wound site. These composite should be able to absorb fluids but not swell to 
excessive amounts which would in turn heavily affect the dimension of the scaffold and 
also compromise its mechanical integrity. Excessive swelling is an undesirable feature 
as it would result scaffold pressure on the wound edges when implanted invivo and this 
could lead to cell death and necrosis of the affected tissue. 
Figure 6-3 demonstrates the water uptake profile of the non-porous and porous 
composites over a period of four weeks, which showed that for all the composites there 
was a rapid uptake of water within the first 3 hours, whilst   equilibrium was reached by 
10 hrs. For the non-porous composites fabricated by 1, 2 and 3 cycles of freeze thawing 
EWC was found to be below 40%, this value was significantly lower than the EWC 
values obtained from DN hydrogels (Chapter 5) which were reported to be above 60%. 
This indicated that incorporation of Bioglass® into the DN system resulted in a dramatic 
decrease of the hydrogel composite’s swelling ability as a result Bioglass® occupying the 
empty voids within the polymeric scaffold that would have otherwise been occupied by 
water upon swelling when hydrated. This decrease in EWC upon addition of Bioglass® is 
an advantage as increase in percentage swelling negatively affects the mechanical 
properties of hydrogels and also the distance between polymer chains which influences 
cell migration and neovascularisation. EWC of the non-porous DN10BG composite 
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networks showed that 3 cycles of freeze thawing resulted in composites with a 
significantly higher (P<0.001) than 1 and 2 cycles of freeze thawing. This result was 
within expectations as previous studies in Chapter 5 demonstrated that PVA base 
network when subjected to more than 2 cycles of freeze thawing did not further enhance 
the stability of the network. The EWC of the porous DN10BG (62.5%) and DN20BG 
(57.8)% was found to be significantly higher (P<0.001) than that of the non-porous 
DN10BG (1, 2 and 3FT) with EWC of (34.1, 34.4 and 40.4%) respectively. This result 
was expected because the porous structure of the composites introduces a larger 
surface area for water absorption, as well as providing an increased area for bulk water 
entrapment. It was also noted that the porous DNBG composites had a lower EWC than 
the DN hydrogels reported in Chapter 5. This can be explained due to the formation of 
strong bonding between hydrophilic groups of Bioglass and the alginate -COOH groups 
and also the P–O and O–H groups of the Bioglass particles can interact with the 
carboxylate groups of the alginate chains thereby firmly attaching to the surface of the 
Bioglass particles. Similar trends have been reported for blends of chitosan and gelatin 
with sol–gel derived nano-bioglass (SiO2–CaO–P2O5) prepared by a freeze-drying 
techniques [317]. The porous DN10BG composite had a significantly higher EWC than 
the porous DN20BG, which was attributed to the higher concentration of PVA resulting in 
a much dense network, with limited mobility of polymer chains owing to decrease in 
water uptake. A study by  Pon-On et al, on PVA-BG/chitosan-collagen composite 
scaffolds for bone tissue engineering applications, reported their biocomposites with the 
best beneficial properties to have a swelling percentage  of 120% after 1 day immersion 
in water, with a maximum of ~130% reached at 3 days [318], which is excessively high in 
comparison with that of the DNBG composites and would therefore negatively impact on 
the mechanical stability of the composites. 
 
Ultimate Tensile Strength 
In this study (Figure 6-4) the highest tensile strength was obtained for DN10BG-2FT 
composites with a value of 2.4MPa, found to be statistically significantly higher (P<0.001) 
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than the DN10BG-3FTcomposites. This trend in results was in agreement with that of 
tensile strength results obtained from the DN hydrogels (chapter 5), reinforcing the 
conclusion drawn before that 2 cycles of freeze thawing yield optimum tensile properties 
of the hydrogels. The stiffness of the DN10BG composites with no porogen was found to 
decrease with increasing cycles of FT. These tensile and stiffness values were higher 
than those of the DN hydrogels, which was due to the incorporation of Bioglass® within 
the network system. The small ~17µm particle size of the bioglass particles also enables 
a firm attachment of the polymeric matrix mainly by virtue of the carboxyl groups of the 
alginate interacting with the P-O and –OH group in the filler.  A composite comprising of 
45S5Bioglass® and alginate with a 3D multi-layered structure was reported  by Nooeaid 
et al [319] for application in osteochondral tissue regeneration. These scaffolds were 
fabricated via polyurethane (PU) sponge method with a slurry of 3.5w/v% PVA and 
40w/v% Bioglass®, the scaffold was then coated 3 times with 3% alginate and bonded 
with a layer of alginate foam, which was then chelated and dried at room temperature. 
These composites had tensile strength of 0.1MPa, substantially lower than the DNBG’s, 
however it was deemed as sufficient mechanical competence and structural stability for 
osteochondral tissue engineering applications.  
 
The tensile and stiffness properties of the porous composites, showed a statistically 
significant (P<0.001) rise with increase in concentration of PVA with 0.2 and 0.9MPa for 
porous DN10BG and DN20BG respectively. However, the porous network resulted in 
lower tensile and stiffness values as compared to the composites with no porogen, due 
to pores that can act as points of failure. Tensile strength values obtained in this study 
were found to be higher than the 0.1MPa [319] and 0.2MPa [320], values reported in 
literature on BG-PVA-alginate and BG-PVA composites respectively. Tensile strength 
obtained by Nooeaid et al [319] were also lower than those obtained for the porous 
composites in this study, by up to 6 fold in comparison with the DN20BG composites, 
which can be related to the double network formation. Bertolla et al, reported on 
Bioglass® based scaffolds reinforced by PVA/microfibrillated cellulose composite 
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coating. The Bioglass scaffolds were formed by PU sponge method, and were coated 
twice with a solution of PVA and microfibrillated cellulose (MFC). The composites 
exhibited tensile strength values of 0.2MPa which is ~ 4 folds lower than the tensile 
strength obtained with the DN20BG composites [320].  
 
Trouser Tear test 
The toughness of the DN10BG composites fabricated via 1, 2 and 3FT was tested along 
with the PVA only and dual network hydrogel fabricated via 2 cycles of freeze thawing, 
so as to serve as a control. Results in Figure 6-5 showed that 2 cycles of FT resulted in 
the DN10BG composites (4.8KJ/m2) with statistically significantly (P≤0.005) higher 
fracture energy as compared to the PVA single network (1.8KJ/m2), DN hydrogel 
(1.1KJ/m2) and DN10BG composites fabricated via 1 and 3 FT cycles (3.2 and 2.4KJ/m2) 
respectively. This result of DN10BG fabricated via 2FT cycles yielding the highest 
toughness is in agreement and solidifies tensile test results obtained from DN hydrogels 
and DN10BG composites where it was observed that 2FT cycles yield optimum 
mechanical properties for the hydrogels and composites, whereas 3FT cycles did not 
serve to further enhance the mechanical properties. The results were also found to be in 
agreement with those obtained in Chapter 5, where it was demonstrated that 2 cycles of 
freeze thawing resulted in higher fracture toughness for the DN network hydrogels. 
 
Compression and cyclic compression 
A statistically significant   (P≤0.045) increase in compressive strength and stiffness of the 
composites were observed with increase in the concentration of PVA with values of 0.2 
and 0.3MPa for DN10BG and DN20BG respectively. A change in the slope of the stress-
strain curves of (Table 6-7) the composites were noted, initially small increases in stress 
gave large extensions however, at larger extensions the material became stiffer and 
more difficult to extend. This behaviour is typical of biomaterials whose microstructure 
evolves during compression to provide an increased stiffness. Porous multi-layered 
scaffolds of PVA, alginate and BG, designed for osteochondral applications have been 
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reported in literature with average compressive strength values in the range 0.01 - 
3MPa, that were suited for osteochondral tissues, however the hydrogel like nature 
combined with the mechanical properties of these composites further lend themselves  
for osteochondral applications [319]. Several studies have reported compressive 
strength data on composites of Bioglass; Bertolla et al, 2014 on BG scaffolds reinforced 
by a composite coating of PVA and micro-fibrillated cellulose with values of 0.3 MPa 
[320]; PCL-BG composites by Rodenas-Rochina et al, 0.1 and 0.04MPa for 10% 20%BG 
respectively in the composite and elastic modulus 0.9 and 0.5MPa respectively [264]; 
BG-PVA-alginate biocomposite foams prepared via sol gel process were reported to 
have a higher compressive strength of 1.6MPa with elastic modulus of 0.02GPa [127]. A 
study on hybrid PVA/BG scaffolds reported compressive strength values of 9.1MPa 
however the authors did not state whether their scaffolds were tested under dry or 
hydrated conditions [321]. The DNBG composites either had values superior or 
comparable to the compressive behaviour reported for similar type of systems reported 
in literature, hence there is good potential to expand the biomedical applications.  
 
It was observed during the compression test that once the applied load was removed 
from the composites, they sprung/returned back to their initial state, thus to understand if 
loading was completely reversible and elastic, cyclic compression tests were carried out. 
Although the composites returned to their original position and shape upon unloading, it 
was assumed that there must be some microscopic failures that occur in the composite 
before it can reach a level where it incurs macroscopic failure. This type of event should 
be mechanically detectable through the presence of a hysteresis loading-unloading 
curve. 
Systematic loading-unloading experiments (Figure 6-8) were carried out on the 
composites at a constant load for 5 consecutive cycles. In both the DN10&20BG 
composites the loading curve of the 1st compressive cycle was different from the 
unloading curve, and equally different from the 2nd loading-unloading curve. The 2nd 
loading-unloading cycles were nearly elastic and followed the path of the 1st cycle, whilst 
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the 3rd, 4th and 5th cycles seemed to reach a steady state where there seemed to be no 
further changes in the loading-unloading curves of the composites. This behaviour is 
typical to that of Mullins effect whereby, the mechanism of stress softening is 
characterised by a decrease of the stress on unloading compared to the stress when 
loading at the same strain, this is as long as the maximum strain of the first loading is not 
reached. The stress drop between successive loading cycles is especially important 
during the first and second cycles and becomes negligible after about 5-10cycles. At a 
stationary state with constant stress amplitude, a stabilised hysteresis loop is then 
reached after several cycles [322]. However it is known that in filled rubbers (elastomeric 
materials) the behaviour of the virgin sample can be recovered when a sample is left to 
rest typically for 1hour [323] but the DNBG composites were found to be able to recover 
after application of a given load without the need for relaxation time. In recording the 
level of hysteresis during the experiments, the heterogeneous structure of the network of 
the composite was investigated and the most likely explanation is that the 
macromolecular chains of the polymers slip and slide with friction over one another, 
whilst the chains connected to the Bioglass® particles are slipping and sliding with 
friction over these particles (Figure 6-20).  The hysteresis curves of the DN20BG 
composites can be further explained  by the macromolecular chains connected to the 
surfaces of the Bioglass® particles undergo deformation  close to macroscopic 
deformation state [322]. 
 








The non-porous DN10BG composite (Figure 6-9) showed a compact network structure 
with porosity that was primarily due to freeze drying. The heterogeneity of the composite 
was observed at higher magnification, the polymer phase was seen coating the 
Bioglass® particles. The micrographs of the DN10&20BG composites displayed a 
porous structure with interconnected pores of varying sizes ranging from ~1mm to < 
20µm. Such large pores should in principle encourage bone cell adhesion and 
proliferation, enable mass transfer and providing increased surface area for cells to grow 
and act as a carrier for growth factors, very small pore sizes are known to hamper 
neovascularisation. Ideal pore size for bone tissue engineering has been reported to be 
in the ranges 300 – 500µm [28] or 200 - 800µm [127]. Pore size plays a very important 
role on the mechanical properties of the scaffold, large pore sizes weaken the 
mechanical properties of the scaffold, and this justifies the lower tensile and compressive 
strength values obtained from the composites. 
 
BIOACTIVITY OF COMPOSITES (MINERALISATION) 
A bioactive material is one that elicits a specific biological response at the interface of the 
material which results in the formation of a bond between the human tissue and the 
biomaterial [324]. The key compositional features that are responsible for the bioactivity 
of bioglass® 45S5 are its low SiO2 content, high Na2O and CaO content and high 
Ca/P2O5 ratio. The bonding of bioglass® 45S5 to bone has been attributed to the 
formation of a carbonate substituted hydroxyapatite (HCA) like layer on the glass surface 
in contact with body fluid, and this HCA layer is generally believed to form as a result of a 
sequence of reactions on the surface of the bioglass implant. The surface reactions 
involves dissolution of critical concentrations of soluble Si and Ca ions that give rise to 
both intracellular and extracellular responses at the interface of the glass with its 
physiological environment [300, 306]. Solution mediated dissolution of bioglass results in 
the accumulation of dissolution products, which cause both the chemical composition 
and pH of the solution to change. This change results in surface sites and pH levels 
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inductive for HCA nucleation. There is a sequence of 11 reactions stages that occur on 
the surface of Bioglass® after implantation. To understand the processes that occur 
when Bioglass® is placed in SBF resulting in mineralisation, the first five stages on the 
mechanism of HCA layer formation are summarised.  
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The DNBG composites on interaction with simulated body fluid, clearly exhibited the 
formation of a mineral layer on the surface of the composites as shown in the SEM 
micropgraphs. Furthermore, tensile strength tests were carried out to investigate the 
effect of mineralisation on the composite networks after immersion in SBF for 7, 14, and 
28 days. The tensile strength after 7 days of immersion showed a decrease in the tensile 
strength (Figure 6-21) of both non-porous and porous composites, which   was attributed 
to the initial degradation of unreacted and uncrosslinked PVA and alginate chains in the 
network.  
 
Figure 6-21: The effect of mineralisation on the tensile strength [A] and Young’s modulus 
[B], observed from the DN10, non-porous DN10BG and porous DN10 and 20 BG 
composites, all fabricated via two cycles of freeze thawing. 
 
Tensile strength of the non-porous DN10BG composite at day 0 (2.4MPa) was 
significantly higher (P=0.005 and 0.038) than at day7 (1.8MPa) and day 14 (2.0MPa) 
respectively, but not significantly higher than that at day28 (2.2MPa). The stiffness at day 
28 (3.5MPa) was found to be significantly higher (P<0.001 and P=0.006) than after 7 
A 
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(2.1MPa) and 14 (2.7MPa) days immersion in SBF respectively. This indicated that there 
was an increase in strength and stiffness in the non-porous DN10BG-2FT-1FT 
composite, due to the reinforcement of the composite network by the HCA crystals 
formed on the surface area of the composite. For the porous DN10BG-2FT-1FT 
composite there was no significant increase in tensile strength however, the stiffness at 
day 28 (0.5MPa) was found to be significantly higher (P<0.001, P=0.048, P=0.014) than 
at days 0, 7 and 14 (0.2, 0.3 and 0.3MPa) respectively. For the porous DN20BG-2FT-
1FT, the tensile strength at day 0 (0.9MPa) was found to be significantly higher 
(P=0.043) than the strength at day 7 (0.7MPa), and was not found to be significantly 
higher than at day 14 and 28 (0.8 and 0.9MPa) respectively. The tensile strength at day 
28 was significantly higher (P=0.049) than after 7 days immersion in SBF, however no 
significant difference was found in stiffness values of the composite. 
These results indicated that mineralisation did occur in both porous and non-porous 
composites, however the non porous composites showed a marked improvement. The 
DN hydrogels were used as the control group in this study, for which the tensile strength 
of 0.7 MPa before immersion in SBF was significantly higher (P<0.001) than after all 
immersion periods, whereas there was no significant difference in stiffness between all 
periods. Therefore, no significant stiffening or increase in tensile strength occurred in the 
DN hydrogels, hence the enhancement in tensile and stiffness properties of the 
composites was mainly due to the mineralisation process that resulted in mineralisation 
of the composite which would reinforce and enhance the already existing mechanical 
properties of the composites. Similar results were reported by Pon-On et al, 2014 where 
they prepared poly(vinyl alcohol)–bioglass/chitosan–collagen composite scaffolds with 
various compositions via 3 freeze thaw cycles followed by freeze drying process to 
impart porosity on the scaffolds. The authors 1st created PVA/BG powder of ratio 2:1 with 
7wt.% PVA solution, they then used this PVA/BG powder to create composites of 
PVABG/ChiCol of ratios 0.5:1, 1:1 and 2.1. The authors found that the compressive 
strength and modulus of the PVA/BG-Chitosan-collagen scaffolds decreased after 7 
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days immersion in SBF for all composite formulations, the study however did not report 
on mechanical properties further than 7 days immersion in SBF [129]. 
 
The bioactivity of composite networks was also assessed by monitoring the rate of HA 
formation on samples after immersion in SBF using FTIR and Raman spectroscopy and 
further validated by the mechanical behaviour of the composites theorised to be 
enhanced due to the mineralisation process.  The P-O bending bands (Figure 6-13) 
located at ~604 and ~565 cm-1 can be considered to be the main characteristics of HA 
and thus they were used for confirming the formation of HA layer. However, weak 
absorption bands were also observed in the FTIR spectra for day 0 at ~604 and ~565 
cm-1 that is typical of the P-O bending of HA, which can be explained that some level of 
interaction had occurred during the formulation of the composite because the PVA-
Bioglass  was subjected to immersion in a sodium alginate.  A new carbonate band at 
800-890cm-1 was observed on the porous composites after 28 days in SBF, which 
suggests the formation of an apatite like layer. Similar observations on absorption bands 
identifying the formation of apatite on Bioglass® and Bioglass® containing composites 
have been reported [311, 314, 325-327]. 
Identification of HCA layer on the composites was supplemented by FTIR-ATR spectra in 
Figure A-1 (see appendix) where: The peaks at ~1400 cm-1 increased in intensity after 
28 days immersion in SBF, these peaks were due to the ʋ3 vibrational mode of 
carbonate ions. The distribution of the carbonate ʋ3 sites is said to depend on the 
maturation and formation of the apatite crystals, as well as on the competition between 
phosphate and carbonate ions. After 28 days immersion in SBF, the phosphate peaks 
(ʋ3) on the composites were observed at 1024, 1051 and 1023 cm-1 for non-porous 
DN10BG and porous DN10, 20BG respectively. Peaks centred at ~914 cm-1 were due to 
mixed stretching and bending vibrations of Si-O-Si bonds, which overlapped the bend 
mode of phosphate vibrations. Resonances attributed to the carbonate (CO3)2- group 
have generally been interpreted as indicating the formation of carbonated substituted 
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HA, whereby some of the (PO4)3- ions in HA are substituted by (CO3)2- due to the 
dissolved CO2 in aqueous solution [327, 328]. 
The results obtained from Raman analysis (Figure 6-14) showed little to no changes 
after 7 and 14 days in SBF. Peaks attributed to the P-O stretching and asymmetric 
stretching at 960 cm-1 and 1085 cm-1, corresponding to HCA formation were clearly 
observed after 28 days immersion in SBF. The DN20BG porous composite were an 
exception and the absence of HCA formation peaks on the DN20BG composite was 
attributed possibly to the random area of mushrooming crystals caused by a high ratio of 
polymer contents as compared to Bioglass® content in the composites. The Raman and 
IR results confirmed the presence of HCA layer formation on the composites, results 
which are supported by the tensile strength and stiffness value trends obtained from the 
composites after immersion in SBF for 7, 14 and 28 days. 
SEM micrographs provide a visual presentation of the formation of cauliflower like 
structures with some fan-like crystallite outgrowths which probably as the Bioglass 
particles are entrapped in polymer matrix, hence the mineralisation mirrors that pattern. . 
The increase in density of the crystals with immersion time in SBF was clearly observed. 
Micro-chemical analysis was carried out on the crystals at each time point and the Ca/P 
ratios calculated to determine the proximity of the formed crystal stoichiometric ratios to 
that of HA which is known to be 1.67  [298]. Results obtained from analysis did not 
display any particular trends with Ca/P ratios. It however was observed that the initial 
Ca/P ratio was high with values in the ranges 2.23 – 2.44, indicative of Bioglass® where 
the Ca to P ratio is 5:1, this value was then observed to decrease with increase 
immersion times in SBF. After 28 days immersion in SBF, the EDX of the porous 
composites displayed calcium deficient HA in which the Ca/P ratio was lower than 1.67. 
The presence of carbonate was however established through FTIR and Raman analysis. 
It has been noted from this study that the composites comprise of only 30% Bioglass® 
and that this would consequently have an over-all effect on the amount of HCA produced 
and detected. The levels of HCA on the surface were therefore not expected to be to 
those within the internal structure of the composite.  
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Cyclic compression tests were carried out to understand the effect of mineralisation on 
the hysteresis of the composites. Initially before immersion in SBF the composites were 
found to have superimposable curves with little to no hysteresis, implying very little 
energy dissipation at a molecular level. However, from the results displayed in Figure 
6-11 and Figure 6-12 show substantial hysteresis on all the cycles ( mostly observed well 
between cycle 1 and 2), which was probably due to molecular friction between the 
composite and new crystal formation due to the process of mineralisation. It was clear 
that the loading and unloading curves were all different, strongly suggesting that the 
hysteresis observed in the first cycle is related to irreversible fracture events taking place 
in the composites. However the nature of these fractures could be investigated further by 
conducting studies were the samples would be allowed relaxation time before applying 
load for the second cycle, before concluding that the fracture incurred and observed here 
was irreversible. It can be stated that “The number of fracture events is directly 
dependant on the maximum strain achieved during the first cycle.” This is to say “if a 
second loading-unloading cycle is performed at a lower or equivalent strain the material 
behaves very elastically, however if the maximum strain of the second cycle surpasses 
that of the first cycle, the loading curve has two parts.” In this case it is the latter. 
 
CYTOCOMPATIBILITY 
Research has shown that glasses with especially high levels of bioactivity can also be 
used to activate genes to stimulate the body to repair itself, this means that Bioglass® 
45S5, which has the highest rate of bioactivity would impact regeneration of trabecular 
bone.  This rapid regeneration of bone is due to a combination of osteostimulation and 
osteoconduction, a consequence of rapid reactions on the bioactive glass surface. 
However, the level of regeneration would be influenced by the ratio of polymer to glass 
content in the composite. To understand how human osteoblast cells would behave on 
the scaffolds, a series of in vitro cell culture tests were carried out.  
MTT results displayed in Figure 6-16 indicated that there was a decrease in cell 
proliferation with increased exposure time to eluents. Calculations of the RGR confirmed 
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the level of cytotoxicity of the degradation products and ions released in the media due 






Relative growth rate (RGR) (%) 
24 exposure 48 exposure 72 exposure 
DN10BG  
No porogen 
24 127.0 48.9 31.9 
48 92.9 32.6 19.9 
72 102.8 39.2 22.3 
DN10BG 
10%porogen 
24 108.6 41.5 23.3 
48 76.3 28.0 14.3 
72 79.3 26.3 17.9 
Table 6-8: Relative growth rate percentage of non-porous DN10BG and porous DN10BG 
demonstrating viability of HOB cells within the hydrogels. 
 
Results in Table 6-8 indicated that elution products were cytotoxic to the cells after 72 
hours exposure (culture period) which resulted in cell death. This result was mediated by 
changing the media solution of the composites with cells seeded on them, during culture 
period every 2-3 days to prevent cell death. This proved to be a major limitation in the 
application of in vitro analysis of scaffolds with a composition of Bioglass® 45S5 within 
their network as the local biological environment can be influenced significantly by their 
chemical degradation products of Bioglass®. Release and increases in the concentration 
of ions such as Na+ and Ca2+ as well as Si (OH)4 and changes in the pH occur as a result 
of degradation particularly in the early stages due to fast degradation of the glass 
component. However it is theorised that, in animal and clinical trials this would not pose 
a big problem because living tissues have a constant flow and diffusion of fluids and ions 
as well as migration of cells all of which allow for extraction of degraded toxic elements 
at the wound site. For example small pieces of Si(OH)4 released during degradation are 
eaten by phagocytes and extracted out [298]. Mishra et al, 2009 assessed the cell 
viability of fibroblasts on their BG-PVA-alginate biocomposite prepared by sol gel 
process and reported that their material indicated good cell viability using MTT assay 
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under in vitro conditions [314]. This is attributed to the fact that sol gel process recreates 
to the same degree of nanoscale order and organisation, the mineral organic 
components as found in vivo. 
 
Live/Dead Staining of the HOB cells cultured on the composites for up to 28 days 
(Figure 6-17) showed cell attachment and proliferation on all the composites. On the 
porous composites good cell penetration and proliferation within the porous network of 
the composite was observed. It was noted that due to the formation of an HCA layer 
formed on the surface areas of the composites, visualisation of live/dead cells on the 
composites became difficult, as this HCA layer formed over the surface of already 
attached and proliferating cells. Instead what was observed was a glowing green colour 
on the whole surface of the composites resulting in limited visualisation of actual cell 
structures or morphologies. At 28 days in culture a flat layer of HOB cells was clearly 
observed on the surface of the composite fabricated with no porogen. On the porous 
composites at day 28, a cell structure through one of the pores that had a connected 
structure through the depths of the composite was observed. This indicated that a 
communication and connection of cells had occurred through the pores to the different 
depths of the composite. 
SEM was utilised to observe and characterise the cell morphology of the HOB cells on 
the composites after 7 and 14 days in culture, results have been displayed in Figure 
6-18. Cellular attachment, adhesion, and spreading are of vital importance in living 
biological processes and belong to the first phase of cell/material interactions. This 
process is involved in various natural phenomena such as embryogenesis, wound 
healing, immune response, the maintenance of tissue structure, metastasis, as well as 
the integration of tissue with biomaterials. After 7 days in culture it was observed 
osteoblast attached to the surface of the composites and spread across the whole 
surface colonising the scaffold and displaying a flattened morphology. Also observed 
was the flattened morphology of cells spreading across pores and forming a sheet over 
them, cells were multi-layered and elongated.  
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Proliferation and differentiation is influenced by the quality of this phase, and Costa et al, 
2012 reported that cell spreading has been divided into three main interaction levels: 
I. Unspread; cells observed to be spherical in appearance, and protrusions or 
lamellipodia were not yet produced. 
II. Partially spread; cells are observed to begin spreading laterally on one or more 
sides, but the extensions of the plasma membrane were not completely 
confluent. 
III. Fully spread; cells are spread laterally with extensions, represents the best result 
of material hosting. [321] 
The observations of the HOB cell morphology indicated that the composites are a good 
cell host scaffold allowing for cell attachment and proliferation on the surface and internal 
structure of the scaffold. 
Higher levels of ALP activity were observed at day 14 for both composites. ALP is 
essential in bone maturation and it is produced at high levels during bone formation 
activity [329]. Bioglass® 45S5 has been reported to show a marked effect on its ability to 
support  the proliferation and functions of cells in vitro [298]. On reaching osteoblast 
maturity, initiation of mineralisation protein is signalled, thus results have indicated that 




Novel dual network composites of PVA-alginate-bioglass were successfully fabricated. 
These composites have the advantage to be easily tailored to have either high or limited 
macroporosity, expanding their potential use in applications as membranes or porous 
plugs. The composites have the potential to function as bone substitutes that can absorb 
and retain biological fluids rich in growth factors allowing for their delivery at the wound 
site, whilst retaining their shape, mechanical strength with limited swelling expansion. 
This has been demonstrated by their water uptake levels and exhibit remarkable 
increase in tensile strength, stiffness and fracture toughness in response to mechanical 
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deformation. The added advantage of the composites is their bioactive component which 
was demonstrated by means of FTIR, Raman, SEM and EDAX analysis and resulted in 
enhanced mechanical tensile properties. The fabricated novel composite systems are 
designed to function as three dimensional frameworks for augmentation of bone voids in 
non-load bearing areas that can have exogenous orthobiologics introduced to them 























Chapter 7  
Conclusion and future work 
The design strategies for bone substitutes used in this study involved two strategies  (i) 
fabrication of elastomeric composites that would have controllable expansion to fit the 
bone defect overcoming the problem of rigid bone substitutes that tend to induce micro-
movement at the bone-substitute interface, adversely impacting bone regeneration and 
(ii)  the porous composite scaffolds to suit vascularisation and orthobiologic approaches 
via the potential for inclusion of platelet rich plasma or bone marrow aspirates within 
them that are rich in biologics and known to promote bone healing.  
Hydrogels were selected as the matrix for the composites to enable fluid uptake and dual 
networks formed to enhance toughness and impart elastomeric properties whilst using 
phosphate calcium phosphate as fillers, in view of their transient role and effectiveness in 
bone regeneration. The base polymer selected was poly(vinyl alcohol), which is an FDA 
approved polymer for medical use and can be crosslinked using physical methods 
alleviating problems associated with use of chemical cross linking agents in devices for 
biomedical applications. Previous studies in our laboratories demonstrated that calcium 
metaphosphate (CMP) scaffolds with mixed porosity promoted bone formation whilst 
undergoing total resorption within 8 weeks in rabbits. In addition the in vitro cell-material 
interaction studies by Buranawat (Buranawat thesis 2012) showed that CMP exhibited 
an osteoinductive potential even in non-induced conditions and Von Kossa staining 
exhibiting nodule formation in non-induced medium. This was further confirmed by gene 
expression of proteins, Runx 2, Osteocalcin, ALP and procollagen. Based on these 
results, this phase of calcium phosphate was selected as the filler and 45S5 Bioglass®, 
which has an established history of bone regeneration capabilities, for designing the 
hydrogel composites towards clinically viable materials to repair, regenerate and 
enhance bone healing across small and large bone defects. In particular, the role of the 
hydrogel matrix would be to allow imbibition and retention of biological fluids such as 
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autologous PRP or growth factors, and allow for their delivery at the wound site. The 
design parameters of the grafts included incorporation of hydrophilic polymers that could 
be cross-linked by physical means, with the ability to be tailored to increase or decrease 
hydrophilicity, allowing for their potential to absorb biological fluids. The overall study 
was carried out in four developmental stages leading to the achievement of the final 
bone graft substitutes, which are now being considered by a commercial enterprise 
towards clinical translation. 
Stage 1: The concentration of PVA and the most effective physical crosslinking method 
between freeze thawing, air drying and a combination of both that yielded optimum 
mechanical properties of PVA single network hydrogels were identified and utilised in the 
development of PVA-CMP composites, interpenetrating dual network hydrogels and their 
composites. A concentration of 10% wt/vol of PVA yielded the viscosity suited for 
composite formulation with freeze-thawing for physical crosslinking. 
Stage 2: Composites of PVA with a high concentration of CMP filler particles were 
fabricated and through freeze-drying, and a porous network was obtained. The inclusion 
of the filler in the composite decreased both swelling and water uptake as compared to 
the parent PVA single network hydrogel. The mechanical properties of the composites 
could be tailored by varying the concentration of PVA in the composite formulation and 
the hydrated composites with 30% concentration of PVA yielded compressive strength of 
48 MPa and modulus of 725 MPa, which were 7 and 2 times higher than composites of 
PVA with hydroxyapatite [239]. The diametral compressive strength was also found to be 
highest for the 30% concentration of PVA, the water uptake being lowest, indicating the 
formation of a tight network with interaction between the filler and matrix which is 
attributed to some H bonding between the PVA and CMP on freeze thawing. The 
inclusion of CMP in the PVA matrix led to a decrease in water uptake and could be 
regulated to low values of 25% EWC with low swelling and enhanced mechanical 
properties in the hydrated form. This study for the first time formed porous hydrogel 
composites of PVA with direct incorporation of the new calcium metaphosphate filler and 
subjecting to physical crosslinking, suited as bone plugs and cavity fillers for bone 
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defects. PVA hydrogels with hydroxyapatite inclusions have been mainly reported for 
articular cartilage where in situ formation of hydroxyapatite is carried out that limits the 
amount of HA that can be incorporated due to agglomerations forming even with 
concentrations of 15% of PVA.  
Stage3: Double network hydrogels are being increasingly used as a convenient method 
of synthesizing tougher hydrogels, which comprises of a first network, in which a second 
interpenetrating polymer network is formed within the first network. Based on this 
concept, for the first time dual network hydrogels were formed with two biocompatible 
FDA approved polymers to create tougher hydrogels than single network PVA hydrogels. 
Unlike double networks, two water soluble polymers were used where the first network 
was a brittle network formed by physical crosslinking of PVA and intrusion of sodium 
alginate was conducted and chelated to yield the neutral gel, which was further freeze 
thawed to create the dual network. These hydrogel networks were successfully formed 
with lower swelling characteristics and increased tensile strength and ductility due to the 
formation of a second network within the first brittle network. The evaluation of the 
properties of the dual network provided the information required to formulate the 
composites using the tough network as the matrix. Interestingly, the texture, water 
uptake and elasticity of these networks highlighted the potential application to form 
wound dressings and as matrices for soft tissue engineering. Although this will be a 
future research project, a preliminary drug release study was carried out using 
vancomycin to study the drug release profile. The drug release was found to be 
~proportional to the swelling ratio of the hydrogels (i.e high swelling ratio resulted in high 
drug release) that showed a steady increase in the release with time, thus could be 
suited for local applications of high doses of vancomycin. The ability to tailor the 
hydration dynamics makes this dual network an attractive system for delivery of drugs. 
The dual network hydrogels demonstrated the multifunctional capability to function not 
only as the initial polymeric phase to serve as a base matrix for the development of 
composites, but with potential for soft tissue applications as well as drug delivery 
matrices.  
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Stage 4: Elastomeric composites facilitate surgical handling and the intimate contact with 
the wound also allows a gradual load transfer to the bone, until it can be mechanically 
capable of enduring loading. Dual networks that were formed in this study were further 
used for formulation of the composites due to their controllable swelling and mechanical 
properties. 45S5 Bioglass® was selected as the filler due to its bioactivity as well as its 
reported ability to form mechanically strong bonds with bone as well as soft tissue. Both 
non porous and porous composites were fabricated Bioglass® 45S5 and the porous 
networks were spongy and found to exhibit hysteresis behaviour typical of that described 
by Mullins effect, a preconditioning condition typically exhibited by soft tissues. The 
interaction with simulated body fluid identified the deposition of an HCA mineral layer on 
both the composites with good biocompatibility, low cytotoxicity and good mechanical 
properties.  These novel composites were found to exhibit a potential to overcome 
current biological challenges of bone substitutes and holds great promise as effective 
bone substitutes and drug delivery devices.  
 
One of the most important design parameters for scaffolds in this study was their ability 
to absorb and retain fluids. This parameter aids in determining the functionality and limits 
thereof of the scaffolds. The trend in comparison of the water uptake of the networks 
fabricated was observed as follows: 
 
PVA single network > Dual networks > DNBG composites 
PVA single network > PVA-CMP composite 
 
The novel dual network hydrogels fabricated with PVA and sodium alginate exhibited 
properties to suit a diverse range of applications in soft tissue applications and it will be 
of future interest to explore, especially as these systems can be used for bio 
therapeutics. Hydration properties of these network gels show potential for wound 
dressing applications, not only to keep the wound hydrated while preventing build-up of 
bacteria and maintain its structural integrity. This could be achieved by incorporating  
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antimicrobial peptides that can bind to the alginate in the dual network, employing similar 
methods as reported in a study by Chan et al, 2004 [330]. Similar clinical studies have 
been reported on hydrogels impregnated dressings for graft fixation, where patients 
treated for skin grafting have been treated with hydrogel impregnated dressings. The 
dressings were coated with hydrophobic fatty acids that irreversibly binds to the bacterial 
surface and mechanically removes bacteria from the wound, so as to prevent infections 
and the skin grafts from drying. The authors concluded by suggesting the dressing to be 
used as a superior alternative over tie-over dressings [331].  
It is postulated that these dual network hydrogels can be applied as internal stabilisation 
devices to provide torsional stability and allow a localised delivery of autologous growth 
factors that would aid and enhance healing time. The composites are elastic and it is 
known that elastic bone substitutes decrease shear forces on the bone-implant interface 
and a study on polyurethanes have shown to be successful in repairing critical bone 
defects [332]. The PU systems however are slow to degrade whilst the dual networks 
with PVA-Alginate/CMP composites are erodible with a CaP phase that assists in bone 
formation. 
 
A recent study by Baker et al, 2016 reported [333] on self-deploying shape memory 
polymer (SMP) scaffolds for grafting and stabilizing mouse femoral segmental defects, in 
which they concluded that their SMP sleeves used in combination with allografts 
provided torsional stability to the bone defect, and showed promise as internal 
stabilisation devices that could be used as supplementary fixation to current strategies. 
The polymer systems used in the study by Baker et al use acrylate based monomers 
with crosslinking agents, tetraethylene glycol dimethacrylate, which yield stable 
polymeric entities, hence will have limitations, however the strategies of their study is 
similar to this study in terms of the ability to absorb fluids rich in growth factors, which 
would allow for their localised delivery at the wound site. Furthermore, the surgical 
handling of the dual networks were assessed by two orthopaedic surgeons and oral 
communications suggested that their placement would be far superior than any other 
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existing bone substitutes (oral communication with consultant orthopaedic surgeon Dr 
Reichert). 
 
The ability to tune the swelling and EWC of the DN hydrogels, DNBG and PVA-CMP 
composites combined with the fact that all exhibited lower water uptake than their 
corresponding PVA single network hydrogel counter parts is clinically desirable, since 
excessive swelling negatively affects the mechanical stability as well the expansion of 
the graft, which may result in undue pressure on the edges of the wound site, eventually 
resulting in cell death and tissue necrosis. 
 
The mechanical stability and integrity of scaffolds has been a major challenge and have 
been one of the causes of limited translation of scaffolds from the laboratory to clinical 
practice. Scaffolds with mechanical properties matching those of native tissue, aid in 
providing the desired mechanical stability at the defect sites, especially in load bearing 
areas.  
The trend in comparison of the mechanical properties of the networks fabricated was 
observed as follows: 
 
Tensile strength: - PVA10 < DN10 < DN10BG 
Compression: - DN10, 20BG < PVA-CMP 
 
Composite grafts reported on the DNBG (Chapter 6) and PVA-CMP (Chapter 4) were 
designed specifically for orthopaedic applications. Both composites had a porous 
structure with a highly interconnected porous structure in the DNBG composites, which 
facilitates nutrient transport, bone ingrowth and vascularisation. The mechanical 
properties of the composites were found to more closely resemble cancellous bone. The 
scaffolds were found to have low brittleness and therefore pose a limited risk of 
catastrophic failure under load. The easy handling and the ability to reshape the 
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composites using a scalpel under hydrated conditions, will ensure that they can be easily 
cut or shaped by the surgeon if need be during surgical procedures. 
 
With a view to highlight the advantages of the composites developed in this study, a 
comparison of selected current grafts reported in recent literature is presented. The SMP 
grafts mentioned earlier, were tested in femoral segmental bone defects in a mouse 
model, however, the grafts did not result in bone regeneration as compared to the 
allografts and it was concluded that incorporation of ceramics or bioglass fibres may 
improve mechanical properties and enable the next generation of SMP sleeve to function 
as a stand-alone bone graft fixation strategy [333]. This is significant as the lack of a 
porous and mechanically stable structure, as well as a bioactive component in a graft 
suggested for bone bridging or augmentation, highly impedes the regeneration of new 
bone into the graft as the environment is unsuitable for osteoblast cell recruitment, 
attachment and proliferation.  
Another novel highly porous ceramic scaffold termed ‘Baghdadite’ (Ca3ZrSi2O9) 
containing zirconium in the crystal structure of calcium silicate was reported however 
were later modified to improve their mechanical properties by introducing a PCL coating 
containing bioglass nano-particles. The resultant compressive strength of the modified 
scaffold was reported to be 1.1MPa which was higher than the 0.2MPa of the unmodified 
scaffold.  On implantation into critical sized segmental bone defects in sheep, the 
scaffolds were reported to be able to withstand physiological loads at the defect site, and 
induced substantial bone formation in the absence of supplements and growth factors 
[334]. These scaffolds can relatively be easily compared to the composites in this study, 
especially with the DNBG composites. While the compressive strength of the modified 
baghdadite is relatively close to the DN10BG composite, they however remain lower 
than those for all DNBG and PVA-CMP composites. Figure 7-1 illustrates a comparison 
and demonstrates the differences in brittle behaviour under load of the baghdadite 
scaffolds with the DNBG composite. It clearly shows that whilst the modified baghdadite 
scaffold does not undergo catastrophic failure under load, it does still undergo total 
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collapse. In contrast, the DNBG composites neither undergo catastrophic failure or total 
collapse when placed under loading conditions, and was observed to spring back to its 
original height when the load placed on it is removed. 
. 
 
Figure 7-1: Comparison images demonstrating the differences in brittleness and lack of, 
of the baghdadite and modified baghdadite scaffolds [334], with the DNBG composites 
before and after loading. 
 
As discussed in the literature review a number of bone substitutes based on ceramics 
are used clinically and their limitations mainly pertain to their brittle nature and in some 
cases very slow resorbability. Most clinically used bone substitutes are dispensed either 
as granules and blocks, which are either packed into defects or plugged into defects and 
the rigidity causes micromovement.  However, the DNBG and PVA-CMP composites can 
be made as whole block grafts that can be easily cut by surgeons during operations if 
desired is a distinct advantage over other existing materials. 
 
Both the DNBG and PVA-CMP composites offer the versatility to be fabricated with 
different types of ceramic and glass fillers. Properties of the composites can be tailored 
to desired needs by changing the polymer concentration used in their fabrication. DNBG 
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Figure 7-2: Image of DNBG 
composite demonstrating the 
porous internal structure, and the 
similar biomimicry to trabecular 
bone. 
composites provide an interconnected porous 
structure that closely mimics the structure of 
trabecular bone. Clinical and animal studies have 
been carried out with scaffolds fabricated from the 
same materials as in the DNBG and PVA-CMP 
composites, demonstrating the biocompatibility of the 
individual components chosen in this study, of which 
has provided further solidification of the 
biocompatibility of the DN hydrogels, DNBG and 
PVA-CMP composites. The hydrogels and 
composites can be fabricated in moulds of different forms to expand their applications. 
For example the DN hydrogel can be fabricated in channelled moulds to be utilised as 
scaffolds applicable for nerve regeneration, with channels that can guide the 
regenerating axons. This is comparable to a study by Gunter et al, 2015 who developed 
alginate hydrogel scaffolds with anisotrpic structure, aimed at regenerating axons after 
spinal cord injury[335]. The non-porous DNBG composites as well as the DN hydrogels 
have the versatility to be fabricated to function as membranes, which can be used to seal 
wounds after graft placement. 
 
7.1 CONCLUSIONS 
This study has explored the use of two polymer networks being PVA and sodium 
alginate, to evaluate their suitability for engineering bones substitute grafts via 
incorporation of CMP and Bioglass® to form either a single network of PVA or an 
interpenetrating dual network of PVA and alginate. The characterisation of the materials 
in each stage of the study, suggest that suitable water uptake and mechanical properties 
as well as cellular interactions can be achieved by varying the concentration of polymers 
used in the fabrication of the composites. Thus, bone graft systems were developed that 
can function both mechanically as well as biologically that allow for absorption and 
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retention of biological fluids rich in growth factors. Simple and methods that did not 
involve use of any chemical crosslinking agents were employed in this study. 
 
PVA displayed a viscous behaviour which increased with increase in concentration. The 
freeze thawing technique was found to yield PVA hydrogels with optimum properties. 
The hydrophilicity of PVA was demonstrated by its high water uptake. The tensile 
strength properties of PVA were found to be easily altered by increasing the 
concentration of PVA. 
Interpenetrating network of PVA and alginate were successfully fabricated to form dual 
network hydrogels, which were initially proposed to function as a continuous polymer 
phase that would allow for incorporation of fillers to form bone graft substitutes. The 
hydrogels were found to have reduced swelling properties and increased tensile 
strength. Their biocompatibility and elasticity with a rubber like nature that resembles 
elastin in soft tissue, implied an expansion of applications from the polymer base for filler 
incorporation to form bone-graft substitutes, to applications in soft tissue areas. 
Bioglass® was successfully incorporated into the DN hydrogel structure to form porous 
and non-porous DNBG composites.  The composites were found to be suitable for bone 
graft augmentation in non-load bearing areas. Tensile strength of the non-porous 
composites were found to be significantly higher than those of the DN hydrogels. The 
composites were found to be biocompatible and their bioactivity in SBF demonstrated. 
PVA-CMP composites with high mineral content were found to have increased 
compressive and diametral strength with increase in concentration of PVA. The 
composites were found to be biocompatible, and seemed to undergo a small level of 
hydrolysis when placed in SBF and culture media. Their properties determined them to 
be suitable for bone graft applications low and non-load bearing areas. 
In conclusion this study has developed systems that can be beneficially applied in the 
advancement of Bio Medical engineering solutions in search for a better quality of life for 
humanity. Systems fabricated in this study show positive and beneficial applications for 
soft and bone tissue regeneration, they have demonstrated potential for good internal 
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bonding of host tissue to the biomaterials and this has been attributed to their  good 
biocompatibility, water uptake, elastic and mechanical properties. 
 
7.2 FUTURE WORK 
Overall, a platform has been formed for continual development of the systems reported 
for further tissue engineering applications. The emphasis of the current research was to 
develop osteoconductive bone substitutes with good structural properties that would be 
able to absorb and retain biological fluids rich in growth factors, and allow for their 
delivery at the wound site. This thesis presented detailed studies on steps taken to 
fabricate and achieve hydrogel and composite systems with optimum properties suitable 
for soft tissue and bone augmentation applications. Therefore in future: 
 
 Detailed in vitro studies on inclusion of PRP within selected hydrogels and 
composite systems with optimum mechanical and physical properties will enable 
to optimise the systems to provide the maximum clinical efficacy for bone healing. 
The kinetics of absorption of PRP and subsequent release in the surrounding 
environment will provide information on the effect of the inclusion of PRP. 
Selected mechanical properties will need to be characterised post absorption of 
PRP and detailed fatigue behaviour of the constructs will need to be 
characterised. The activity of the PRP within the constructs will need an 
evaluation, especially as the construct may provide binding sites for the 
proteins/peptides in the PRP, thus standard assays for growth factors such as 
PDGF and TGFβ should be assessed. 
 
 The hydrogels and the composite hydrogels are versatile materials and can be 
further exploited for other applications such as nerve regeneration and wound 
healing. Forming the composite in fibre form with aligned bundles can be 
explored for nerve regeneration, especially as the materials can be easily 
moulded and expected to provide the requisite properties for the same. The 
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morphology of the fibres can be tailored for guided cell regeneration, for example 
hydrogels fabricated in a striated mould would be suited in axonal growth for 
nerve regeneration. 
 
 Rapid prototyping fabrication techniques can be explored, for more patient 
specific design applications. Different designs from rapid prototyping may also 
result in improved mechanical properties, especially in the case of highly porous 
composite systems.  
 
 Detailed in vivo studies in small animal models will be carried out using the 
optimised scaffolds in combination with and without autologous PRP. This study 
will help elucidate the effects and benefits of the scaffolds in regeneration of the 
bone tissue, and demonstrate advantages of the scaffold’s ability to allow for 
localised delivery of PRP. The results would form the basis of extending this to 
large animal models in future towards clinical translation.  
 
 Osteochondral defects that involve both cartilage and the underlying subchondral 
bone are particularly challenging to repair. Current treatment options provide 
limited success that often eventually need a joint replacement. The complex 
architecture through the articular cartilage to subchondral bone pose a significant 
challenge in developing tissue engineering strategies to regenerate this tissue. 
The fact, that there are integrated tissue sites involved in osteochondral defects, 
the continuum of this complex architecture is difficult to simulate. Literature 
suggests that there have been numerous attempts especially involving hydrogels, 
reinforced hydrogels with different fillers and interpenetrating networks have been 
explored, however the suitability is limited. 
Within this study, I have been able to create hierarchical structures and based on 
the fabrication of multilayer scaffolds of the PVA-CMP as well as the dual network 
composites, a combination can be adopted to develop scaffolds for 
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osteochondral plug applications without the delamination at the interface. The 
scaffolds would comprise of two layers, the fabricated PVA-CMP or DNBG layer 
(emulating bone) and a second tough hydrogel layer (emulating cartilage). These 
new systems can be tailored to the physical and mechanical requirements to suit 
a scaffold for multi-layered structures as the osteochondral defect. Most 
importantly determination of the integration and strength between the two layers 
would enable an understanding of the force or load limits the scaffold can 
undergo without rupture at the interface.  
 
Figure 7-3: Illustration of the two layer composite to be fabricated, consisting of a 
composite and polymer layer. 
 
 Tissue engineering strategies are an advancing area in healthcare. Bone tissue 
engineering is a promising field and extensive research on both development of 
scaffolds and cell based technologies are being progressed to achieve clinically 
viable translation. To increase the clinical relevance of my study the next step will 
be to utilize the elastomeric properties of (PVA-CMP and DNBG) scaffolds and 
subject them to mechanical loading in a bioreactor whilst using perfusion to allow 
the transport of nutrients and oxygen through the cell seeded scaffolds. The 
bioreactor essentially is able to maintain a culture environment for the cells, 
however as the mechanical loading also plays a role on the behaviour of cells a 
simultaneous application of fluid flow and mechanical loading will help determine 
the relationship between mechanical loading, perfusion parameters, cell 
proliferation and differentiation to provide an insight into the feasibility and 
optimisation of the constructs prior to in vivo studies.  
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 The dual network hydrogel could be studied for further applications, such as 
wound dressings and wound healing applications. The benefits of using hydrogel 
based dressings for wound care, include provision of moisture to a dry lesion 
which in turn simplifies common healing phases such as granulation, epidermis 
repair and removal of excess dead tissue. Drug loaded hydrogel wound 
dressings also aide in providing pain relief to the patient during the healing 
process. A new type of dual network was developed within this study, a ductile 
and flexible material with an interconnected micro porosity. Drug release studies 
on the dual network hydrogels demonstrated the ability of the hydrogels to be 
loaded with drugs, and potential to function as drug delivery matrices. The initial 
linear followed by the slower drug release profile of the DN hydrogels would 
prove to be suitable for simultaneously irradicating an existing infection while 
preventing recolonisation of the wound by bacteria. The study also demonstrated 
that swelling ratio as well as tensile strengths of the DN hydrogels could be 
tailored for desired specific functions. Water uptake studies of the DN hydrogels, 
demonstrated that these hydrogels would be suited to absorb biological fluids 
such as PRP. This allows the hydrogels to play an enhanced role in simple yet 
effective methods of enhanced recovery, by allowing the retained growth factors 
in the scaffold to be delivered locally at the wound site and injured tissue area. If 
possible studies could be conducted using wound healing simulations to allow for 
a more accurate interpretation on the performance of the hydrogel, as well as 
highlighting areas which may need further improvements. 
 
 To further enhance the healing performance of the DN hydrogels and the DNBG 
composites, crosslinking of sodium alginates in the network could be carried out 
with different ions such as zinc or strontium. Zinc with trace elements found in the 
human body, has been demonstrated to have a beneficial effect on wound 
healing, with functions on the immune system, cell division as well as formation, 
mineralisation, development and maintenance of healthy bones. Strontium has 
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also been reported to have beneficial effects on bone regeneration, with potential 
as an anti-osteoporotic factor at low doses. Studies demonstrating the effect of 
using these ions to crosslink the alginate, on the resultant properties of the DN 
hydrogel and DNBG composite, would enable a clear understanding of the 
hydrogel and composite properties. Cell culture studies aimed at determining 
whether healing is enhanced due to the incorporation of these ions in the network 

























IN VITRO BIOMINERALISATION 
FTIR-ATR analysis 
 
Figure A-1: FTIR spectra non-porous 
DN10BG and porous DN10, 20BG 
composites fabricated by two cycles of 




































Figure A-2: EDX spectra of mineral deposition on both the non-porous and porous 
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